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ABSTRACT
Each individual experiences many sequential infections throughout the 
lifetime. An
increasing body of work indicates that prior exposure to unrelated pathogens can greatly
alter the disease course during a later infection. This can be a consequence of a
phenomenon known as heterologous immunity. Most viruses invade the host through
the mucosa of a variety of organs and tissues. Using the intranasal mucosal route of
infection, the thesis focused on studying modulation of lymphocytic choriomeningitis
virus (LCMV)-specific memory C08 T cells upon respiratory vaccinia virus (W) infection
and the role of these memory C08 T cells in heterologous immunity against Wand
altered immunopathology in the lung.
The W infection had a profound impact on memory T cells specific for LCMV.
The impact included the up-regulation of C069 expression on LCMV-specific C08
memory T cells and the activation of their in vivo IFN-y production and cytotoxic
function. Some of these antigen-specific memory T cells selectively expanded in number
resulting in modulation of the original LCMV-specific T cell repertoire. In addition, there
was a selective organ-dependent redistribution of these LCMV-specific memory T cell
populations in secondary lymphoid tissue (the 
mediastinal lymph node and spleen) and
the non-lymphoid peripheral (the lung) organs. The 
presence of these LCMV-specific
mempry T cells correlated with IFN-y-dependent enhanced W clearance
, decreased
mortality and marked changes in lung immunopathology. Thus, the participation of pre-
existing memory T cells specific for unrelated agents can alter the 
dynamics of mucosal
immunity. This is associated with an altered disease 
course in response to a pathogen.
V11
The roles for T cell cross-reactivity and cyokines in the 
modulation of memory
COB T cells during heterologous mem?ry COB T cell-
mediated immunity and
immunopathology were investigated. Upon W challenge
, there were preferential
expansions of several LCMV-
specific memory 
COB cell populations. This selectivity
suggested that cross-reactive responses played a role in this expansion. Moreover
, a W
peptide, partially homologous to LCMV NP 205, stimulated LCMV-NP205 specific COB T
cells, suggesting that NP205 may be a cross-reactive epitope. Poly I:C treatment of
LCMV-immune mice resulted in a transient increase but no repertoire alteration of 
LCMV-
epitope-specific COB T cells. These T cells did not produce IFN-
in vivo. These results
imply that poly I:C
, presumably through its induced cytokines
, was assisting in initial
recruitment of LCMV-specific memory COB T cells in a nonspecific manner. 
W challenge
of LCMV-immune IL-12KO mice resulted in activation and slightly decreased
accumulation of LCMV-specific COB T cells. Moreover
, there was a dramatic reduction of
in vivo IFN-y production by LCMV-specific IL-12KO COB T cells in the lung. I interpreted
this to mean that IL-12 was important to augment IFN-
y production by memory COB T
cells upon TCR engagement by antigens and to induce 
further accumulation of activated
memory COB T cells during the heterologous viral infection.
This thesis also systematically examined what effect 
the sequence of two
heterologous virus challenges had on 
viral clearance
, early cyokine profiles and
imlTunopathology in the lung 
after infecting mice immune to one virus with another
unrelated viruses. Four unrelated viruses
, (LCMV, W, influenza A virus or murine
cytomegalovirus (MCMV)), were used. There were many common changes observed in
the acute response to W as a consequence of prior immunity to any of three viruses
VIl
LCMV, MCMV or influenza A virus. These included the 
enhanced clearance of W in the
lung, associated with enhanced T 1 type responses with increased IFN-y and suppressed
pro-inflammatory responses. However
, immunity to the three different 
viruses resulted
in unique pathologies in the W-infected lungs
, but with one common feature
, the
substitution of lymphocytic and chronic mononuclear infiltrates for the 
usual acute
polymorphonuclear response seen in non-immune mice. 
Immunity to influenza A virus
appeared to influence the outcome of subsequent acute infections with any of the three
viruses, W, LCMV and MCMV. Most notably, influenza A virus-immunity protected
against W but it actually enhanced LCMV and MCMV titers. This enhanced MCMV
replication was associated with 
enhanced THI type response and pro-inflammatory
cytokine responses. Immunity to influenza A virus appeared to dramatically enhance the
mild lymphocytic and chronic mononuclear response usually 
observed during acute
infection with either LCMV or MCMV in non- immune mice, but LCMV infection and MCMV
infection of influenza A virus-immune mice each had its own unique features. Thus
, the
specific sequence of virus infections controls the outcome of disease.
TABLE OF CONTENTS
COPYRIGHT NOTICE................ ................................ ..... ................. ................. 
ACKNOWLEDG MENTS..... .......... .................. I" I""""'" 
..... 
I""""""""""""""'" IV
ABSTRACT I""'.' 1..1." I"" II' ... II.'." I'" II" II II 1.1.. ... .... ... II'. I.'...' II ...... II I" II ....... ... .... II. 
TABLE OF CONTENTS....... 1"..'..'.1.".'..'....'...'. .................. I..........'............"...'.. IX
LIST OF TABLES.........'."'......'I'...."'..'............'I.. I........ ....... I............................ 
LIST OF FIGURES ....... I...... ...........................'
............... ..... ...... .............. ...
XVI
ABBREVIATIONS 
..... ...........................................  ..... . ...... .  ..... 
CHAPTER I: INTRODUCTION. .......... ....................................................... ......... 1
Heterologous immunity and variability in pathogenesis of infections with
microorganisms. 
.. .. ...  ... .. ..... ...... ......
The biology, genetics and pathogenesis of LCMV, W, influenza virus and MCMV....
C. The host immune responses to viral infections and virus- induced immunopathology.
....................................................................................................................... 5
O. Antigen recognition and activation of T cells........................................................ 7
COB T cell response to viruses and its role in antiviral immunity and
immunopathology during viral infections. ............................................................ 9
Memory COB T cells and their role in antiviral immunity and immunopathology
during viral infections............. 
. .  .  
G. T cell cross-reactivity and its possible role in the activation of memory COB T cells.
............................................................................. ........................................ 16
H. Antigen-independent Tcell stimulation by cytokines and its possible role in the
activation of memory COB T cells. ....................................................................
Modulation of memory C08 T cells during sequential viral infections. ..................
T cell-mediated heterologous immunity and immunopathology. 
.......................... 25
Mucosally transmitted respiratory viral infections and immune system in the lung.
The respiratory heterologous viral infection of C57BL/6 mice, as a model system to
study heterologous mucosal immunity. 
................................................. ............
M. Objective of the thesis..................................................................................... 31
CHAPTER II: MATERIALS AND METHODS ......................................................
Mice............................................................ ..................................................
Viruses........................................................................................................... 32
Cell lines ..... 
............................... ........  .
O. Infection protocol........................................................................................... 33
Synthetic peptides 
. .............. ................................ .............
Plaque assay. .............. 
.................................. ................................................. 35
G. . Spleen and lymph node cell preparation............................................................ 36
H. Isolation of lung lymphocytes............................................... ...........................
Limiting dilution assay (LOA)............................................................................ 37
Flow cytometry............................................................................................... 38
Peptide-induced intracellular IFN-y staining 
 
H2D and H2K IgG1 MHC dimer staining and modified intracellular staining of 
vivo IFN-y 
...................................................................................................... 39
M. NP205-specific H2K IgG1 MHC dimer or H2K MHC tetramer staining and peptide-
induced intracellular IFN-y staining................................................................... 40
Direct ex vivo cytotoxicity assay.... ..... 
 
O. Cytokine RNase protection assay.. ....................................................................
Cytokine ELISA............................................................................................... 43
Q. Depletion of NK cells in vivo............................................................................. 
R. In vivo IFN y depletion.................................................................................... 45
S. Adoptive transfer............................................................................................ 45
Lung histological evaluation............................................................ ................. 45
U. Immunohistochemistry staining........................................................................ 46
V. In situ MHC-tetramerjdimer staining and confocal laser scanner microscopy (CLSM)
of lung tissue sections..................................... ................................................
W. Statistical analysis........................................................... ................................ 47
CHAPTER III: MODULATION OF LCMV-SPECIFIC MEMORY CDS T CELLS AND
THEIR POTENTIAL ROLE HETEROLOGOUS IMMUNITY AND
IMMUNOPATHOLOGY IN THE LUNG AGAINST 
W ................................. 
Respiratory infection of C57BLj6 mice with LCMV or W.....................................
Prior respiratory exposure to LCMV provides protection against a lethal W
challenge.................................. 
..................................................................... 54
C. Time course of protective immunity to W in LCMV- immune mice........................ 54
O. Adoptively transferred LCMV-immune splenocytes into na"ive mice provide
protection against W challenge....................... 
............................................... 56
E. High frequencies of LCMV-specific memory COB T cells in lymphoid and peripheral
tissues long after respiratory LCMV infection ... ........ ....... 
............. ......... ............. 
Organ-specific accumulation of LCMV-specific memory COB T cells after W
challenge........ ............................... ..................... ...........................................
XlI
Repertoire alteration in LCMV-specific memory C08 T cells in organ-specific manner
after W challenge............................................................................ ...............
H. Up-regulation of early activation marker C069 on LCMV-specific C08 T cells in the
infected LCMV- immune mice....................................................................... 69
Cytolytic function in LCMV-specific memory C08 T cells after W challenge .......... 72
A modified intracellular IFN-y assay directly visualizes activation of LCMV-specific
memory C08 T cells in vivo by W early in infection ...........................................
Enhanced IFN-y production in LCMV-immune mice early after W challenge ......... 81
An important role for IFN- in mediating protective immunity to in LCMV-
immune mice................................................................................................. 83
M. Altered immunopathology in W- infected LCMV-immune mouse lungs 
................. 85
Bronchiolitis obliterans and BAL T persist in the LCMV- immune mouse lungs long
after W challenge........................................................................................... 88
O. In vivo depletion of IFN-y results in severe pulmonary edema and no induction of
BAL T in W- infected LCMV-immune mice.......... 
..................... ............................ 94
Detecting in situ LCMV-specific C08 T cells in BAL T of W- infected LCMV-immune
mouse lung by using MHC tetramer and confocal laser scanner microscopy......... 96
Q. Brief summary.................................................... ..... .......................................
CHAPTER IV: THE MECHANISMS INVOLVED IN ACTIATION AND
MODULATION OF MEMORY CDS T CELLS DURING THE HETEROLOGOUS VIRAL
IN FECTIONS................................................................................ ................. 100
Alteration of LCMV-specific memory C08 T cell repertoire after W challenge ..... 101
NP20S-cross-reactive W peptides stimulate LCMV NP205-specific C08 T cells.... 103
X1l
Poly I:C induces up-regulation of C0122 and CD69 on COB T cells and a transient
increase in LCMV-specific COB T cells in LCMV-immune mouse lungs................. 109
O. Poly I:C causes no alteration of LCMV-specific COB T cell repertoire and no in vivo
IFN y production in LCMV-immune mice.......................................................... 112
Frequency and repertoire of LCMV-specific COB T cells in IL-12KO LCMV-immune
mouse lungs...................................................................................
.............. 114
Up-regulation of C069 and C044 but not C0122 on COB T cells in LCMV-immune
IL -12KO mice............................................................................................... 117
G. Accumulation of LCMV-specific COB T cells in W- infected LCMV- immune IL-12KO
mice. 
........................................................................................................... 
120
H. The role of IL- 12 in IFN-y production by LCMV-specific COB T cells upon antigenic
stimulation................................................................................................... 122
Brief summary to Chapter IV......................................................................... 126
CHAPTER V: THE SEQUENCE OF INFECTIONS WITH DIFFERENT VIRUSES
DETERMINES THE PAITERN ANTIIRAL IMMUNITY AND
IMMUNOPATHOLOGY IN THE LUNG ............................................................. 128
Respiratory infection of C57BLj6 mice with LCMV
, influenza A virus or MCMV .... 12B
B. The sequence of heterologous virus infections determines whether viral clearance is
enhanced or impeded............................................................... ..................... 129
C. The sequence of heterologous virus infections determines the cyokine profile... 135
O. Distinctive lung pathology during acute respiratory infection of non- immune mice
with LCMV, MCMV, influenza A virus, or W ..................................................... 139
XIV
Alterations in W- induced lung pathology is dependent on the specific history of
heterologous virus exposure............................................................. ............. 144
F. Prior immunity to influenza markedly enhances the usual mild chronic mononuclear
responses in the lung upon acute LCMV or MCMV infection 
.............................. 
155
G. Brief summarY and discussion 
..........................................
156
CHAPTER VI: DISCUSSION 
.......  ........  ... ....  
..................... .... 160
A. The frequency and hierarchy of virus-specific memory C08 T cells in lymphoid and
non- lymphoid organs of mice with a respiratory viral infection 
.......................... 
161
Dynamic modulation of memory C08 T cell repertoire specific to one virus during a
heterologous viral infection......... 
................. i.. ...... 
 
164
C. The roles for T cell cross-reactivity and cytokine and chemokine mileu in activation
and modulation of virus-specific memory C08 T cells during heterologous viral
infections. 
.......................  ............. ..  
168
O. Altered pathogenesis to a virus in association with virus- induced modulation of
memory C08 T cells specific for another unrelated virus................................... 179
The sequence of infections with different viruses determines the consequences of
antiviral immunity and immunopathology in the lung 
 
182
New aspect of heterologous immunity in mouse and human diseases .............. 190
G. Conclusions.................................................................................................. 193
CHAPTER VII: REFERENCES 
............................. ............................................ 196
Table 1
Table 2
Table 3
Table 4
Table 5
Table 6
Table 7
Table 8
Table 9
Table 10
LIST OF TABLES
Some known epitopes aligned in mice......... ............. .............. 
................ 10
Kinetics of viral clearance from normal C57BLj6 mice. 
............................. 50
Prior immunity to LCMV lowered W titer during the course of a sub- lethal
Ln. challenge.. 
.................. ........ .............. ......... .........;............... ......
Adoptively transferred splenocytes containing LCMV-specific memory T cells
into na"ive mice provide protection against W challenge. .........................
A respiratory LCMV infection induces a high frequency of C08+ memory
cells in mouse spleens, compared to LCMV i.p. infection as determined by
LOA. 
............................. ................ ...................... ......... ....................... 59
Increased C069 expression on LCMV epitope-specific memory C08 
T cells 
vivo early after W infection..................................................... ............. 71
Production of IFN-y in vivo in the LCMV-immune mice 3 days after 
challenge... 
............ ...... . . .... . ....... .  .
In vivo IFN-y production by LCMV epitope-specific memory C08 T cells in
the lung after W challenge.... ............ ............. ................ ......................
Enhanced titers of in the LCMV- immune mice on treatment with anti-
IFN-y mAb. 
.......................................................................................... 84
Altered Immunopathology in the Ln. W-infected LCMV-immune lungs...... 87
Table 11a Altered Immunopathology persists in the LCMV-immune lungs long after 
challenge................................................... ..........................................
XVI
Table llb Presence of BAL in the lungs of LCMV- or W-immune mice after
Table 12
Table 13
Table 14
Table 15
Table 16
Table 17
Table 18
Table 19
Table 20
Table 21
homologous viral challenge. ..................................................................
IFN- producing C08 T cells in response to W pi, p10, and p24 stimulation
and LCMV NP205-specific C08 T cells in response to W pi stimulation after
W challenge of LCMV- immune mice .................................................... 107
No in vivo IFN-y production by LCMV-specific C08 T cells in Poly I:C-treated
LCMV-immune mice............................. ........... .................... ................ 116
In vitro IL -12 treatment enhances peptide induced IFN-y production by
LCMV-specific C08 T cells from LCMV- immune mice.............................. 125
Previous heterologous viral infections protected against W ................... 130
Prior immunity to influenza A virus can enhance or impede viral clearance
........................................................................................................ 
131
Heterologous immunity between viruses in the lung .............................. 134
An acute respiratory infection with 4 different viruses causes distinct
immunopathological changes in the lung............................................. 141
Prior heterologous virus exposure induces variations in enhanced chronic
mononuclear responses in W-infected mouse lungs.............................. 147
Prior immunity to influenza A virus enhances the usual mild chronic
mononuclear infiltrates in the lung upon LCMV and MCMV infection........ 151
The sequence of heterologous virus infections influences viral clearance
early cytokine profiles and histopathology in the lung............................ 157
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
XVll
LIST OF FIGURES
Decreased mortality of LCMV-immune mice challenged intra 
nasally with a
lethal dose of W as compared to the age-
matched control mice. .............
Immunity to LCMV provides protection against respiratory W infections. ..
LCMV-specific memory C08 T cells in resting LCMV-immune mice. ...........
Persistence of LCMV epitope-specific memory C08+ T cells in lungs and
MLNs of resting LCMV-immune mice and during Ln. 
W infection.............. 64
Organ-specific accumulation of LCMV-specific 
memory C08 T cells after W
challenge............................................................................................. 66
Alterations in the LCMV-specific C08+ T cell repertoire in the W-infected
LCMV-immune mouse MLN and lung................................ ................ ......
Increased C069 expression on LCMV-specific memory C08 T cells early after
infection. 
.................................... ..................... ...............................
Activation of LCMV-specific cytolytic activity in lymphocytes isolated from
the lungs and spleens of LCMV-immune mice 6 days after Ln. W challenge.
..................................................................................... ..................... 73
in vivo IFN- producing cells in the LCMV- immune mouse lungs 3 days after
W challenge........................................................................................ 76
Increased in vivd' IFN-y production by LCMV-specific C08 memory T cells
early after W infection. ...................... ..................................................
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
XVlI
Increased IFN-y in LCMV-immune mice after challenge as assessed by
(a) an RNase protection assay of cytokine mRNA levels in the lung tissue
and (b) an ELISA assay that measured IFN-y in pooled sera. 
................... 82
Enhanced lymphocytic infiltration in the lungs of LCMV- immune mice after
infection with W.................................................................................. 86
The predominant infiltrates in the BAL T of the LCMV- immune mouse lung
challenged with Ware T cells. .. ........ 
............................................. ...... 
Severe edema and impaired lymphocyic infiltration in the lungs of W-
infected LCMV-immune mice upon treatment with anti-IFN-y mAb............ 95
In situ detection of LCMV epitope-specific C08 T cells in lung tissue with
NP396-specific tetramer..................... ...................................................
Figure 16 Alteration of LCMV-specific C08 memory T cell repertoire in W-infected
Figure 17
Figure 18
Figure 19
Figure 20
Figure 21
Figure 22
LCMV-immune mouse lung. 
............... ................   . . 
102
NP205-crossreactive W peptides........................................................ 104
W peptides cross reactivate LCMV NP205-specific C08 T cells. .............. 106
Poly I:C-induced up regulation of C0122 and C069 on C08 T cells in LCMV-
immune mouse lungs. 
................... ....... .  
111
Poly I:C-induced transient increase in LCMV-specific C08 T cells in LCMV-
immune Mice. 
.....................  
113
Poly I:C causes no alteration of LCMV-specific C08 T cell repertoire in LCMV-
immune mice..................................................................................... 115
Frequency and repertoire of LCMV-specific memory CDS T cells in the lung
(a) and MLN (b) of resting LCMV- immune IL-12KO mice........................ 118
figure 23
XIX
Phenotypic changes on C08 T Cells in W- infected LCMV- immune IL-12KO
mouse Lungs. ... 
................................................................................. 
119
Eigure 24 Accumulation of LCMV-specific C08 T cells in the W- infected LCMV-immune
IL- 12KO mice...... .....,.. ........ ...... 121
Figure 25
Figure 26
Figure 27
Figure 28
Figure 29
Figure 30
Figure 31
Reduced in vivo IFNy production by LCMV-specific C08 T cells in W-infected
LCMV- immune IL-12KO mouse lungs. .................................................. 123
In vitro IL-12 treatment enhances peptide-induced IFN-y production by
LCMV-specific C08 T cells from LCMV-immune mice. ............................. 124
Cytokine profile alteration during heterologous virus infections varies
depending on the specific virus infection sequence. .............................. 136
Lung immunopathology varies depending on the infecting virus and can be
further dramatically altered by prior immunity to heterologous viruses.... 140
Pattern of chronic mononuclear infiltrates in W- infected mouse lungs vary
depending on prior heterologous virus exposure. 
 
145
Prior immunity to influenza A virus markedly enhances the usual mild
chronic mononuclear infiltrates in the lung upon LCMV- and MCMV-infection.
.... .... . ...... ............ .  ...........  .......... ..........  
.... 150
Unique immunopathology in MCMV- infected mouse lungs induced by prior
immunity to influenza A virus. 
................. ................. ....... 
153
ABBREVIATIONS
amino acid
AMI acute mixed infiltrates
APC antigen-presenting cell
BAL bronchial alveolar lavage
BALT Bronchus-associated lymphoid tissue
BCG bacilus Calmette-Guerin
bronchiolitis obliterans
calcium
CCR7 CC chemokine receptor 7
CFSE carboxyuorescein succinimidyl ester
CMI chronic mononuclear infiltrates
CMV cyomegalovirus
cpm counts per minute
CTL cytotoxic T lymphocyes
CXCR CXC chemokine receptor
E:T effector to target ratio
EAE experimental autoimmune encephalomyelitis
EBV Epstein-Barr virus
EUSA enzyme- linked immunosorbant assay
FasL Fas ligand
FCS fetal calf serum
XXI
=Elu influenza A virus
GALT
GAPOH
gut-associated lymphoid tissue
glyceraldehyde- 3-phosphate dehyd rogenase
glycoprotein
H+E hematoxylin and eosin
hemagglutinin
HCV hepatitis C virus
HIV human immunodeficiency virus
HLA human leukocyte antigen
HSV herpes simplex virus
Ln. intranasal
intraperitoneal
intravenous
ICOSL immunocostimulatory signaling ligand
immediate early
IFN- interferon-gamma
immunoglobulin
interleukin
kilo Dalton
knock-out
LAl linker for activation ofT-celis
LCMV lymphocytic choriomeningitis virus
LOA limiting dilution assay
matrix
mAb monoclonal antibody
MAPK mitogen-activated protein kinase
MBP
myelin basic protein
MCMV
murine cytomegalovirus
MCP monocye chemoattractant protein
MEKK MAPK extracellular signal-regulated kinase 
kinase
MFI mean fluorescent intensity
MHC major histocompatibilty complex
MIP macrophage inflammatory protein
MLN mediastinal lymph node
mononuclear
MOl
multiplicity of infection
mRNA messenger RNA
neuraminidase
necrotizing bronchiolitis
not done
No. number
NOD
non-obese diabetic
nucleoprotein
pCTL
PFU
CTL precursors
plaque-forming unit
PMN pOlymorphonuclear
XXll
XX11
poly I:C poly inosinicfcyidylic acid
Pichinde virus
RsV respiratory syncytial virus
TCR T cell receptor
T help type
TMEV Theiler s murine encephalomyelitis virus
TNF tumor necrosis factor
vsv vesicular stomatitis virus
Wp1 vaccinia virus peptide 1
vaccinia virus
wild type
CHAPTER I
INTRODUCTION
Heterologous immunity and variabilty in pathogenesis of
infections with microorganisms. Infections with microorganisms can run markedly
different courses in different individuals
, ranging from subclinical to clinical or nonlethal to
lethal. This variabilty in responsiveness is related to the dose of pathogen, its route of
infection, as well as the genetics
, physiological state, and immune status of the host.
Heterologous immunity, or protection by one invading organism against another unrelated
pathogen, has been recognized in bacterial infectons and parasitic malaria infections for
decades (Clark et aI. , 1976; Cox, 1970). However, in those cases, heterologous immunity
has been often referred to as a phenomenon occurring between concomitant infections
, in
which pro-inflammatory cyokines and nitric oxide produced by macrophages are important
players (Clark, 2001). Another situation
, different from concomitant infections, is when
individuals experience many sequential infections throughout their lifetime. 
Until recently,
research into anti-viral immune responses in animal models has focused on studying host
that were infected with one virus and sheltered from other 
environmental pathogens.
However, evidence is gradually accumulating to suggest that prior immunity to
heterologous pathogens can have a significant impact on the outcome of each new
infection. An example of this in human disease is dengue fever
, for which a severe shock
syndrome can arise if a host that has been exposed previously to one of the four dengue-
virus serotypes is later exposed to a second serotype (Halstead
, 1989; Mathew et aI.
1998). The earlier work conducted in our laboratory has clearly shown with intraperitoneal
(i.p.) systemic viral infectons that memory T cells generated in response to one virus can
indeed alter the course of disease caused by unrelated viruses (Selin et aI.
, 1998). This
phenomenon has been termed T cell-mediated heterologous immunity.
The biology, genetics and pathogenesis of LCMV, W, influenza
virus and MCMV. Infections of mice with lymphocyic 
choriomeningitis virus (LCMV),
vaccinia virus (W), influenza A virus or murine cyomegalovirus (MCMV) have proven to
be some of the most important model systems for the study of the immune response to
viral infections and viral diseases in human. Research presented in this thesis utilzed the
mouse models of infections with these four viruses to study heterologous immunity.
Studies in the model of LCMV infection have laid the basis for many seminal
concepts of immunology, the discovery of two of which resulted in the 1960 and 1996
Nobel prizes in Medicine (Burnet FM, 1949; Zinkernagel and Dohert, 1974). LCMV is the
prototype virus of the arenavirus family, which consists of ambisense enveloped RNA
viruses. Of the two ambisense RNAs of LCMV, the small 23S S RNA encodes the 63-
nucleoprotein (NP) and the 75-kd glycoprotein, which is cleaved into the virion surface
glycoproteins GP1 and GP2 (Buchmeier et aI. , 1978). The larger 31S L RNA encodes a
200-kd L protein , which serves as an RNA-dependent RNA polymerase, and a small 11-
kd zinc binding Z protein (Salvato et al.
, 1992; Salvato and Shimomaye
, 1989). Alpha-
dystroglycan has recently been identified as the receptor for LCMV and some other
arenaviruses (Cao et aI., 1998). This ubiquitous receptor allows LCMV to infect a wide
variety of hosts, including mice, humans, chimpanzees, and hamsters. The LCMV
infection is relatively non-cytopathic, and the LCMV infection in human can either be
subclinical or else present as a nonmeningeal grippe- like ailment or a moderate to
severe meningitis (Welsh, 2000). Several strains have been isolated for laboratory use
since the 1930's. The strain used most in this thesis is the Armstrong strain
, which was
originally derived from a monkey that was suffering from lymphocyic choriomeningitis.
Infection of adult immunocompetent mice with strain Armstrong leads to viral clearance
and life long immunity. Occasionally used in this thesis is the clone 13 variant that
differs from the Armstrong strain by only two amino acids (Salvato et aI.
, 1991). These
changes result in an increased ability to infect macrophages and increased replication in
infected cells (Matloubian et aI., 1993).
is a member of the family Poxviridae which comprises a group of complex
animal DNA viruses (Wittek, 1999). Poxviruses are among the largest and most complex
viruses known. W virions contain a large double-stranded DNA genome that consists 
about 192 kb. The DNA sequence of the viral genome provides evidence for the
presence of about 200 potential protein-coding sequences. The genome encodes
many enzymes and structural proteins for its infection cycle. W is cytolytic, has a very
broad host range and can infect most vertebrate animals. Although W is not associated
with a naturally occurring disease in humans, it is used as a smallpox vaccine and the
serious complications of smallpox vaccination
, a phenomenon called progressive
vaccinia, occur at very low frequency. The strain used in this thesis is the Western
Reserve (WR) laboratory strain.
The highly contagious acute respiratory ilness known as influenza has afficted
humans since ancient times (Webster, 1999). Influenza A virus belongs to the
Orthomyxoviridae family of RNA viruses. It has eight segmented negative-strand RNA
genomes enclosed in a lipid envelope derived from the host cell. There are
..,
hemagglutinin (HA), enzyme neuraminidase (NA) and ion channel M2 proteins in the
envelope. Beneath the lipid envelope is a membrane or matrix (M) protein 
surrounding a
helical complex containing the nucleoprotein (NP) and three polymerase proteins.
Influenza A virus commonly causes disease in humans
, pigs horses, and occasionally in
birds. It can be also adapted to experimental 
animals such as mice. The virus replicates
in the mouse upper and lower respiratory tract and
, after adaptation
, can cause
pneumonia and death. The strain used in this thesis is 
AjPRj8j34 (Hi Nl).
CMVs, the prototype members of the l3-herpesvirus subfamily of the
Herpesvin"dae family, are widely distributed in nature. Many animal species have an
associated CMV which exhibits exquisite 
species-specificity. These viruses infect for life
and are readily isolated from salivary gland explants. The importance of CMV as a
human pathogen has increased
, as immunosuppressive post-transplant therapies and
AIDS, as well as other immunodeficiency states
, have come to the forefront of medicine.
MCMV is a surrogate for studying human CMV-associated pathogenesis (Staczek
, 1999).
DNA sequencing of the Smith strain (used in this thesis) genome reveals 230 kb. 
Like
MCMV encodes its own enzymes and structural proteins for its infection cycle.
Infected cells display a cytopathology that is 
characterized by the enlargement
(cytomegaly) of the cell. Strain variation influences disease presentation and recovery.
Most laboratory strains of MCMV are descendents from the 
original Smith strain isolated
in 1934. Immunocompetent mice manifest minor illness when inoculated with a
sublethal dose. Resolution of the productive infection need not clear virus 
from organs
such as salivary glands
, which become chronically infected in either a persistent or 
latent
manner.
The host immune responses to viral infections and virus-induced
immunopathology. During the early stages of infection with viruses such as LCMV
W, influenza A virus or MCMV, various components of host natural immunity play roles
in maximizing the effectiveness of the natural immune system and initiating the specific
immunity against viruses. The components of host natural immunity include humoral
factors (e.g. natural antibodies and complement), preexisting and inducible anti-viral
cytokines and chemotactic factors (e.
g. type I and II interferons, IL-l, IL-6, TNF- , IL-
, MIP, MCP, and IL -8) produced by virus- infected macrophages or other cells
, and
peptide defensins made by neutrophils
, as well as other components of the acute phase
response (Welsh and Sen, 1997). Natural kiler (NK) cells represent an early host
response mechanism particularly suited to control viral infections such as MCMV
(Bukowski et aI.
, 1984). yeS T cells also playa role against viruses such W
, HSV and
influenza A virus (Carding et aI.
, 1990; Rakasz et aI.
, 1999; Selin et aI. , 2001; Welsh and
Sen, 1997). Of note
, there are redundancies of the components of natural immunity.
Different effector systems may have greater or lesser 
significance against a given virus.
In addition, the rapidly mobilized response by memory cytotoxic T lymphocytes (CT)
may be able to contribute to the natural resistance against virus by more specific
mechanisms. This wil be one of the major topics in this thesis (see below).
Viral infections are dealt with largely by the specific 
adaptive humoral and T cell-
mediated immune responses in which effector T lymphocyes and secreted
immunoglobulin (Ig) molecules eliminate infected cells and neutralize free virions
respectively (Dohert and Ahmed
, 1997). Continuous antibody production lasts for
months (influenza A virus
, up to 1 year in human) to many years (W
, up to 30 years in
Ruman). In the long term, LCMV-specific plasma cells are found at highest frequency in
mouse bone marrow (Slifka et al., 1995). However, LCMV-specific neutralizing antibodies
are generated rather late, i.e., after 1 to 3 mo (Battegay et al., 1993b). Upon secondary
viral infection, pre-existing antibody provides the first line of defense against reinfection
(Thomsen and Marker, 1988; Wells et aI. , 1979). C04 T cells are potent regulators of
the immune system as a consequence of the cyokines they produce. During the acute
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infection with a virus, C04 T cells may act as effector cells through the secretion of anti-
viral cyokines such as IFN-y and TNF-a (Biron , 1994; Dohert et aI., 1997; Lucin et al.
1992; Zinkernagel , 1996). Providing B cells with the help necessary to produce anti-viral
antibodies is one of the primary roles C04 T cells play during virus infections (Bachmann
and Zinkernagel, 1996; Dohert et aI., 1997; Graham and Braciale, 1997; Jonjic et al.
1989). The role of C04 T cells in the induction of the virus-specific C08 T cell response
varies between experimental systems. C08 CTL responses to VSV, certain subtypes of
influenza A virus, and Ware significantly diminished in mice that lack CD4 T cells
(Battegay et aI. , 1996; Leist et a/. , 1989; Tripp et aI. , 1995b), whereas the C08 T cell
response to an acute LCMV infection seems to be less dependent on C04 T cells (Ahmed
et aI., 1988; Nahil and Welsh , 1993). LCMV, influenza A virus, CMV and W, like many
other viruses, are potent inducers of C08 T cell responses. These virus-specific CTL
responses are important for clearance of these viruses and recovery from infection
(Byrne and Oldstone, 1984; Flynn et aI. , 1998; Koszinowski et al. , 1987; Spriggs et aI.
1992). Increased frequency of virus-specific memory T cells and ability of these cells 
rapidly proliferate and develop into effector T cells provides a highly effective second
line of defense against re-infection. This will be one major object of this thesis.
Although viruses like W, influenza A virus, and MCMV can cause disease directly
through their cytopathic effects, which lead to cytolysis necrosis or apoptosis of host
target cells protection by immune mechanisms is often accompanied by
immunopathology. For example, during a viral infection, the inflammatory responses
induced by components of the innate and adaptive immune systems play roles in
defense against viruses but also contribute to many of the symptoms of disease.
Although LCMV is relatively non-cyopathic, the LCMV-induced potent T cell responses
which are importance to control viral clearance
, cause severe immunopathology 
targeted organs of their host (Zinkernagel and Dohert, 1975). This wil be another
major topic of this thesis.
Antigen recognition and activation of T 
cells. T cells playa central
role in the immune response to many virus infections (Dohert et aI. , 1992; Zinkernagel
et aI. , 1996). The majority of mature T cells express a T cell receptor (TCR), which is a
membrane-bound heterodimer composed of and f3 chains (Fields and Mariuzza, 1996).
T cells that express a/f TCR can be divided into cells expressing either C08 or C04
surface antigens. T cells must have antigen presented to them in the context of a major
histocompatibilty (MHC) class I molecule
, in the case of C08 T cells, or in the context of
a MHC class II molecule, in the case of C04 T cells.
In the mouse there are 3 different MHC class I molecules, referred to as H2K, 0
L. Each of these molecules comes in many different allelic forms
, each with cleft on its
surface for the presentation of a wide variety of peptides predominantly generated from
intracellular proteins (e.g. viral proteins synthesized in infected cells) by a process called
antigen processing. There are motifs that govern the sequence of the various peptides
that a given MHC molecule may bind. For example, the H20 binding motif is
characterized by a peptide sequence of 9-11 amino acids with two anchors: Asn at
position 5 and an hydrophobic C-terminal residue (Met, lie, Leu), while the H2K
molecule binds octomers that have an aromatic amino acid at position 5 and a
hydrophobic amino acid at position 8 (Falk et al. , 1991).
Activation of na'ive T cells requires two signals. Signal one is received through
the TCR after engaging its cognate peptide-MHC complex on an APC (Schwart, 1985).
The affnity of TCR for MHCjpeptide complexes is relatively low, being in the order of
10- to 10- M (Corr et al. , 1994). Studies with C04 T cells have shown that a threshold
of approximately 8 000 TCRs must be triggered before T cell activation takes place
(Viola and Lanzavecchia , 1996). However, the second costimulatory signal provided by
one or more distinct APC surface molecules (e.g. B7. 1jB7.2 and ICOS) interacting with
coreceptors on the T cells (C028 and ICOSL) (Sharpe and Freeman, 2002) can lower the
activation threshold to 1 500 TCRs (Viola and Lanzavecchia, 1996). Signals mediated
through C040L-C040 and C0137 (4-1BB)-C0137L interactions can further enhance
interactions between a T cell and an APC (Grewal and Flavell , 1998; Halstead et al.
2002). It has been shown that a single peptidejHLA-OR complex is capable of triggering
up to 200 TCRs in a serial fashion (Valitutti et aI. , 1995), and that a peptide only needs
to occupy less than 0.08% of the total 258 000 H20 molecules present on the surface
of a cell in order to stimulate a T cell (Christinck et aI., 1991). At the immunological
synapse, the rapidly formed area of contact between a T cell and an APC, membrane
molecules are organized in supra molecular clusters with short molecules, such as TCR-
C03-t; complex, C02 and C028, in a central region and large molecules, such as LFA-1
and C045, in a peripheral ring. TCRs are continuously internalized and recycled. Those
that are engaged by peptide-MHC are tethered into lipid raft microdomains
, which
contain kinases (LcK) and adapters (LAT), and initiate the signaling cascade (Cherukuri
et al. , 2001; Kane et aI. , 2000; Lanzavecchia and Sallusto
, 2001). However
, a recent
report showing that TCR signaling precedes immunological synapse formation challenges
current ideas about the role of immunological synapse in T cell activation (Lee et aI.
2002). In addition, C08 can act as a coreceptor, stabilzing the TCRjMHC-peptide
complex and amplifying signals, or it can act as an adhesion molecule (Daniels et aI.
2001). The second messengers, diacylglycerol and inositol 1 5-trisphosphate, can
increase intracellular Ca++
, leading to the activation of calcium-dependent kinases that
then further phosphorylate other proteins
, producing the changes in transcriptional
regulation that result in T cell activation.
CDS T cell response to viruses and its role in antiviral immunity
and immunopathologV during viral infections. Virus-specific C08 T cell responses
are important for the immunologic control of viral infections (Dohert et al., 1997; Gairin
and Oldstone, 1992; Reddehase et aI.
, 1987). The hierarchies of virus-derived CTL
epitopes have been defined in numerous viral systems. In C57BLj6 mice
, four H20
- and
three H2K restricted CTL epitopes have been defined for LCMV; five are contained
within the glycoprotein (GP33-
, GP34- , GP92-101 , GP118-125 and GP276-286) and
two are within the nucleoprotein (NP396-404 and NP205-212; Table 1) (Gairin et aI.
1995; Hudrisier et aI. , 1997; van der Most et aI. , 1998; Whitton et al.
, 1988). The
NP396, GP33, GP34 and GP276 epitopes are considered immunodominant
, whereas
NP205, GP118 and GP92 are subdominant. In B6 mice
, two H20 restricted and two
Table 1. Some known epitopes aligned in mice
Epitope Sequence MHCI
restriction
NP396-404
GP33-
GP276-286
GP92-101
GP34-
NP205-212
GP118- 125
Flu APR8 NP366-374
PA224-233
NS2114-121
M 112-135
MCMV
IElpp89
168-176
m04 pp34
243-251
M84 pp65
297-305
m164
257-265
References: see page 9 and 11.
Underlined amino acid residues: D or K binding motifs
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-restricted CTL epitopes have been defined for influenza A pr/8/34
, contained
- ithin the nucleoprotein (NP366-374), the polymerase (PA224-233), the nonstructural
protein (NS2114-l2) and the matrix protein (M1 128 '13S, Table 1) (Belz et aI. , 2000; Flynn et
al., 1998; Townsend et aI., 1985; Vitiello et aI., 1996). Four H2
-restricted MCMV-
specific C08 T cell epitopes have been defined in Balb/c mice (Table 1) (Holtappels et
aI., 2000b; Holtappels et aI., 2002; Holtappels et aI.
, 2000c; Reddehase
, 2000;
Reddehase et aI., 1989), but no W-specific C08 T cell epitope has been fully
characterized. However, our laboratory has found that three W peptides which could
be potential C08 T cell epitopes, stimulate C08 T cells from W-infected mice to produce
IFN-y (Figure 23, and Selin et aI., unpublished data).
The dissection of C08 T cell-mediated immunity has greatly been facilitated due
to the recent development of advanced techniques for staining antigen-specific C08+ T
cells with MHC tetramers (Altman et al.
, 1996) and dimeric MHC-IgG chimeras (Oal
Porto et aI., 1993), or examining the functionality of individual T cells with peptide-
induced intracellular cytokine stains and EUSPOT assays (Dohert and Christensen
2000; Openshaw et aI. , 1995). Consistent with previous studies demonstrating minimal
virus-induced bystander expansion of T cell populations (Zarozinski and Welsh
, 1997),
these new approaches have shown that the majority of the proliferating CD8 T cells
elicited by LCMV or influenza A virus infection are virus-specific (Butz and Bevan
, 1998;
Flynn et aI., 1998; Murali-Krishna et aI.
, 1998; Selin et aI., 1999). The CD8 T cell
response to a virus is divided into three segments
, beginning with the activation and
proliferation of C08 T cells
, continuing with the effector phase, and ending with the
silencing of the response (Selin et aI. , 2000; Welsh et aI. , 1997). Recent studies suggest
- that the proliferation and differentiation program is predetermined and can be initiated
by only brief contact with the APC (Kaech and Ahmed
, 2001; van Stipdonk et aI.
, 2001).
. Due to independence of the magnitude of expansion
, dose and duration of infection or
amount of antigen displayed the onset and kinetics of C08 T cell contraction may also
be programmed early after infection (Badovinac et aI.
, 2002). Following the expansion of
T cells, the repertoire of virus-specific T cells is significantly altered
, and the altered
profile is maintained in the memory T cell repertoire (Bousso and 
Kouri/sky, 1999; Lin et
a/., 2000; Lin and Welsh
, 1998). After the priming of 
virus-specific T cells within
secondary lymphoid organs (spleen and draining lymph nodes), T cells express
chemokine receptors that induce them to leave the lymphoid tissue and migrate to
peripheral infection sites
, where inflammatory chemokines are being synthesized (Price
et aI., 1999; Sallusto et aI.
, 2000). It has been shown that activated T cells
, once
recruited
, are mostly retained as nondividing 
cells in non lymphoid tissues (Harris et a/.
2002). However
, a small population (10%) of Ag-specific C08+ T cells is maintained in
the lung airways by homeostatic proliferation and migration to lung airways from 
the
lymphoid organs after viral clearance (Hogan et aI.
, 2002).
The potent C08 T cell response can not only effciently clear virus but also
induce substantial immunopathology. LCMV induces a potent C08 T cell response
, in
which at least 40% to 60% of the C08 population is LCMV-specific (Murali-Krishna et a/.
1998), leading to clearance of virus. LCMV persists in mice devoid of C08+ T
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lymphocytes as a result of disruption of the beta 2-
microglobulin gene (Lehmann-Grube
et aI., 1993). The same T cells responsible for viral clearance can mediate 
a severe
leptomeningitis if the virus is replicating in the brain (Dohert and Zinkernagel
, 1974;
Zinkernagel and Dohert, 1975).
In influenza A virus infection of mice
, 20% of the C08 population in the
bronchoalveolar lavage is influenza A virus NP366-specific (Flynn et aI.
, 1998). C08 T
cells playa critical role in recovery from murine influenza A virus infection (Yap et aL
1979), and p2-M knock-out mice that lack MHC class I-restricted T cells have delayed
viral clearance and increased mortality after influenza A virus challenge (Bender et aI.
1992). However
, in experimental murine influenza A virus infection
, immunodeficient
mice were observed to have a more protracted time to death than immunocompetent
mice after lethal intranasal (Ln. inoculation indicating immune-mediated
immunopathology (Bot et aI.
, 1996; Scherle et 1992; Wells et aI.
, 1983). Virus-
specific C08+ cytotoxic T cells have also been shown to contribute to pathologic
manifestations of influenza A virus infection in a TcR transgenic mouse model
(Moskophidis and Kioussis
, 1998). The cellular targets of influenza A virus-specific CTLs
may participate directly in the development of progressive tissue injury by becoming
activated in response to interaction with the T cells and producing proinflammatory
mediators (Small et aI.
, 2001).
During W infection , antiviral cytokines such as IFN-y produced by activated C08
T cells are important to clear W (Ruby and Ramshaw, 1991). In this thesis
, there will be
more evidence that activated C08 T cells also contributed to immunopathology in the
mouse lugg in the late stages of infection. MCMV-specific COB'T cells playa critical
role in controlling MCMV infection (Holtappels et aI.
, 1998; Holtappels et aI.
, 2001;
Quinnan et al. , 1978; Steffens et aI.
, 1998). However, in a model of bone marrow
transplantation, once a critical MCMV load was reached
, C08 T cells produced IFN-
which then stimulated macrophages to make high levels of TNF-
, leading to
aggravation of direct CMV-associated cytopathic 
effect (Barry et aI.
, 2000). Therefore
the C08 T cell response that effciently clears virus may sometimes induce substantial
immunopathology.
Memory CDS T cells and their role in antiviral immunity and
immunopathology during viral 
infections. Upon secondary infection
, the faster
memory T-cell response, in association with antibody responses
, can control infections
quickly and eliminate the pathogen (Kaech et al.
, 2002). This rapid memory T cell
response Occurs due to a substantial increase (fV1000-fold) 
in the precursor frequency of
antigen-specific T cells in immune animals (Flynn et aI.
, 1998; Murali-Krishna et aI.
1998; Selin et aI. , 1996). Memory C08 T cells are also at a higher activation state than
ive T cells (Pihlgren et aI., 1996; Tabi et aI.
, 1988; Veiga-Fernandes et aI.
, 2000).
Expression of increased levels of cyokine receptors and adhesion molecules on 
memory
C08 T cells further enhances their ease of 
activation (Dutton et aI.
, 1998; Razvi et aI.
1995). The gene-expression profile of memory T cells is reprogrammed by changes in
chromatin structure and the profile of active transcription factors. For example, the
ftJ
genes that encode IFN-y and cytotoxic molecules
, such as perforin and granzyme B
, are
constitutively expressed in effector and memory C08+ T cells (Bachmann et al.
, 1999;
Grayson et aI. , 2001; Masopust et aI.
, 2001; Selin and Welsh
, 1997; Yang et aI.
, 1998).
Although the synthesis of these proteins occurs in an '
on-off fashion that is regulated
by antigen contact
, elevated levels of the mRNA transcripts endow memory CD8+ T cells
with the capacity to produce larger quantities of these proteins more 
rapidly than naive
T cells (Kaech and Ahmed
, 2001; Veiga-Fernandes et aI.
, 2000). Memory C08+ T cells
.. express a different pattern of surface proteins that are involved in cell adhesion (C062L)
and chemotaxis (CCR7) from naive T cells, allowing memory T cells to extravasate into
non- lymphoid tissues and mucosal sites (Moser and Loetscher
, 2001). This enables
memory T cells to survey peripheral tissues, where microbial infections are generally
initiated. Recently, memory C08+' T cells that reside in these peripheral tissues have
been termed 'effector' memory T cells , whereas those that are found in lymphoid organs
have been termed 'central' memory T cells (Masopust et aI.
, 2001; Sallusto et aI. , 1999;
Weninger et al., 2001). Memory C08 T-cell populations are maintained for a long .time
(Homann et aI., 2001; Selin et aI., 1996) due to slowly turning over at a slow
, yet
steady, pace (Razvi et aI. , 1995; Sprent et aI. , 1999) in a process called homeostatic cell
proliferation. Cytokines such as IL-
, IL-15, IL-7, and IFNajp might make important
contributions to this homeostatic process, but their roles have yet to be fully defined (Ku
et aI. , 2000; McNally et aI. , 2001; Schluns et aI. , 2000; Tan et aI. , 2002; Zhang et aI.
1998). Recently, it was shown that memory T cells could use either IL-7Ra- or IL-15-
mediated signals for acute homeostatic proliferation in a Iymphopenic host and that
basal homeostatic proliferation of memory C08 T cells in a full T cell compartment was
blocked completely in IL - is-deficient hosts (Goldrath et aI. , 2002). In contrast to C08+
T-cell memory, a recent study indicated that virus-specific C04+ T-cell memory
decreases slowly over time (Homann et aI.
, 2001). It is interesting to speculate that the
differential stability of C04+ and C08+ T-cell memory could stem from the distinct effects
of IL-15 on the respective populations 
- memory C08+ T cells proliferate in response to
IL-15, whereas memory C04+ T cells do not (Tan et aI., 2002; Zhang et aI.
, 1998).
Therefore, it is the increased number of antigen-specific T cells
, and their faster
responses, anatomical location (that is, near the sites of microbial entry) and longevity
that collectively explain how memory C08 T cells confer long-term protective immunity.
Although memory C08 T cells can not act like neutralizing antibodies to prevent
infection from being initiated , memory T cells do prevent the infection from progressing
and protect against a lethal viral challenge. Evidence that memory cells keep a
persistent infection from progressing is that enrichment of IE1 pp89 peptide-specific
C08 T cells was observed in a pulmonary memory C08 T cell pool during latent MCMV,
infection of the lungs (Holtappels et aI. , 200021). In the case of secondary infections with
influenza A virus or LCMV, the recall response and inflamory process in the infection
sites develop more rapidly and to a much greater level, thus the virus is eliminated 2 to
3 days earlier than a primary infection (Belz et aI. , 2000; Welsh et aI. , 1997). There also
is a risk of enhanced immunopathology with a greater secondary response, especially
with a secondary infection after vaccination that induces C08 T cells but no protective
antibodies. For instance, in OBA/2 mice which were previously vaccinated with either a
major or minor LCMV T-cell epitope-containing vaccine, subsequent LCMV infection
aggravated disease and caused lethal immunopathology (Oehen et al., 1991). T cell-
mediated enhanced immunopathology was also observed in mice immunized with DNA
encoding an internal LCMV virion protein (Zarozinski et aI., 1995). This thesis will
provide insight into memory T cell-mediated immunopathology during heterologous viral
infections.
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T cell cross-reactivity and its possible role in the activation of
memory CDS T cells. Much work has been done to examine cross-reactivity between
viruses and viral proteins. It is clear that similarities in linear sequences of amino acids
can lead to cross-reactive immunity (Mathew et a!., 1998). However, a TCR that
recognizes a given MHC-presented peptide might also recognize diverse peptides that
have the appropriate MHC binding motif and have, projecting from the antigen-binding
groove, amino-acid side chains that are able to stimulate the TCR. As a result, T cell
cross-reactivity may differ from antibody cross-reactivity and be much less predictable
based simply on amino acid sequence similarity. This T-cell degeneracy was first
uncovered by unexpected cross-reactivity in that VSV- and influenza A virus-specific CTL
clones were shown to cross-react with uninfected allogeneic targets (Braciale et aI.,
1981; Sheil et aI., 1987). Cross-reactive epitopes may exist within a virus or a single
viral protein. The RSV M2 protein contains two distinct cross-reactive epitopes that share
very little amino acid similarity outside of the anchor residues required for presentation
by H2K (Kulkarni et aI. , 1993). An influenza A virus NP-specific clone was shown to lyse
targets that were coated with an unrelated peptide derived from a different influenza A
virus-encoded protein PB2 (Anderson et aI., 1992), and an H2K -restricted CTL clone
was also shown to recognize two distinct and very different peptides from the HA and
NS1 proteins of influenza A virus (Kuwano et aI., 1991). Cross-reactivity has also been
documented to occur between viral and self-proteins. A Kd-restricted C08 T cell line
specific for influenza A virus HA was found to cross-react with a peptide derived from
the Ig heavy-chain variable region (Cao et aI. , 1995). HSV- l specific T cells were shown
to cross-react with corneal autoantigens and cause stromal keratitis, and these T cells
.,'
also cross-reacted with a peptide derived from IgG2a (Avery et a!., 1995). Studies of
several virus infections in mice and of EBV infections in humans have shown that a high
degree of allospecific CTL activity is generated during infection (Burrows et aI.
, 1994;
- .
Yang and Welsh, 1986). This was first attributed to non-specific, polyclonal bystander
activation, but limiting-dilution clonal assays have shown that much of this activity can
be attributed to T-cell clones that are cross-reactive between virus-infected syngeneic
targets and uninfected targets that express allogeneic MHC antigens (Burrows et aI.
1999; Nahill and Welsh, 1993). Two structural studies that examined T-cell cross-
reactivity against allogeneic cells have shown that the same TCR can bind to different
peptide-ligand structures (Daniel et aI. , 1998; Speir et aI. , 1998).
Cross-reactivity has also been demonstrated between different viruses. An
influenza A virus matrix-protein-specific clone was shown to cross-react with a rotavirus
VP4 peptide (Shimojb et al., 1989). An immunodominant, HLA-A2-restricted T-cell
epitope that is encoded by hepatitis C virus (HCV NS3-1073; CVNGVCWT) has seven
out of nine amino acids in common with an influenza A virus immunodominant peptide
(NA-231; CVNGSCFT), and T cells cross-react with the two epitopes (Wedemeyer et aI.
2001).
Cross-reactivity may account for reactivation of memory T cells specific for one
virus during heterologous virus infections. CTLs that are specific for LCMV were
reactivated in LCMV-immune mice that were challenged with Pichinde virus (PV), W 
MCMV (Yang et aI., 1989). Again, this was speculated originally to be due to the
polyclonal bystander activation of 'memory CTLs, but clonal analyses showed T-cell
clones cross-reactive between LCMV and PV, and between LCMV and (Selin et aI.
1994). Based on positional analysis of various amino-acid substitutions at different
residues of a peptide, it has been calculated that a given TCR has the potential to
recognize a million different peptide-MHC combinations (Mason, 1998). This result
-= suggests that peptides do not necessarily need to have high sequence homology to be
cross-reactive with the same T cell. Moreover, memory T cells are in a higher activation
state than na'ive cells, and they can be productively stimulated by a peptide
concentration that is 50 times lower than that required for the stimulation of naive T
cells (Pihlgren et al. , 1996; Tabi et al. , 1988; Veiga-Fernandes et aI., 2000). Therefore, it
would not be surprising if a memory T cell could be stimulated by a cross-reactive
peptide with substantially less affnity for the TCR than the original peptide that created
the memory T-cell pool. Cross-reactivity between unrelated viruses could influence the
C08+ T-cell memory pool and viral pathogenesis
, which is the very important aspect of
memory T cell-mediated heterologous immunity.
Antigen-independent T cell stimulation by cyokines and its
possible role in the activation of 
memory CDS T cells. Functional activation of
naive T cells has been well known to require TCR-triggering and appropriate
costimulatory signals. However
, there are some misleading studies
, which propose TCR-
independent bystander activation of naive T cells. LCMV-specific transgenic CD8 T cells
were shown to acquire IL- dependent cytolytic effector function 
in vivo during acute
infection with unrelated pathogens such as W or Listeria monocyogenes (Ehl et aI.
1997), but these experiments did not exclude the possibility of cross-
reactivity between
the transgenic T cells and the unrelated pathogens. Another study showed that
treatment with IL-15, in the absence of exogenous antigen
, led to cell division as well as
an increase in the expression of the activation marker C069 on 
na'ive C08 T cells in vitro
(Kanegane and Tosato, 1996). However
, a role for TCR stimulation in this observation
was not excluded. Unlike na"ie T cells memory C08+ T cells
, which are at a higher
\;.
activation state than na"ive T cells, are able to respond to stimuli in a bystander manner
in the apparent absence of the cognate antigen (Tough et aI. , 1999).
Certain combinations of cytokines, including type I IFN and IL- , have been
shown to induce memory C08 T cell activation and differentiation in the absence of the
cognate antigen. C08 T cells with a memory phenotype (C044 ) wil incorporate the
DNA precursor BrdU and upregulate C025 after in vivo exposure to type I IFN (Tough et
al. , 1996; Tough et al. , 1997). Memory C08+ T cells have receptors for IL- , a cyokine
produced by monocytes and other cells. IL -15 has biological activities similar to those 
IL-2, including growth stimulation of NK cells and activated T cells and induction of
cyolytic function of NK cells. Moreover, IL-15 seems to regulate their homeostasis (Ku
et aI. , 2000; Sprent et aI., 1999). During viral infection, there is an induction of type I
interferon, which can then induce IL-15 production in macro phages and dendritic cells.
In turn, IL-15 can enhance the division of memory C08+ T cells, as shown by the uptake
of BrdU in vivo (Ku et aI., 2000; McNally et aI. , 2001; Tough et aI. , 1996). This division
does not lead to a significant increase in the total number of C08+ T cells (McNally et
aI. , 2001). In fact, homeostatic division might be necessary during the virus-induced IFN
response because of type I IFN-induced apoptosis of memory C08+ T cells (McNally et
aI., 2001). Homeostatic proliferation of memory C08 T cells is largely MHC I
independent (Tuma and Pamer, 2002), but TCR-dependence is yet unclear.
IL - , IL -18 and IFN-y can induce activation and homeostatic proliferation of
"','
memory C08 T cells. IL-12 is another important cyokine for controllng many viral and
mycobacterial infections. It regulates Thl/Th2 responses, promotes specific CTL
responses, and enhances the lytic activity of NK cells. IL-12 also enhances the
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production of IFN-y from memory T cells and NK cells (Trinchieri G, 1995). IL-18 is a
cyokine with potent IFN- inducing activity and plays an important role in the T
mediated immune response in collaboration with IL-12 (Akira, 2000). Recently, IL-
has been reported to drive memory C08 T cells into homeostatic cell division in vivo
(Kieper et al. , 2001) and this effect is IFN-y or IL-18-dependent and possibly through
IL-15 signaling (Tough et aI. , 2001). Bystander proliferation of memory C08 T cells was
also observed upon culture of memory C08 T cells with NKT or T cells activated by
superantigens. The proliferation could be induced by an IL-12- or IFN- dependent but
IFN-a/l3-independent pathway (Eberl et aI., 2000).
A few studies suggest that non-specifically stimulated T cells, which do not seem
to increase substantially in number, have some antimicrobial effector functions like
producing IFN-y. One study showed that bystander activation of memory-phenotype
C08 T cells contributes to the rapid production of IFN-y in response to bacterial
pathogens, and this was dependent on IL-12 and IL-18 (Lertmemongkolchai et al.
2001). GA004513 is a protein that activates mitogen-activated protein kinase
extracellular signal-regulated kinase kinase 4 (MEKK4) in T cells. This is required for
cytokine-induced IFN-y transcription. IL-18-stimulated GA004513 was required in IL-
and IL-18-induced but not TCR-induced IFN-y production (Yang et al. , 2001). However
IL -15 induced memory C08 T cell proliferation but was unable to drive cyokine
production in the absence of TCR activation or IL- 12 stimulation in vitro (Niedbala et aI.
2002).
It is diffcult to exclude a role for TCR stimulation during the cytokine-induced
activation of memory T cells, because all TCRs have some low level of reactivity against
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endogenous ligands, the expression of which might be up-regulated by exogenous or
virus- induced cytokines. Studies showed that transgenic T-cell populations that were not
specific for the virus did not increase in number in the spleen during viral infections
(McNally et aI. , 2001; Zarozinski and Welsh, 1997). This does not negate the possibility
that the non-specific T cells experience some level of activation. Recent BrdU-labeling
studies in influenza A virus- and mouse y-herpesvirus-infected mice have indicated that
antigen-specific T cells divide much more rapidly than bystander T cells (Belz and
Dohert, 2001; Flynn et aI. , 1999; Turner et aI., 2001). In a study that used two
influenza A virus strains that encode closely related T-cell epitopes, there was a
substantially greater proliferation of T cells that are cross-reactive with the challenge-
virus epitope than of T cells that are specific only for the previously encountered virus
(Haanen et a!., 1999). Therefore, antigen-stimulated T cells have a greater potential in
response to stimuli than bystander T cells.
During a viral infection, it is diffcult to be certain when T cells are responding as
result of bystander mechanisms or cross-reactive stimulation with viral peptides.
Despite the above observations a complete absence of TCR stimulation was seldom
conclusively shown, and the physiological relevance of T cell activation by such high
levels of diverse cyokines and its importance to viral infections are unclear.
Modulation of memory CDS T cells during sequential viral
infections. A memory T cell, which is easier to activate, would be sensitive to low
affnity cross-reactive TCR-triggering. Moreover, memory T cells may also be much more
susceptible to cyokine stimulation in the absence of cognate antigen. It is important to
understand the functional characteristics of this complex population during sequential
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viral infections, where both cross-reactive epitopes and bystander stimulating cytokines
could be present. The previous studies conducted in our laboratory on heterologous
immunity with systemic viral infections (Selin et aI., 1994; Selin et aI. , 1998; Yang et aI.
1985) laid the groundwork to my thesis research. However
, the knowledge of
modulation of memory C08 T cells during sequential viral infections was stil very
limited. Among the studies conducted in our laboratory discussed below, some of those
were done concurrently with the studies presented in this thesis.
Cross-reactivity between heterologous viruses alters T cell immunodominance
hierarchies (Brehm et aI. , 2002). Carefully controlled experiments in mice have indicated
that the hierarchy of the T-cell response to immunodominant peptides is consistent and
predictable (van der Most et aI., 1998; Yewdell and Bennink, 1999). Hence, the
specificity of the response is similar between genetically identical animals. Despite this,
the TCR usage differs from animal to animal (Un and Welsh
, 1998). Previous exposure
to other pathogens can alter the hierarchy of the T-cell repertoire. LCMV and PV encode
cross-reactive C08+ T-cell epitopes (LCMV NP205 and PV NP205) that have six out of
eight amino acids in common (Brehm et aI. , 2002). These peptides are subdominant in
each infection; they elicit T-cell responses that account for less than 3% of the antigen-
specific C08+ T cells during acute infection and about 1% of the C08+ T cells in the
memory pool. If LCMV-immune mice are infected with PV, or if PV-immune mice are
infected with LCMV, the T-cell responses to these NP205-specific peptides become
dominant; involving more than 20% of the C08+ T cells. Hence, infections with
heterologous agents can affect immunodominance when cross-reactive ' peptides are
present. This is similar to the concept of original antigenic sin that was used to describe
memory Ab responses and more recently to describe the cross-reactive T-cell responses
to variants of the same viruses (Haanen et aI. , 1999; Klenerman and Zinkernagel
, 1998).
Original antigenic sin is an asymmetric pattern of antibody or CTL cross-reactivity
determined by exposure to previously existing strains (De St Groth and Webster
, 1966).
This brings in to question any studies of immunodominance hierarchies in response to
human viral infections, as we have no idea how previous infections may have influenced
these hierarchies.
Following heterologous viral infections, there is attrition of memory CD8 T cells
while cross-reactive T cells remain in the memory C08 T cell populations. In the absence
of antigenic stimulation, the high frequency of C08+ memory T-cells is stable in a host
that has previously experienced a viral infection. This can be disrupted by infection with
heterologous viruses. After only 2 to 3 subsequent infections, there were 5- to 8-fold
reductions in memory C08+ T cells specific for previously encountered pathogens (Selin
et aI. , 1999; Selin et aI. , 1996). One of the factors related to this loss in the long-term
memory T-cell pool may be the type I IFN-dependent apoptosis of memory C08+ T cells
that are specific for agents other than the infecting virus (McNally et aI. , 2001). When
there are cross-reactive epitopes between the heterologous viruses, cross-reactive T cell
responses may enrich cross-reactive memory C08 T cell populations. For example, T
cells that recognize cross-reactive NP20S epitopes between LCMV and PV are preserved
and might be enriched in the memory population in either LCMV- or PV-immune mice
challenged with the heterologous virus (Brehm et aI. , 2002). Antigen is not required to
maintain memory C08+ T cells (Murali-Krishna et al., 1999), but cross-reactive antigen
wil offset the non-specific deletion of memory T cells (attrition) that occurs during new
infections.
Memory C08 T cells specific for one virus respond differently to cyokines and to
a heterologous virus infection. Examinations of adoptively transferred CSFE-Iabeled
LCMV-immune donor T cells in Thy-1 congeneic hosts inoculated with viruses or with the
cyokine inducer poly I:C (Kim et aI., 2002) found that poly I:C stimulation caused a
limited synchronized division of memory C08 T cells specific to each of five LCMV
epitopes, with no increase and sometimes a loss in number, and no change in their
epitope hierarchy. Infections with the heterologous viruses PV and W caused more than
seven divisions (similar to homologous LCMV challenge) and increases in number of T
cells specific to some putatively cross-reactive but not other epitopes and resulted in
substantial changes in the hierarchy of the LCMV-specific T cells. Thus, depending on
the pathogen and the sequence of infections
, a heterologous agent may selectively
stimulate the memory pool.
Cross-reactive C04+ T-cell responses between heterologous viruses have not
been examined systematically. There is a gradual erosion of the memory CD4+ T-cell
response with time (Homann et aI. , 2001). It is of interest, however, that heterologous
viral infections do not accelerate the decline in C04+ T-cell memory, perhaps because
relatively few C04+ T cells enter the memory pool and compete with the resident
population (Varga et al. , 2001).
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T cell-mediated heterologous immunity and immunopathology.
The term "heterologous immunity" was coined to describe a phenomenon occurring
between concomitant infections with different bacteria or intracellular parasites several
decades ago (Clark, 2001). This type of heterologous immunity is thought to be 
mediated
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by pro-inflammatory cyokines and nitric oxide produced by macrophages. Furthermore,
some cases in which the protection that Mycobacterium tuberculosis bacillus Calmette-
Guerin (BCG) gives against parasites or other bacteria has been shown to be fully active for
many months after the initial BCG challenge and to be through a mechanism that is
effective in the absence of antibody (Clark et aI., 1977), suggesting that other components
such as T cells through activating macrophages may playa role in this long-lasting
heterologous immunity between bacterial and parasites. However, the steps along the
pathway of antigen recognition are stil imperfectly understood in those cases (Clark,
2001).
A recent study indicates that prior immunity to a virus wil confer partial
protection against unrelated viruses during systemic i.p. infections and this heterologous
immunity is T cell-dependent (Selin et aI., 1998). This heterologous protection was
significant, although it was considerably less than the almost total protection that is seen
after challenge with a homologous virus. Adoptive-transfer studies indicated that
protection against PV and W was mediated by a combination of C04+ and C08+ T cells
from LCMV-immune mice.
history of unrelated viral infections can also greatly influence
immunopathology. LCMV- immune mice infected i.p. with W clear W more rapidly than
na"ive mice but also develop immunopathology in the form of acute fatt necrosis of their
peritoneal fat pads (Selin et aI. , 1998; Yang et aI., 1985). T cells have an important role
in immunopathology, as the lesions in fat were dependent on C08 and C04 T cells from
LCMV- immune mice (Selin et aI. , 1998).
The T 1 or T 2 bias of a memory response might affect the T 1 or T 2 bias of
the primary response to a heterologous agent. In a murine model of respiratory
syncytial virus (RSV) infection, if mice are infected with influenza A virus (inducing a
type response) before the recombinant W-RSV immunization (inducing a T type
response (Alwan et al., 1994)) and RSV challenge, the immune response to RSV 
altered and the infection resolves quickly without a strong 2 response and serious
eosinophilia (Walzl et aI. , 2000).
Heterologous virus infections can result in exacerbations and remissions of
autoimmune conditions. Cross-reactive C04 T cell responses between pathogens and
self-antigens have been associated with autoimmune diseases. For instance, HSV-
infections have been associated with the induction of T cell-dependent autoimmune
reactions to corneal tissue (Zhao et aI., 1998). In addition, infection of SJL/J mice with
Theiler s murine encephalomyelitis virus (TMEV) leads to a late onset of CD4 T cell-
mediated demyelinating disease similar to multiple sclerosis (Olson et aI., 2001). The
onset of the demyelinating disease can be accelerated by a TMEV variant encoding the
MBP peptide or a bacterial mimic peptide that shared 6 out of 13 amino acids with the
MBP peptide.
Taken together, heterologous immunity can result in protective immunity, altered
immunopathology, and changes in the T 1/TH2 balance in future pathogen exposure as
well as induction of autoimmune diseases. However, our understanding of mechanisms
involved in mediating heterologous immunity is stil in its infancy.
Mucosally transmitted respiratory viral infections and immune
system in the lung. Most viruses enter hosts through the mucosa (Nathanson and K.
1997). For respiratory mucosal viral infections, some viruses such as influenza A virus
tend to replicate only in the superfcial epithelial cells of the mucosal tract, while many
other viruses classically invade through the mucosa, but cause disease as a
ill
consequence of systemic spread (Dohert and Ahmed, 1997). Like influenza A virus
infection, as long as the viral antigens can be recruited into, processed and presented in
the secondary lymphoid tissues such as local draining lymph nodes and spleen, immune
responses primed from both mucosal and systemic lymphoid organs can participate in
the fight against viruses. Of course, mucosal IgA as well as IgG antibodies and easily
activated resident cellular immune components such as macrophages and memory T
cells are the first line of defense against mucosal virus infections.
In addition to nonspecific viral defense mechanisms such as mucus and soluble
factors (e.g. protease inhibitor acantitrypsin, and complement), a highly integrated
mucosal immune system exists in the lower respiratory tract. The immune system in the
lung is composed of draining lymph nodes including mediastinal lymph node (MLN) and
bronchial lymph nodes, and bronchus-associated lymphoid tissue (BAL T), as well as the
leukocytes of the interstitium, the bronchoalveolar and intravascular spaces (Pabst
1992; Pabst and Tschernig, 1995; Tschernig and Pabst, 2000). BALT, less well defined
than gut-associated lymphoid tissue (GALT), was first described as the nodules of
lymphoid tissue containing T cells, B cells, macrophages and dendritic cells in the branch
points of an airway or between the bronchus and an artery (Bienenstock et aI., 1973a;
Bienenstock et aI. , 1973b). The frequency of BAL T in species other than rabbits and rats
is variable, and certain stimuli are essential for the development of BAL T. Studies in
humans and experimental animal models show that the numbers of lymphocytes in the
,:;:;,'\' . , ' \, .
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lung interstitium are comparable to those of the circulating blood pool in the lung, and
these interstitial lymphocyes have a characteristic subset composition, size, distribution
and cytokine production profile (Nelson et aI., 1990; Pabst 1990). The lung
intravascular pool of lymphocytes is large, on a per gram basis nearly ten times larger
than for the liver or kidney (Pabst, 1990). Lymphocyes and Iymphoblasts from this pool
differ from peripheral blood or splenic lymphocyes in their migration patterns (Binns et
al., 1992). The lymphocye influx into the bronchoalveolar space from the circulating
pool can be seen in some conditions such as influenza A virus infection. These cells can
leave the bronchoalveolar space by entering the lung parenchyma and reaching the
draining lymph nodes via afferent lymphatic vessels (Pabst and Binns, 1995).
The respiratory heterologous viral infecion of CS7BL/6 mice, as
a model system to study heterologous mucosal immunity. Since many viruses
enter the host through the mucosa of the respiratory tract, it is important to examine the
role of memory T cells in immunity and immunopathogenesis with heterologous viruses
which are inoculated via the natural intranasal mucosal route of infection. Another
advantage of the mucosal system is that we wil be able to assess heterologous immune
responses with the common human virus, influenza A virus.
The viruses used in this thesis are known to be capable of being transmitted via
the respiratory route and to induce distinctive lung pathologies. Using this baseline
knowledge I could then assess what effect heterologous immunity would have on lung
pathology. LCMV, a relatively common human pathogen, with 4-15% of the general
population reported to be serologically positive, is predominantly transmitted via the
respiratory route in the natural environment (Lehmann-Grube, 1986; Marrie and Saron,
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1998). In arenaviral hemorrhagic fever patients, interstitial pneumonitis and pulmonary
edema are sometimes seen (Walker and Murphy, 1987). One study with LCMV infection 
guinea pigs showed that those infected with the more virulent LCMV WE strain had
pneumonitis (Martinez Peralta et aI., 1990). has been used for vaccination against
. - smallpox which in the environment can be transmitted via the respiratory mucosa (Fenner
et al., 1988; Wehrle et aI., 1970). W has also been used in a murine pneumonia model
(Tufariello et aI., 1994). In this study with recombinant W, pulmonary edema (at higher
dose) and infiltration of inflammatory cells, including mononuclear, polymorphonuclear and
eosinophilc leukocyes around bronchioles and arterioles, were observed in the intranasally
infected Balbjc mouse lungs. Influenza A virus causes a highly contagious acute
respiratory illness among humans. Acute influenza A virus infection in mice induces loss
of epithelium , airway obliteration, peribronchiolar and perivascular accumulation with
mixed PMN and MN cells, as well as mild SALT in the lung (Lemercier et aI., 1979;
Mackenzie et al., 1989). As the lungs become more and more consolidated, there is
epithelial bronchiolization (Loosli et aI., 1975; Yap et aI., 1979). Day 30 to one year after
acute infection, the lungs still show a patchy MN interstitial pneumonia, deposition of
collagen in the affected areas, and mild BALT (Jakab et aI. , 1983). Interstitial pneumonia
is a severe organ manifestation of CMV disease in the immunocompromised host, in
particular in recipients of bone marrow transplantation. MCMV infections have been used
as models for the human disease. When large i.n. dosages of MCMV are administrated 
BRVS mice:' a diffse and interstitial pneumonitis develops, characterized by thickening of
the alveolar walls due to infiltration with mononuclear cells and the presence of
proteinaceous fluid in the air spaces (Jordan, 1978; Staczek, 1999). It is important to
examine the influence, if any, of prior exposure to one of these viruses on immunity and
immunopathogenesis to a later respiratory infection with a heterologous virus.
Objective of the thesis. The goal of this thesis was to study virus-
specific memory C08 T cells and their role in heterologous immunity and
immunopathology in the mouse lung with respiratory viral infections that are inoculated
via the intranasal mucosal route of infection. I have also taken advantage of several viral
systems to pose the following questions:
1. What is the effect of prior immunity to one virus (LCMV MCMV or influenza) 
immunity against and immunopathology induced by a second unrelated virus in the
mouse lung during a respiratory infection?
2. How are the frequency and repertoire of LCMV-specific memory COB T cells
modulated during a respiratory heterologous W infection?
3. What are the mechanisms involved in activation of LCMV-specific memory C08 T
cells during heterologous W infections?
4. What are the immunological and immunopathological consequences of modulation of
memory C08 T cells specific to LCMV during the heterologous W infections?
5. What are the effector mechanisms involved in mediating those immunological and
immunopathological consequences during the heterologous viral infections?
6. Are patterns of lung immunopathology in murine models of respiratory heterologous
J.,
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viral infections reflective of human diseases?
CHAPTER II
MATERIALS AND METHODS
Mice
Six-week old C57BL/6J (B6, H2 ) male mice were purchased from The Jackson
Laboratory (Bar Harbor, ME). C57BL/6 IL-12 knock-out mice (B6. 129-IL12B) were bred
and maintained under microisolator conditions at the University of Massachusett
Medical School Department of Animal Medicine. All mice used in this study were
between 2 months to 2 years of age and maintained at the University of Massachusett
Medical School Department of Animal Medicine.
Viruses
The Armstrong or clone 13 strains of LCMV, an RNA virus in the Old World
arenavirus family, were propagated in BHK21 baby hamster kidney cells (Selin et aI.
1994). The WR strain of W, a DNA virus in the poxvirus family, was propagated in L929
cells (Selin et aI. , 1994). MCMV, strain Smith , a DNA virus in the herpesvirus family, was
extracted from salivary glands of infected weanling BALB/c mice (Bukowski et al., 1984).
The mouse-adapted influenza virus A/PR/8/34 (H1Nl), a RNA virus in the
orthomyxovirus family, was grown in the allantoic fluid of lO-day old embryonated
chicken eggs (SPAFAS, Preston, CT. This virus was a kind gift of Dr. Harriet Robinson
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Emory University, Atlanta. For acute virus infections, metofane-anesthetized mice were
challenged intranasally with 4 x 10 PFU of LCMV, 400 or 10 PFU of MCMV, or 70 or 200
PFU of influenza virus. Various W doses (lxl03 - lxl0 PFU) were used, as there was
some variability of virulence among different W stocks.
Cell lines
MC57G (H20 ), a methylcholanthrene-induced fibroblast cell line from C57BLj6
mice, and Vero African green monkey kidney cells were cultured in Eagle s MEM (Gibco
laboratories, Grand Island , NY). Highly NK-sensitive YAC-l cells, derived from a Moloney
leukemia virus-induced lymphoma in AjSn mice, were maintained in RPMI 1640 medium
(Gibco Laboratories). Madin-Oarby canine kidney (MOCK) cells were grown in Eagle
MEM (Gibco laboratories). GT-KO cells are mouse embryonic fibroblast lines cultured
from a- galactosyltransferase (GT-deficient transgenic mice. They were cultivated as
monolayers in Oulbecco modified Eagle medium (Gibco BRL, Grand Island, N. ) (Welsh
et aI., 1998). All cell lines were supplemented with 100 Ujml penicilln G, 100 J.gjml
streptomycin sulfate, 2 mM L-glutamine, lOmM HEPES, and 10% heat- inactivated (56
30 min) fetal bovine serum (FBS: Sigma , St. Louis, MO).
Infection protocol
For mice that were acutely infected with a single virus, metofane-anesthetized
mice were intra nasally inoculated with a sublethal dose of the virus. At various times
after the inoculation, the spleen , lung, and jor MLN were harvested, homogenized, and
titrated for virus plaques. The lungs were also harvested, fixed and sectioned for
histological evaluation. In most experiments metofane-anesthetized mice were
immunized with a sublethal dose of one virus. After the rise and fall of the acute T cell
response and when the immune system had returned to homeostasis (usually 6 weeks
or later), the mice were challenged with the second heterologous virus. At various times
after the second virus infection, the spleen , lung, and lor MLN were harvested
homogenized, and titrated for virus plaques. The lungs were also harvested, fixed and
sectioned for histological evaluation. The viruses used were either purified over sucrose
gradients and diluted in PBS (W) or were diluted in PBS (LCMV; MCMV; and influenza 
virus, containing allantoic fluid, diluted in PBS supplement with 1% BSA). Control na"ive
mice were intranasally immunized with culture media sedimented like virus over a
sucrose gradient. All mice used were healthy with no evidence of any underlying
disease. The immune mice were always age-matched to the control mice and housed
under exactly the same pathogen-free conditions for the same time period.
Synthetic peptides
Synthetic peptides were generated by either Genemed Synthesis (San Francisco,
CA) or American Peptide Company (Sunnyvale, CA) and were purified with reverse
phase-high pressure liquid chromatography to 90% purity. Final products were analyzed
by mass spectroscopy. The different sources yielded consistent data for all peptides
examined. The following synthetic peptides were used. LCMV-specific peptides: NP396-
404 (FQPQNGQFI; D binding), GP33-41 (KAVYNFATC; D binding), GP34-
(AVYNFATCGI; K binding) GP276-286 (SGVENPGGYCL; D binding), NP205-212
(YTKYPNL; K binding), GP92-101 (CSANNSHHYI; D binding) and GP118-125
(rSHNFCNL; K binding). W-specific peptides: Wp1 (YNSLYPNV), WplO (STLNFNNL),
and Wp24 (AIVNYANL). Influenza A virus-specific peptides: NP366-374 (ASNENMETM;
binding) and polymerase A (PA224-233, SSLENFRAYV; binding). Ovalbumin
peptide: OVA257-264 (SIINFEKL; K binding).
Plaque assay
LCMV and W were titrated by plaque assays on Vero cell monolayers. MCMV and
influenza A virus were titrated by plaque assays on GT-KO and MOCK cell monolayers
respectively. Individual tissues taken from virus- infected mice were put in 1 ml complete
RPMI, homogenized, and stored at -80 e. The frozen' aliquots were thawed on the day
of the plaque assay and used to titrate the virus on cells grown in 6-well plates (Costar,
Cambridge, MA). Serial ten-fold dilutions of 100 I were added to the cells in 1 ml of
MEM media and incubated for 90 min at 37 C with repeated rocking. A 1: 1 mixture of
8% Seakemp agarose (FMC, Rockland, ME) and EMEM (BioWhittacker, Walkersvile
MO) supplemented with antibiotics and 10% FCS was overlaid onto the cells. The plates
were incubated at 37 C and on day 4 (LCMV) or 2 (W) were stained with 2 ml of the
above overlay mixture containing 0. 1% neutral red (Sigma). Plaques were counted on
the next day. For MCMV plaque assay, on day 5, the overlay agarose was gently
removed from each well without damage of monolayers. Cells were then stained with
1 % crystal violet (Sigma)-PBS containing 1% of paraformaldehyde for 10 min, and
then rinsed once with PBS. The plates were air-dried, and plaques were counted. Virus
titers were reported as IOg10 PFU per whole organ. Results were expressed as the
geometric mean titers per whole organ , i. , the arithmetic average of the IOg10 for 4 or
5 mice titrated for virus individually (:tSEM).
For influenza A virus plaque assays, confluent MOCK cell monolayers were rinsed
once with serum-free MEM and infected with 10-fold dilutions of samples in a total
volume of 0.2 ml of PBS- 2% BSA for 1 h with rocking every 5 to 10 min. Cells were
then covered with an overlay of MEM containing 0.4% agarose
, 0.2% glucose (Sigma),
002% OEAE-dextran, O.Olmgjml Trypsin type III (Sigma), and 3x MEM vitamin
solution (Gibco BRL). Cells were incubated at 37
, and plaques were stained 3 days
postinfection with 2 ml of the above overlay mixture containing 0. 1% neutral red
(Sigma). Plaques were counted on the next day.
Spleen and lymph node cell preparation
Spleens and lymph nodes were isolated and ground between the frosted ends 
two glass microscope slides. The cell suspension was then passed through a fine nylon
mesh to obtain a single cell suspension. Eryhrocyes were lysed by briefly suspending
the cell pellets in a 0.84% NH CI solution before rinsing twice with RPMI 1640.
Isolation of lung lymphocyes
Lung lymphocyes were isolated using an adaptation of a previously described
prptocol (Khali and Greenberg, 1989). The lung vascular bed was first flushed with 10
ml chiled HBSS introduced via cannulation of the right ventricle of the heart, with the
aorta being first severed above the liver. Washing was performed until the lungs
glistened clear white, at which point they were immediately excised and cleared of
trachea, major bronchi, and all associated lymph nodes. The tissue was then minced
into very small pieces and incubated for 1 h in 5 ml of HBSS (10% FCS) containing 125
Ujml collagenase I (Bibco, BRL), 60 Ujml DNase I (Sigma, St. Louis, MO), and 60 Ujml
hyaluronidase (Sigma , St. Louis, MO). To obtain a single cell suspension the incubation
media and tissue were passed through a 1-mm mesh to remove undigested tissue. The
resulting cell suspension was layered over Lympholyte-M (Cedarlane Labs., Hornby,
Ontario, Canada) and centrifuged at 500 g for 20 min at room temperature. The
resulting mononuclear band was collected, washed, and analyzed.
Limiting dilution assay (LDA)
C57BLj6 mice were inoculated intra nasally with LCMV, and at the indicated times
after infection spleens were harvested. The LCMV-specific precursor frequency (pjf) per
C08+ cell was quantified by LOAs of unsorted splenocyes. The percentage of C08+ T
cells was determined by fluorescent antibody staining and FACS analysis, as described
below. For the LOAs, splenic lymphocyes from infected mice were harvested and titrated
in U-bottomed, 96-well plates with 24 replicates at each dilution. They were stimulated
with virus-infected peritoneal cells (3-4 x 10 jwell) and supplemented with irradiated
splenic feeders (1-2 x 10 jwell) and growth factors provided by using a 16% culture
supernatant from IL-2-secreting, gibbon lymphoma tumor cell line MLA. l44 (American
Type Culture Collection, Rockville, MO). After 4 d, the cultures were fed with 10
irradiated, virus-infected peritoneal cells. On days 7-8 of culture, individual wells were
split twofold and assayed for cyolytic function on LCMV-infected or uninfected syngeneic
target cells (KO) using a modified Cr-release assay. Cr-labeled targets (5 x 103) were
added to all wells, and after 8-10 h incubation at 37 C the supernatant was harvested.
Positive wells were defined as those wells whose Cr-release exceeded the mean
- .
spontaneous release by 3 standard deviations. All wells that lysed uninfected syngeneic
targets were eliminated from the analysis. Frequencies were calculated using ,.l analysis
(Taswell, 1981) on a computer program kindly provided by Dr. Richard Miler (University
of Michigan , Ann Arbor, MI).
Flow cytometry
For multicolor FACS analysis, approximately 1 x 10 cells were stained in staining
buffer (1% FCS and 0.02% NaN in PBS). Stained cells were fixed with 
paraformaldehyde, washed and resuspended in staining buffer and analyzed on either a
FACSQi 440 (Becton-Dickinson, San Jose, CA) or FACSstarQi plus (Becton-Dickinson).
Single color controls were used in all multiparameter FACS analyses for electronic
compensation settings on the flow cytometer. Data analysis was performed using the
program CELL QUEST (Becton-Dickinson).
Peptide-induced intracellular IFN-y staining
Isolated leukocyes from the spleens, lungs or MLNs from the pooled mice were
stained for intracellular IFN-y based on the protocol from CytofixjCytoperm PlugTM with
Golgiplug TM Kit (Pharmingen, San Diego, CA). The isolated cells were stimulated with
individual peptides (5 Ilgjml) in the presence of 10 Ujml human recombinant IL-2 and
2 III Golgiplug TM (1% Brefeldin A in 100%OMSO) for 5 h at 37 e. The cells were then
blocked by purified 2.4G2 antibody (Pharmingen) specific for Fe receptors for 15 min 
C and stained with FITC-conjugated anti-mouse C08 (clone 53- 7) and C069 PE
(clone H1.2F3 , Pharmingen). Cells were fixed and permeabilzed with CytofixjCyoperm
.. PlugTM solution (4% formaldehyde; 0. 1% saponin) for 20 min at 4 C. They were then
washed with 1X perm/wash 
1M solution (0.009% Sodium azide; 0. 1% saponin) before
c adding PE or APC-conjugated rat anti-mouse anti-IFN-y mAb (clone R4-6A2
Pharmingen) or control PE or APC-conjugated rat IgG1 isotype. All stainings with the
isotype control were consistently -:0.04%. Cells were analyzed on either a FACSQi 440
(Secton Dickinson) or FACSstarQi plus (Becton Dickinson). The total number of C08+ or
the total number of C08+ cells secreting IFN-y was determined by multiplying the
percentage times the total cell yield from each mouse. For each experiment
lymphocytes from 3 mice were pooled in order to sample a. large number of mice 
experiments which involved very large numbers of samples where at the same time
responses to 5 peptides plus isotype controls at 4 different time points in 3 organs were
examined. Also, it was diffcult to obtain the number of lymphocyes needed to test 5
peptides from the lung or MLN of one mouse.
H2D and H2K -IgGl MHC dimer staining and modified intracellular
staining of in vivo IFN-
Lymphocytes immediately after isolation from mouse lungs were stained with a
mouse Ob IgG1 fusion protein conjugated with 2-microglobulin and the appropriate
peptide (Greten et al. , 1998; Selin et aI. , 1999). Briefly, 1 !lg of the peptide- IgGl
MHC dimer mixture was incubated with cells for 1.5 hr at 4 C. The cells were then
stained with FITC-conjugated anti-C08 (clone 53- 7) and biotinylated anti-mouse IgGl
(Pharmingen) for 30 min at 4 , followed by incubation with streptavidin PE
(Pharmingen) for 20 min at 4 e. The cells were then fixed and permeabilzed with
, !If
Cytofix/Cytoperm Plug 
TM solution. They were stained with APC-conjugated anti-IFNy
mAb (clone R4-6A2, Pharmingen) or control APC-conjugated IgGl isotype. As no in vitro
stimulation or incubation was carried out, any positive staining for intracellular IFN-
U indicated that 
the C08 T cells producing IFN-y. would have been activated in vivd'
directly by the infection. All stainings with the isotype control were consistently -:0.04%.
second control was also done using purified anti-IFN-y mAb (clone R4-6A2,
Pharmingen), which specifically blocked intracellular IFN-y staining with APC-conjugated
anti-IFN-y mAb. The cells were analyzed either on a FACS 440 or FACSstar plus
(Becton Dickinson).
NP20S-specific H2K -IgG1 MHC dimer or H2K MHC tetra mer stining
and peptide-induced intracellular IFN- staining
Isolated cells were stimulated with individual peptides (5 Ilg/ml) in the presence
of 10 U/ml human recombinant IL-2 and 0. III GolgiplugTM (1% Brefeldin A in 100%
OMSO) for 5 h at 37 e. For dimer staining, the cells were then blocked by purified 2.4G2
antibody (1 Ill/well, Pharmingen) specific for Fc receptors for 15 min at 4 C. Then 1 Ilg
of NP205-212 peptide- IgGl MHC dimer mixture was incubated with cells for 1.5 hr
at 4 e. The cells were then stained with FITC-conjugated anti-C08 (clone 53- 7) and
biotinylated anti-mouse IgG1 (Pharmingen) for 30 min at 4 , followed by incubation
with st ptavidin PE (Pharmingen) for 20 min at 4 e. For tetramer staining, the cells
were blocked by purified 2.4G2 antibody (Pharmingen) specific for Fc receptors and
streptavidin at 20 Ilg/ml for 15 min at 4 e. After washing, the cells were resuspended in
100 JlI staining buffer containing PE-conjugated NP205-212-specific tetramer at 1 mgjml
and FITC-conjugated anti-C08 (clone 53- 7) for 1 hr at 4
After cell surface staining, the cells were fixed and permeabilzed with
CytofixjCyoperm PlugTM solution (4% formaldehyde; 0. 1% saponin) for 20 min at 4
They were then washed with 1X permjwash TM solution (0.009% Sodium azide; 0.
saponin) before adding APC-conjugated rat anti-mouse anti-IFN-y mAb (clone R4 6A2
Pharmingen) or control APC-conjugated rat IgG1 isotype. Cells were analyzed on either
a FACS(! 440 (Becton Dickinson) or FACSstar(! plus (Becton Dickinson).
Direct ex vivo cyotoxicity assay
Cell-mediated cytotoxicity was determined using a standard Cr-release CTL
assay (Selin and Welsh, 1997). MC57G target cells were infected with LCMV and W at a
multiplicity of infection (MOl) of 0. 1 and 10 PFUjcell , and incubated for 2 d and 2h at
C respectively. YAC- , MC57G and virus-infected MC57G cells were pelleted and
resuspended in 100 JlCi of Na Cr (Amersham Corp. , Arlington Heights, IL) per 10 cells
and incubated at 37 C in a humidified 5% C02 incubator for 1 h. Two-fold serial-diluted
effector lung leukocytes or splenocytes were plated in triplicates to achieve the desired
E:T ratio. Cr-labeled target cells (5xl0 ), either uninfected or infected with LCMV or
, were added to all wells. For a spontaneous Cr release control, 0. 1 ml of complete
MEM or RPMI 1640 was substituted for effectors. Maximum release was determined by
adding 0:1 ml of 1% Nonidet P-40 to the well (United States Biochemical, Cleveland
OH). After a 6 h incubation at 37 , the plates were centrifuged at 200 X g for 5 min
and 25 JlI of supernatant was harvested from each well and counted on a gamma
counter (Model 5000; Beckman instruments, Inc, Palo Alto, CA). Results were presented
as percent specific Cr-release = 100 x ((experimental cpm - spontaneous release
cpm)j(maximum release cpm - spontaneous release cpm)J. The spontaneous release for
each target used in these assays was -c 20%.
Cytokine RNase protection assay
Total RNA was extracted from the whole lung tissue or isolated leukocytes from
the spleen, lung or MLNs using Trizol agent (Gibco, BRL). Briefly, lung tissue samples
from individual mice were homogenized in 1 ml of TRIZOL Reagent using a power
homogenizer. For cell samples, 5-10 x 10 cells were lysed in 1 ml of TRIZOL Reagent
by repetitive pipetting. The homogenized samples were incubated for 5 min at room
temperature prior to adding 0.2 ml of chloroform (Mallinckrodt Baker, Inc., Paris, KY)
per 1 ml of TRIZOL Reagent. The samples were shaken vigorously and centrifuged at no
more than 12 000 x g for 15 min at 2 to 8 C after incubation for 2 to 3 min at room
temperature. The upper aqueous phase was transferred to a fresh tube, and the RNA
was precipitated by mixing with 0.5 ml of isopropyl alcohol (Fisher Scientific, Fair Lawn
NJ) per 1 ml of TRIZOL Reagent used for the initial homogenization. After incubation for
10 min at room temperature, the samples were centrifuged at 12 000 x g for 10 min at
2 to 8 e. The RNA pellet was washed with 75% ethanol, completely air-dried and
dissolved in RNase-free water.
.,'
Detection and quantification of a variety of murine cyokine mRNAs were
accomplished with the mutiprobe RNase protection assay system (Pharmingen). Briefly,
a mixture of (y_ p) UTP-Iabeled antisense riboprobes was generated from a panel of
- - 
different cyokine templates using an in vitro transcription kit containing GACU pool
OTT, RNasin, T7 RNA polymerase, RNase-free DNase, and transcription buffer. Each
template set also contained templates for the murine housekeeping genes encoding
glyceraldehyde- phosphate dehydrogenase (GAPOH) and L32 (a murine ribosomal
protein), to ensure equal loading of total RNA onto the gel. A predetermined amount of
total RNA (20-40 Ilg) was hybridized overnight at 56 C with labelled antisense
riboprobe mixture and then the samples were digested with RNase. RNase-protected
RNA fragments were purified by ethanol precipitation
, and then the samples were
resolved on a 5% PAGE. The protected bands were observed after exposure of the gels
to a Phosphorlmager (Molecular Dynamics, Inc., Sunnyvale, CA) and. X-ray films
(Kodak). The specific cytokine bands were identified on the basis of their individual
migration patterns in comparison with the undigested probes. The bands were
quantified by densitometric analysis with ImageQuant densitometric softare (Molecular
Dynamics).
Cytokine ELISA
Cytokine levels in sera or bronchial alveolar lavage (BAL) of mice were measured
by enzyme-linked immunosorbant assay (ELISA) based on the protocol provided by
Pharmingen. Briefly, an ELISA plate was coated by incubation overnight at 4 C with
purified anti-cyokine capture monoclonal antibody diluted in 50 Ill/well PBS (1-4 Ilgjml).
The plates were then washed with PBS- 05% Tween 20 after each of the following
steps. The coated plate was then blocked by 200 III blocking buffer containing 10% fetal
bovine serum for 2 hr at room temperature. Samples (sera and BAL) were added at 100
IJI per well , and a standard curve was constructed for each plate by using eight 2-fold
serial dilutions of recombinant mouse cytokine (Pharmingen). The plates were incubated
overnight at 4 C followed by addition of the diluted (1 IJgjml) biotinylated anti-cytokine
detecting antibody at 100 IJI per well. After a 1-hr incubation at room temperature, 100
IJI of streptavidin-HRP (lj400 dilution in PBS- lO% FCS; obtained from Sigma) per well
were added, and the plates were incubated at room temperature for 30 min. After
washing, plates were developed with 3 -tetramethyl-benzidine dihydrochloride
peroxidase (Sigma) dissolved in 0.05 M phosphate citrate buffer, pH 5.0. The reaction
was stopped with 25 IJI of 2 N H S04. Plates were read at 450 nm using a microplate
reader (Emax). A standard curve for each assay was generated and cyokine levels were
calculated by a softare program Softmax(Qpro3. (Molecular Devices Corporation
Menlo Park, CA). The following pairs of mAb were used: anti-IFN-y, R4-6A2 and
biotinylated XMG1.2; anti-IL-6, MP5-20F3 and biotinylated MP5-32C11; anti-TNF-
G281-2626 and biotinylated MP6-XT; anti-IL- , 11Bll and biotinylated BV06-24G2 (all
from Pharmingen). Limits of detection for IFN-y, IL-6, TNF- , IL-4 were 0.2 ngjml, 0.4
ngjml , 0.2 ngjml , and 0.03 ngjml, respectively.
Depletion of NK cells in vivo
Mice acutely infected with W were injected i.p. with 100 IJI (200 IJg) of purified
anti NK1.1 mAb (clone PK136) at day 0 and 4 postinfection. This greatly reduced NK cell
activity for at least an 8 day time period.
In vivo IFN-y depletion
In vivo depletion of IFN-y was performed by Lv. (day 0 and 3) and i. p. (daily)
injection of 100 III of an ascites of rat anti-IFN-y mAb (R4-6A2) or a control rat IgGl
isotype (clone A110- , Pharmingen) following W challenge. At day 6. after W
infection , the lungs, MLNs and spleens were harvested and underwent virus titration and
histological analysis.
Adoptive transfer
Naive C57BL/6 mice were injected i.v. with one spleen equivalent (IV 5-10 xl0
cells) of naive splenocyes or LCMV-immune splenocyes, which were prepared under
sterile conditions and challenged Ln. with 3x10 PFU of W. At 6.5 d after infection
lungs, MLNs and spleens were harvested , and titrated for W.
Lung histological evaluation
At various times after mice were either acutely infected with a single virus
immunized with a single virus or immunized first with one virus and then acutely
challenged with a second virus, lungs were harvested, fixed in 10% neutral buffered
formaldehyde and paraffn embedded. Tissue sections (5 11m) were then stained with
hemotoxylin and eosin. Each section slide was concurrently examined microscopically by
four persons, among whom two pathologists (Dr. Isabelle Joris and Dr. Armando Fraire,
at the UniversitY of Massachusett Medical School the Department of Pathology) were
blinded in regards to treatments the mice had received and two other members were
Dr. Liisa Selin and myself. Scores for lung pathology were graded by the two
:".
pathologists. The level of lung diseases was scored based on the distribution and the
severity of disease from 0/- to 3/+++ (0, within normal limit; 1/+, 1-9% involvement of
the lung parenchyma; 2/++, 10-49% involvement of the lung parenchyma; 3/+++
50% involvement of the lung parenchyma). Histological pictures of representative lung
sections were taken using Nikon microscope ECLIPSE E800 (Nikon Instruments, Inc.
Melvile, NY) and Spot RT (Real time) slider "F" mount digital camera and Spot
softare v. 3.0 (Diagnostic Instruments, Inc. , Sterling Heights, MI) under the objectives
of 4x, lOx and 40x magnifications. The digital picture files were organized using AdobeCI
Photoshop 6.0 softare (Adobe Systems Inc., San Jose, CA).
Immunohistochemistry staining
Lungs from the control and LCMV- immune mice were frozen in OCT compound
(Miles Co., Eikhart, IN). Sections (5 11m) were fixed in acetone for 10 min, air-dried and
then immersed in 3% in methanol for 10 min at room temperature to block
endogenous peroxidase activity. After rinsing, the sections were incubated with biotin-
labeled mAbs to C03 (clone 145-2Cll), C04 (clone RM4-5), C08 (clone 53- 8), or
C019 (Clone 103), (all from PharMingen) overnight at 4 C in a humidified chamber.
Horse serum was used in staining buffer to inhibit background staining. Sections were
then stained with streptavidin-HRP (1:25 dilution; Pharmingen) for 30 min at room
temperature in a humidified chamber. Slides were stained with diaminobenzidene (DAB
'-,'
Sigma) solution for 3-5 min at room temperature. The reaction was stopped by rinsing
in PBS, and the sections were counterstained with hematoxylin.
In situ MHC-tetramer/dimer staining and confocal laser scanner
microscopy (CLSM) of lung tissue sections
NP396-specific D tetramer was prepared using a previously described protocol
(Mylin et aI. , 2000). Lungs from the control and LCMV- immune mice were frozen in OCT
compound (Miles Co., Eikhart, IN). Sections (20 
/lm) were cut, mounted on microscope
slides and blocked by purified 2.4G2 antibody (Pharmingen) specific for Fc receptors for
15 min at 4 , and then incubated overnight at 4 C with FITC-Iabeled anti-CD8 mAb
(clone 53- , PharMingen , 6 /lg/ml) and PE- Iabeled NP396-specific MHC tetramer (20
/lg/ml) in PBS/l0% normal mouse serum, followed by washing 3 times with PBS/l0%
normal mouse serum (Skinner et aI., 2000). Sections were protected by The ProLongTM
antifade kit (Molecular Probe, Eugene, OR) before CLSM. Green (FITC) and red (PE)
signals were collected on a Leica TCS NT (Leica Microsystems
, Heidelberg, Germany)
confocal system. Images were taken using a 40X NA1.4 objective. Possible overlapping
signals between the different fluorochromes were subtracted.
Statistical analysis
Data, where appropriate, were analyzed by Student's t-test for each individual
, experiment using either SigmaPlot softare (SPSS Inc, Chicago, IL) or Microsoft's Excel
softare (Microsoft Corporation, Redmond, WA). Statistical significance was established
at a p value of ..0.05.
CHAPTER III
MODULATION OF LCMV-SPECIFIC MEMORY CDS T CELLS AND THEIR
POTENTIAL ROLE IN HETEROLOGOUS IMMUNITY AND
IMMUNOPATHOLOGY IN THE LUNG AGAINST 
Virus-specific memory T cells, generated after the host has been vaccinated
against or infected with a virus, can prevent the infection with the homologous virus
from progressing. The effcacy of memory T cells may be due to the fact that they persist
at relatively high frequencies and are constitutively at a higher state of activation than
naive T cells (Flynn et aI. , 1998; Hogan et aI. , 2001a; Masopust et aI., 2001; Murali-Krishna
et aI. , 1998; Selin et aI. , 1996). They can be induced into cell cycle by cyokines such as
IFNa/B and IL-15 (Tough et aI., 1999) and can be triggered by relatively low affnity
interactions through their TCRs (Bradley et al. , 1993; Tabi et aI. , 1988). Some apparently
resting memory T cells can be cyolytically active (Selin and Welsh, 1997).
Each individual- experiences many sequential infections that give rise to memory
T cell pools of significant size and complexity. Analysis of experimental Lp. infections in
mice has suggested that memory T cells generated in response to one virus can indeed
alter the course of disease in response to unrelated viruses (Selin et al. , 1998). Based on
our observations on heterologous immunity, we would predict that each new infection
wil activiite some of these memory T cells and modulate the original T cell repertoire
which is associated with alteration of the disease course. The following study develops
these hypotheses.
' '
I focused my studies on a respiratory mucosal model of heterologous virus
infection. Developments in the identification of antigen-specific T cell responses (Altman
et a!., 1996; Oal Porto et aI. , 1993; Openshawet aI. , 1995) enabled me to examine the
extent of heterologous memory T cell participation in a peripheral organ, the lung, which
is the initial site of virus replication, as well as in the conventional lymphoid
compartments. By immunizing mice first with LCMV, which has several well defined
epitopes, it allowed us to examine the ability of a heterologous virus to reactivate
discrete LCMV epitope-specific memory T cell populations. I show here that an acute
respiratory W infection functionally activates memory C08+ T cells specific to LCMV 
vivo. infection resulted in selective expansion of LCMV-specific T cells and modulation
of the LCMV-specific T cell repertoire in association, with modification of the lung
pathology and disease outcome.
Respiratory infection of CS7BL/6 mice with LCMV or 
In order to study the effect of prior immunity to LCMV on immunity against W
during a respiratory infection, I first examined the kinetics of viral clearance during a
respiratory infection of na ive C57BL/6 mice with LCMV or (Table 2). When mice were
infected with LCMV strain Armstrong, which I used in most of the experiments
comparable LCMV PFUs were detected in the lung, the draining MLN and the spleen at
day 3 postinfection. Seven days after infection, LCMV titers in these three organs
decreased. By day 16 postinfection, no LCMV was detectable in these organs. The
.,:
kinetics of LCMV clearance was slightly delayed but still comparable to systemic i.
LCMV infection (Selin et aI., 2000). In some of the early experiments, I used the more
, ' , '
Tl'
Table 2. Kinetics of viral clearance from normalCS7BL/6 mice
Challenge virus Days post Virus TIter (lOgIO PFU/organ)'
infection Spleen MLN (pooled) Lung
LCMV Armstrong (4)a 5:! 0. 3:! 0.
2.4 :! 0. 1.5 6:! 0.
.:1.0 .:1.0 -:1.0
LCMV clone 13 ( 7:! 0. 1 :! 0.
9 :! 0.3 2:! 0.
.:1.0
-:1.0
Influenza virus (2) .:0. 3 :! 0.
.:0. 8:! 0.
.:1.0 -:1.0
W(2) 1.7 :! 0.4 6.4 :! 0.
1.5 :! 0. 6:! 0.
.:1.0 7 :! 0.
.:1.0 1 :! 0.
.:1.0 5 :! 1.1
.:1.0 0:! 0.
.:1.0 -:1.0
The infection ofinice was done as described in Materials and Methods. a, The number in
parentheses represents the number of mice per treatment group. b, virus was also
titrated in the organs of the immune-mice (at least 6 weeks after the acute infection). c,
Data are presented as the mean titers in each group:! SEM.
highly disseminating LCMV clone 13. Seven days after infection, LCMV clone 13 titers in
the lung and spleen were more than 1.5 IOg10 higher than LCMV strain Armstrong titers
(Table 2). Nonetheless, no LCMV clone 13 was detectable in these two organs by day 14
postinfection. The exact day for complete LCMV clearance during the respiratory
infections is not known because of the limited time points examined. However, both
LCMV strain Armstrong and clone 13 were no longer recovered from the lungs and
spleens of LCMV-immune mice (:: 6 weeks after LCMV challenge) by plaque assays
(Table 2). Therefore, a respiratory infection of C57BLj6 mice with the selected dose of
LCMV could be used to study the effect of prior immunity to one virus on immunity
against a second unrelated virus.
When na"ie mice were infected with a sub-lethal dose of W (2 x 10 PFU)/ W
titers in the lungs sampled in one of the two representative experiments showed a
prolonged plateau from day 3 of i.n. challenge until day 9, and then a decline thereafter
(Table 2). Therefore, C57BLj6 mice were very sensitive to respiratory W infection. " By
day 15, W could not be detected in the lung homogenates. In the spleen, there was a
low level of W replication, and W was cleared by day 7 postinfection. These data are
similar to one study showing a similar kinetics of pulmonary Cowpox virus replication in
Balbjc mice after aerosol infection (Bray et al., 2000).
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Figure 1. Decreased mortlity of LCMV-immune mice
challenged intranasally with a lethal dose of W as
compared to the age-matched control mice. Mice (n=6
mice/group) were infected with W (1 x 10 PFU) , and the time of
their death after infection was recorded. These are representative
data of 3 similar experiments.
Pc:0.
100
Control+W LCMV-imm+W
Figure 2. Immunity to LCMV provides protection against
respiratory W infection. Decreased mortality of LCMV-immune
mice challenged with W was seen as compared with the age-
matched control mice. Data are presented as the mean::S.O. of %
survival from 3 similar experiments, in which LCMV- immune mice
were infected with W 6, 12, and 18 weeks after the initial LCMV
infection , respectively.
!II'
" T
Prior respiratory exposure to LCMV provides protection against a lethal
W challenge
When mice were infected with a lethal dose (1 x PFU) of W, there was,
the representative experiment shown in Figure 1, a marked difference between the
groups: 83% of the LCMV-immune mice survived compared to only 17% of 
the control
mice. Three similar experiments showed that the difference in mortality between the
groups was statistically significant: 94::6% of the LCMV-immune mice survived the
lethal W challenge compared to only 42::12% of the control mice (Figure 2, p-:0.02).
These experiments were carried out at different times from 6-18 weeks after LCMV
infection (Figure 2), so this protection appeared to be independent of the time of W
challenge after LCMV infection. When the LCMV-immune and control mice were given a
very high dose of W (1 x 10 PFU), both groups of mice died
, suggesting that the
protection provided by heterologous immunity to LCMV was not at the same level as the
protection conferred by homologous W immunity. Nonetheless, the heterologous
protection against a lethal dose of W in the LCMV-immune mice was significant.
Time course of protective immunity to W in LCMV-immune mice
Immune and control mice were acutely infected with a sub-lethal dose of W
and the W titers in the spleens and lungs were assessed at various time points (Table
3). By day 3 after infection there was a slight decrease in lung W titers compared to
that in LCMV-itnmune mice, but by day 5 there were lower W titers in the spleens and
lungs-95% (P-:0.05) and 97% (P-:O. l), respectively-of the LCMV-immune compared
to the control mice. There continued to be a significant 83-90% (P-:O.05) reduction in
Table 3. Prior immunity to LCMV lowers W titer during the course of a
sub-lethal W i.n. challenge
W Titer (mean 10glO PFUjorgan :I SEM)a
Immunizing Days after W Spleen Lung
virus challenge
Control 1:10.3
LCMV 9:10.
Control 1:!0. 2:10.
LCMV oe 2. 8:!0 7:11.4
Control 0:10.
LCMV 8:10.
Control 2:10.3
LCMV 504:10.3 d
Control oe 1.3:!0 6:10.
LCMV oe 1.3:!0 ' 6. 7:10A
, ,
a, Lungs and spleens from W- infected with mice were harvested and load'
was titrated. b, LCMV- immune mice were challenged with W 10-15 weeks after
initial LCMV infection. 3 similar experiments were carried out at each time
pOint. c, Mice acutely infected with W were NK cell-depleted by Lp. injection of
100 III (200 Ilg) of anti NK1.1 mAb (clone PK136) at day 0 and 4 PI. ND, not
done. d, Statistically significant difference between the control and LCMV-
immune mice (PoeO.05). e, P=O. 1. f, P=0.07.
. .
W titers in the LCMV-immune mice lungs, as the W infection progressed over days 6
and 7. Therefore; the decrease in mortality in the LCMV-immune mice was associated
with a decreased W load throughout the course of the acute W infection.
Once again, the decrease in W titer was independent of the time of 
challenge after LCMV infection (6 weeks after LCMV infection: control+W, 5.6 :t 1.0 iii
i11,
!I!
10glOPFU/lung; LCMV-immune+W, 6.5 :t 0. 6 10glOPFU/lung, Day 7 W postinfection, po:
1, n=4 mice/group. 15 weeks after LCMV infection: Table 3). These differences in 
titers were also seen under more stringent conditions in which both groups of mice were
depleted of NK cells, as indicated in the two experiments done on day 6 after W
infection (Table 3). These experiments suggested that NK cells did not playa role in this
protection.
Adoptively transferred LCMV-immune splenoces into naive mice
provide protection against W challenge
It is predictable that residual effects of interferon and activated macrophages
might provide a level of heterologous immunity immediately after infection. The
heterologous immunity I have shown here is a long- lasting effect independent of the
time of the initial immunization with one virus (Table 3). Moreover, as shown above, NK
cells did not playa role in this protection. Since LCMV induces a potent T cell response, I
hypothesized that the heterologous immunity against W could be associated with prior
immunity to LCMV.
To test this hypothesis, LCMV-immune splenocytes were adoptively transferred
into na ive mice, which were then challenged with W. As shown in Table 4, in the two
-" 11 
! I
Table 4. Adoptively transferred LCMV-immune splenocytes into naive
mice provide protection against W challenge
Virus Titer Change
Donor (n = number of (mean 10glO (Immune 
Exp # Organ
recipients) PFUjorgan :t NaIve)
SEM)
No. MLN NaIve-control (n = 6)
(pooled) LCMV-immune (n = 1.3 99%-1
Lung NaIve-control (n = 6) 5 :t 0.
LCMV- immune (n = 7) 2 :t 0. 50%-1, P = 0.
No. MLN NaIve-control (n = 3)
(pooled) LCMV- immune (n = 4) -:1.0 90%-1
Lung NaIve-control (n = 3) 3 :t 0.
LCMV-immune (n = 4) 6 :t 0. 80%-1, P = 0.
Naive C57BLj6 mice were injected Lv. with one spleen equivalent (tV 5-10 x10
cells) of naive or LCMV-immune splenocyes, prepared under sterile conditions
then challenged Ln. with 3xl04 PFU of W. At 6.5 d after infection, lungs and
.,,'
MLNs were harvested and titrated for W.
experiments there were 90% and 99%, respectively, reductions of titers in the
pooled MLNs of mice adoptively reconstituted with LCMV- immune splenocyes at day 6.
post W infection as compared to naTve splenocyes. In the lungs, 50% reductions of W
titers were also observed in mice adoptively reconstituted with LCMV-immune
splenocyes compared to naTve splenocytes. This suggested that the protective
heterologous immunity against acute respiratory infection with W was dependent on
LCMV-immune splenocytes.
High frequencies of LCMV-specific memory CDS T cells in lymphoid and
peripheral tissues long after respiratory LCMV infection
To examine LCMV-specific memory C08+ T cells before and during infection
and to determine how they could be contributing to the protective immunity, I first
defined the LCMV epitope-specific populations present in resting LCMV-immune mice. As
determined originally by LOAs (Table 5), mice with respiratory LCMV infection developed
high and stable frequencies of LCMV-specific memory CTL precursors (pCTL) in the
spleen, equivalent to LCMV i.p. infection. There was no drop of the frequencies of pCTL
from 2 (1/69 C08 T cells) to 7.5 months (1/68 and 1/106) after LCMV infection.
The development of antigen-specific T cell staining using tetrameric (Altman et
aI., 1996) or dimeric (Greten et aI., 1998) peptide/MHC complexes as well as
intracellular cytokine staining (Openshaw et al. , 1995) has made it possible to visualize
antigen-specific T cells. Pooling of data on the intracellular IFN-y responses to five
individual epitopes (NP396, GP33, GP276, NP205, and GP92) showed a much higher
percentage of LCMV-specific C08+ T cells in the lung than in the MLNs (Figure 3a). The
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Figure 3. LCMV-specific memory CDS T cells in resting
LCMV-immune mice. Lymphocyes were isolated from the
lungs, spleens and MLNs, stimulated with 5 individual
peptides and stained for intracellular IFN-y. Lymphocyes from
groups of three mice each were pooled before staining. a, Y-
axis represents the LCMV-specific CD8+ T cell frequencies.
Data are representative of 2 similar experiments for lung and
MLN , and 1 experiment for spleen. b. Different LCMV-specific
repertoire in the MLN and lung of LCMV-immune mice. Data
represent the mean of two (spleen) and three (lung and MLN)
similar experiments. Cells were analyzed 6-13 weeks after
LCMV infection for lung and MLN , and 13-15 weeks after
LCMV infection for spleen.
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proportion of the C08+ T cells that were LCMV-specific in the LCMV-immune lung
decreased slowly from rv 42% (2.5 x 10 cells) at 6 weeks to 26% (1.0 x cells) at
12 weeks and to 14% (9.3 x 10 cells) at 52 weeks after Ln. LCMV infection. In
contrast, the proportion of LCMV-specific C08+ T cells in the MLNs of these same mice
remained stable: 2.2% (2.0 x 10 cells) at 6 weeks; 1.6% (4.3 x 10 cells) at 12 weeks;
and 2.0% (2. 1 x 10 cells) at 52 weeks; n = 3 mice/group. The C08+ memory T cell
frequency in the spleen was higher than in the MLNs and also relatively stable after i.
LCMV infection: 17% (2.0 x 10 cells) at 13 weeks; 13% (2. 1 x 10 cells) at 15 weeks;
3% (1.6 x 10 cells) at 52 weeks; n = 3 mice/group. Observations about the stabilty
of memory C08+ T cells in the spleen after Lp. LCMV infection (Butz and Bevan, 1998;
Murali-Krishna et aI., 1998; Selin et aI., 1999) and differences in the frequency of
memory C08+ T cells in lung, MLN and spleen were consistent with published data
(Hogan et aI. , 2001a; Masopust et aI. , 2001).
Of interest was the unexpected result that the specificity of the CD8+ T cell
response between MLN and lung differed. This was because up to 64% of the LCMV-
specific C08+ T cells in the MLN were GP33-specific, whereas T cells in the lung had
broader specificities, comparably targeting NP396 (36%) and GP33 (39%) and with
some recognition of GP276 and NP205 (Figure 3b). Analysis of the data from three
similar experiments revealed 62% (p=0.03) and 53% (p=0.08) proportional reductions
in NP396- and GP276-, specific C08 T cells, respectively, in the MLN as compared to the
lung. Meanwhile, there was 1.6-fold (p=0.07, n= 3 experiments) increase in the
proportion of GP33-specific C08 T cells in the MLN as compared to the lung. The
alteration in proportions of these three immunodominant epitope-specific CD8 T cell
I' P ! r
populations resulted in a different repertoire between the two organs in the LCMV-
immune mice. The spleen tended to have a similar repertoire to the lung (Figure 3b).
These results suggested that different C08+ memory T cell homeostatic mechanisms
- ' were involved in the lung, its draining MLN , and the spleen.
Organ-specific accumulation of LCMV-specific memory CDS T cells after
W challenge
After LCMV- immune mice were acutely challenged with W, LCMV epitope-
specific C08+ memory T cells in both the lungs and MLNs were not diluted out, as one
might have expected, by the W-specific C08+ T cell response (Figure 4 and 5). In fact
the total number of LCMV-specific C08+ T cells in the MLN increased four-fold (PoeO.05)
3 days after W challenge and continued to rise to six-fold (PoeO.05) higher by day 12
after infection (Figure 5). There was only a moderate increase in LCMV-specific C08+ T
cells in the lung 3 days after W challenge, but by day 12 after infection there was a
four-fold increase (PoeO. , Figure 5). In contrast to these results, the spleen showed a
significant 67% decrease (PoeO.05) of LCMV-specific C08+ T cells by day 3 and a further
decrease by day 7 (PoeO.05). Then, by day 12 after infection, the number of LCMV-
specific C08+ T cells returned to the numbers in resting LCMV- immune mice (Figure 5).
All these changes occurred in the presence of W antigens, as W was stil detectable in
the lungs by day 12 post infection (Table 2). Therefore, there was an organ-specific
accumulation o(LCMV-specific memory C08 T cells after W challenge.
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Figure 5. Organ-specific accumulation of LCMV-specific memory
CDS T cells after W challenge. The total number of memory CD8+
T cells specific for each LCMV epitope was calculated by multiplying
the total cell yield from each mouse organ by the percentage of I FN-
y -staining CD8+ cells specific for that epitope. The sum of the total
numbers for each of five LCMV epitopes are shown. Because IFN-
production by CD8+ T cells without peptide stimulation was observed,
this was subtracted from each antigen-specific response before
calculating the total numbers. Although some of these CD8+ T cells
were LCMV-specific, we used conservative estimates. Statistically
significant differences, between the unchallenged and the 
chall nged LCMV- immune mice, in the increase or decrease in total
LCMV-specific CD8+ T cells, * , po:O.05; #, po:O.1. Data represent the
mean of four similar experiments. For each experiment , lymphocytes
from groups of three mice each were pooled before staining.
Repertoire alteration in LCMV-specific memory CDS T cells in organ-
specific manner after W challenge
To examine whether there was a W-induced nonspecific bystander equal
accumulation of all LCMV-specific C08+ T cells in the lungs and MLNs or whether there
was some selectivity to this accumulation, I analyzed the proportion of each epitope-
specific C08+ T cell population in the total LCMV-specific pool (Figure 6). As already
noted, there was a different LCMV-specific repertoire in the resting LCMV-immune MLN
and lung: GP33-specific C08+ T cells dominated the repertoire in the MLN, whereas
NP396- and GP33-specific C08+ T cells co-dominated in the lung. We found that 
infection modified the LCMV-specific repertoire differently in both these two organs in
such a manner that it further enhanced the difference between these two sites. In the
MLN , by day 12 after W, there was a significant (P 05) and consistent skewing of the
LCMV repertoire in all four experiments, which resulted in increased proportions of
NP396- and GP276-specific C08+ T cells and a decreased proportion of GP33-specific
C08+ T cells, respectively (Figure 6). In the lung there was a different skewing of the
LCMV-specific repertoire, and , although between experiments there was more variabilty
in the lung than in the MLN , there was always a marked change in the selective
specificities, with either the GP33- or NP205-specific responses dominating the
repertoire. In one representative experiment (Figure 6), there was a seven-fold selective
expansion of the NP205-specific population, retention of the GP33-specific population
but a 50- /d loss of the NP396- and GP276-specific populations. Overall, these data
indicated that W infection in an LCMV- immune mouse can markedly alter, in an organ-
dependent manner, the LCMV-specific memory T cell population.
Lung
!! 40
80 -
o 60
e 20
MLN
Im N P396
D GP33
c: GP276
rz N P205
- GP92
LCMV-IMM LCMV+Wd12
Figure 6. Alterations in the LCMV-specific CDS+ T cell
repertoire in the W-infected LCMV-immune mouse
MLN and lung. Data were derived from intracellular IFN-
staining analysis in Figure 10 a and b with five known LCMV-
specific epitopes and are representative of four similar
expe iments. LCMV-IMM , resting LCMV- immune mice;
LCMV+Wd12 , LCMV-immune mice 12 days after- infection.
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Up-regulation of early activation marker CD69 on LCMV-specific CDS T
cells in the W-infected LCMV-immune mice
To examine if there was any evidence that these accumulating LCMV-specific
memory C08 T cells were activated during W infection , I stimulated T cells with peptide
in vitro to identify LCMV-specific T cells and then co-stained those cells with mAb to the
early activation antigen C069 (Figure 7): Just 3 days after W infection, there were
dramatic increases in percents of LCMV epitope-specific C08+ C069+ memory T cell
populations in the lung and MLN of LCMV- immune mice. By day-12 PI, the percentages
of LCMV epitope-specific C08+ CD69+ memory T cell populations returned to the same
levels as before W infection , even though IFNy was still induced. Figure 7 only shows
C069 staining patterns on NP396 and GP33-specific C08 T cells. Three other tested
epitope-specific C08 T cell populations (GP276, NP205 and GP92) showed similar
patterns for C069 surface staining (not shown). Although peptides induced C069
expression on C08 T cells in some circumstances, these results would suggest that the
LCMV-specific memory C08 T cells were at a higher activation state early after 
infection than in a resting LCMV- immune mouse or on day 12 PI.
To directly visualize in vivo C069 expression on LCMV epitope-specific C08 
cells after W challenge, I performed the C069 staining without any in vitro stimulation
and combined this with epitope-specific MHC dimer staining on ice. As shown in Table 6, 3
days after W infection , there were dramatic 3 to 10-fold increases in percents of C069+
NP396-, GP33-, and NP205-specific C08 memory T cell populations in the lung of LCMV-
immune mice. Following in vitro peptide stimulation all five tested LCMV-epitope-specific
Stimulation
Lung
NP396 GP336 6.
MLN
GP33
LCMV- imm
-::.t
LCMV+VV
\:.
:)1t
j/:
LCMV+VV
d12
5.4
:j: ;"';,.,
CD69
D8 (CD8+ IFN-
Figure 7. Increased CD69 expression on LCMV-specific
memory CDS T cells early after W infection. Activation
was assessed by staining for the early activation marker
C069. The x-axis represents COB staining and the y-axis
represents C069 staining of the population gated on the COB
T cells producing IFN-y in response to the indicated peptide.
The numbers recorded in the right upper quadrants represent
the percentage of C069-staining COB T cells specific for the
indicated epitope. There was no C069+ staining of the gated
cells from the control mouse lung and MLN after infection.
These are representative data from 2 similar experiments. For
each experiment lymphocyes from groups of 3 mice each
were pooled prior to staining.
Table 6. Increased CD69 expression on LCMV epitope-specific memory
CDS T cells in vivo early after W infection
Group % CD69+ ofCD8+ cells
% CD69+ of IgG1-MHC I dimer+ CDS+ cellsNP396 GP33 NP20S
LCMV-
immune 2.3
LCMV-
immune +
W day 3
The numbers recorded represent the percentage of CD69 staining of gated CD8+
and LCMV epitope-specific peptide IgG1-MHC I dimer complex+ cells. There were
no CDS+ and LCMV-specific dimer+ cells from the control mouse lung after W
infection. Lung lymphocyes from groups of 3 mice each were pooled prior to
staining.
-=-.;, "
C08 T cell populations demonstrated equivalent levels of C069 expression (Figure 7 and
not shown). It is possible that without any in vitro stimulation the differences in fold
increases in percents of C069+ C08+ T cells among the three epitopes tested (Table 6)
reflected the differences in the in vivo activation state of these three LCMV-specific
memory C08 T cell populations. Since rapid transient up-regulation of C069 on the
surface of T cells has been linked to engagement of TCR (Testi et aI., 1994), up-
regulation of C069 on LCMV epitope-specific C08 T cells in LCMV-immune mice early
after W challenge suggest that the W-induced activation of LCMV-specific CD8 T cells
may involve TCR triggering.
Cyolytic function in LCMV-specific memory CDS T cells after W
challenge
I further assessed the activation status of the accumulating LCMV-specific
memory C08+ T cells by determining their cytolytic capacity ex vivo in bulk cyotoxicity
assays of pooled mouse lung lymphocytes and splenocyes (Figure 8). Both LCMV-
immune and control mice that had been treated with anti- NK1.1 to deplete NK cells 
vivo mounted equivalent W-specific CTL responses on day after W challenge.
However, only in T cells from the W- infected LCMV-immune mice did a W-induced
reactivation of LCMV-specific cyotoxicity occur (Figure 8). In nonchallenged LCMV-
immune and control mice, there was no LCMV-specific lysis (Figure 8). These results
further supported the findings that LCMV-specific C08+ cells were not only
accumulating but were also functionally activated during acute infection.
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A modified intracellular IFN-y assay direcly visualizes activation of
LCMV-specific memory CDS T cells in vivo by W early in infection
Was there any direct evidence that these accumulating LCMV-specific memory
C08 T cells were functionally activated in vivo during W infection? Immediately after
isolation, the lung lymphocyes, without any in vitro stimulation or incubation, were stained
for intracellular IFN-y. Among the tested populations, NK cells (16%, 2.3x10 cells), C04 T
cells (0.2%, 1.0x10 cells), and yo T cells (2. , 6.0x10 cells) pooled from the lungs of 3
infected LCMV-immune mice had produced IFNy in vivd' Day 3 is considered the peak
of the host response by NK and yo T cells (Selin et aI., 2001; Tay et aI., 1999). However
there was no increase in IFN-y production by these cells in LCMV-immune mice 3 days after
challenge, when compared to the W-infected control mice (lung lymphocyes pooled
from 3 control mice: NK cells, 23%, 3.7x10 cells; C04 T cells, 0.5%, 1.4x10 cells; and 
T cells, 1.7%, 4.0x10 cells; Figure 9 and Table 7). Although the percentage of IFN-
producing NK cells inW-infected LCMV-immune mouse lungs was slightly lower than that
in W-infected control mouse lungs, the total number of IFN- producing cells in W-
infected LCMV-immune mouse lungs was twice as high as that in W-infected control
mouse lungs (Figure 9 and Table 7). This was because of a significant increase in IFN-
producing C08 T cells in W-infected LCMV-immune mouse lungs as compared to the
controls (Figure 9 and Table 7). Similar patterns were also observed in the MLN and
spleen 3 days after W challenge (Table 7). Furthermore, the C08 T cells which were
producing IFN-: in vivd' did not co-express the NK cell associated molecule, NK1.1.
In order to determine whether these IFN- producing C08 T cells were LCMV-
specific, the lung lymphocytes immediately after isolation and without any in vitro
-- 
Q) 20
o Control+VV
LCW+VV
COB CD4 gdT
Figure 9. in vivo IFN- producing cells in the LCMV-
immune mouse lungs 3 days after W challenge.
Lymphocytes isolated from mouse lungs were immediately
placed at 4 oC and stained with anti-CD3, CDB, CD4, NK1.1, and
yo TCR mAbs, as well as anti-IFN-y mAb without any stimulation
in vitro. Y-axis indicates the percentage of cells stained with
intracellular IFN-y. These are representative data from one of 2
similar experiments. For each experiment lymphocyes from
groups of 3 mice were pooled prior to staining.
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stimulation or incubation were stained for intracellular IFN-y and, with LCMV epitope-
specific MHC dimers on ice (Figure 10). There was no in vivo IFN-y production by LCMV-
epitope specific memory C08 T cells isolated from resting LCMV-immune mice. As
compared to minimal in vivd' IFN-y production by 0.7% of C08 T cells (4.2x10 cells)
from the W-infected control mouse lungs, 16% of C08 T cells (6.2x10 cells) from the
LCMV- immune mouse lungs were producing IFN-y in vivd' 3 days after W challenge.
Among them, 29% of the NP205-specific, 25% of the GP33-specific and 16% of the
NP396-specific C08 memory T cells in the lung were producing IFN- in vivd' (Figure
10).
This experiment with MHC dimers charged with three of the six LCMV-specific
epitopes accounted for 26% of the IFN- producing cells being LCMV-specific (Table 8
Exp. 3). Two additional similar experiments with MHC dimers to define four of the LCMV
epitope-specific responses (NP205, NP396, GP33 and GP34) showed that 11% and 10%
of the lung C08+ T cells produced intracellular IFN-y 3 days after W infection, and that
58% and 42% of those responses, respectively, could be attributed to COS+ T cells
specific to those LCMV epitopes (Table 8 Exp 5 and 6). These experiments may indicate
that, at this time after W infection, most of the IFN-y-producing cells were LCMV-
specific, because not all the LCMV epitopes are tested for IFN-y production. Two of the
immunodominant epitopes were not tested, and it is unlikely that low-affnity responses
or responses by receptor down-modulated T cells would be recorded. This, of course
does not rule out the possibility that some of this response was mediated by memory T
cells not specific to LCMV or newly activated na"ive T cells specific to 
LCMV
+Wd3
LCMV
imm
Control
+Wd3
'FN
GP33
IgG1 MHC Dimer (gated on CD8+
Figure 10. Increased" in vivd' IFN-y production by LCMV-
specific CDS memory T cells early after W infection. Mice
were infected as indicated. Lymphocytes isolated from mouse
lungs were immediately placed at 4 oC and stained with anti-CDS
mAb, 3 of 6 potential LCMV epitope-specific MHC dimers (NP20S,
NP396, and GP33) for which we had functioning dimers and anti-
IFN-y mAb without any stimulation in vitro. The data presented
in this figure have been gated on CDS+ T cells. The numbers in
each quadrant indicate the percentage of CDS T cells stained
with the indicated MHC dimer and/or intracellular IFN-y. These
are representative data from one of 3 similar experiments. For
each experiment lymphocytes from groups of 3 mice each were
pooled prior to staining.
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The control H2K dimer loaded with ovalbumin-specific peptide (OVA257 264) bound
c: 0.2% of C08 T cells. The control Ob
-dimer loaded with the' influenza A virus peptide
(NP366 374) bound c: 0.8% of C08 T cells, and they produced minimal IFN-y. Some degree of
recognition of influenza NP366-pulsed targets by LCMV-specific CTLs has been observed
(Selin and Welsh, 1997). A low level (2.3%, Figure 10) binding of the GP33-specific dimers
to C08 T cells from the lungs of W-infected control mice also occurred with CD8 T cells
from the lungs of non-infected control mice, suggestng that GP33-specific dimers might
have a low level of non-specific binding, or that GP33 might cross-react with Wand some
self antigens.
Enhanced IFNi' production in LCMV-immune mice early after W
challenge
RNase protection assays showed 4. fold higher levels of IFN- mRNA in the
LCMV- immune mouse lungs, compared to W-challenged control mouse lungs, 3 days
after W challenge (relative intensity of IFN-y: LCMV+W, 0.33:0.01; control +W
07:t0. 003, P=0.00003) (Figure 11a). In the unchallenged LCMV-immune mouse lungs
compared to the nonchallenged control mouse lungs, a low basal amount of IFN-
mRNA was observed. In addition, three- to five-fold higher concentrations of IFN-
'- protein-as detected by enzyme linked immunosorbant assay (ELISA)-were observed in
the sera of W-challenged LCMV-immune mice (Figure llb). The difference in IFN-
.,'
levels between W- infected LCMV- immune and control groups was seen as early as 3
days after W infection. The greatest difference occurred by day 5' after W
infection. In contrast, after challenge two-fold higher mRNA levels of IL- , a potent
LCMV Control
tt 
!: 
I +Wd3 I I +Wd3 
IFN-y
GAPDH
(d 0)
VV (d 3) 
VV (d 5)
VV (d 6) 
VV (d 7)
. Control+VV
LCMV- imm+VV
200 400 600
IFN-y levels in sera (pg/ml)
Figure 11. Increased IFN-y in LCMV-immune mice after
W challenge as assessed by (a) an RNase protection assay
of cyokine mRNA levels in the lung tissue and (b) an ELISA
assay that measured IFN-y in pooled sera. tRNA, negative
control; mRNA, positive control; GAPDH , the housekeeping
gene (used to normalize mRNA levels).
pro-inflammatory cytokine, were observed in control mouse lungs compared to the
LCMV- immune mouse lungs (relative intensity of IL-6: LCMV+W
, 0.04:0.0003; control
+W, 0.08;;0. , P-:0.05) (Figure Ua). Higher amounts of serum IL-6 were also found
in the W-infectec/ control mice (42 pgjml
, sera pooled from three mice) compared to
the W-challenged LCMV-immune mice (12 pgjml
, sera pooled from three mice).
Because IL -6 is a pro-inflammatory cytokine (Ramshaw et, aI.
, 1997), these results
suggested that a stronger acute inflammatory response took place in the control mice
and that previous immunity to LCMV markedly altered the 
cyokine responses induced
by W infection.
An importnt role for IFN-y in mediating protecive immunity to W in
LCMV-immune mice
IFN-y has marked impact on replication (Muller et aI.
, 1994). To further test
whether the increased IFN-y, produced in the LCMV-immune mice was important in this
protective immunity, LCMV-immune mice were treated with anti-IFN-y and infected with
W. In two similar experiments (Table 9), anti-IFN-y treatment, in comparison to control
mAb, resulted in significant 4- and 3. fold increases in W titers in the lungs, and 5-
and 15-fold increases in W titers in the pooled MLNs of LCMV-immune mice. The
importance of IFN-y in regulating W synthesis in LCMV-immune mice has also been
documented in mice during i.p. W infections. 129jSEV mice immune to LCMV developed
protective h terologous immunity to W, similar to that in the C57BLj6 mice, whereas
IFN-yR KG 129jSEV mice immune to LCMV did not resist W infection (Selin et aI.
, 1998).
_c:,
-_.
Table 9. Enhanced titers of W in the LCMV-immune mice on treatment
with aIFN- mAb
Virus Titer P value (aIFN- 
Treatment (n = number (mean IOg10
v.s. IgG 1Exp # Organ
of mice per group) PFU/organ :!
control)
SEM)b
NO. Lung aIFN-y (n = 6) , 6.8:: 0. P = 0.002
IgG 1 control (n = 6) 2:: 0.
Spleen aIFN-y (n = 6) 1.7 :: 0. P -: 0.
IgG 1 control (n = 6)
-:1
MLN aIFN-y (n = 6) 1.7
(pooled)
IgG 1 control (n = 6)
No. Lung aIFN-y (n = 5) 8 :! 0. P = 0.
IgG 1 control (n = 5) 6.3 :! 0.
MLN aIFN-y (n = 5)
(pooled)
IgG 1 control (n = 5) 1.5
In vivo depletion of IFN-y was performed by Lv. (day a and 3) and Lp. (daily)
injection of 100 I-l of an ascites of rat anti-IFN-y mAb (R4-6A2) or a control rat
IgG1 isotype (clone AllO-1, Pharmingen) following W challenge. At day 6.
after W infection, the lungs MLNs and spleens were harvested and underwent
virus titration and histological analysis.
::\'*1:
;'c
. .
!i.
: j
Altered immunopathology in W-infected LCMV-immune mouse lungs
To examine whether immunity to LCMV would influence W- induced pathology in
the lung, tissue sections were stained with hematoxylin and eosin (Figure 12).
Compared to sections from na ive mouse lungs (Figure 12a), sections from LCMV-
immune mouse lungs (Figure 12b) showed some mononuclear 
(MN) infiltrating cells and
occasional lymphocye aggregates in the interstitium
, a pattern that can be seen in older
na"ie mice in any clean mouse colony. The majority of the LCMV-immune lung
architecture was normal. Seven days after W infection
, the lungs from the LCMV-
immune and control mice had completely different 
pathologies (Figure 12c e and Table
i I
10). We found that 72% of the control mouse lungs had severe alveolar edema (Figure
12c and Table 10): an accumulation of the extravascular fluid in the air spaces
, which
presumably disturbed gas exchange. In addition
, the W-infected control mouse lungs
mainly showed acute mixed inflammatory infiltrates (AMI) with polymorphornuclear
(PMN) and MN cells in the 'peribronchial areas (86%) and interstitium (71%), as well as
in the perivascular areas (71%) (Figure 12d and Table 10). In contrast, the lungs 
LCMV-immune mice challenged with W showed a prominent lymphocyic response
which may have aided in the clearance of W. In addition
, 80% of the LCMV-immune
mouse lungs had marked induction of the lung lymphoid 
system (Figure 12e and Table
10), as shown by prominent bronchus-associated lymphoid tissue (BAL T). BAL Twas
defined by nodules of lymphoid tissue , in the bronchial lamina propria near the branch
points of an airW y or between the bronchus and an 
artery (Pabst
, 1992). Although
acute LCMV infection induced a minimal transient BAL T, there was no BAL T present in
the resting LCMV- immune mouse lungs (Figure 12b). Prominent chronic MN infiltration
:" :::
Figure 12. Enhance lymphocic infiltration in the lungs of LCMV-immune mice
aftr infeion with W. Lung sections from mice that did not receive W (a-b) or from
infected mice 7 days PI (c-f) were stained with H+E. a) Naive mouse lungs had normal
architecture. b) LCMV-immune mouse lungs had very mild lymphocyic infiltrates in the
interstitium. c) W-infected control mouse lungs mainly showed severe alveolar edema
(pink material 4n air spaces), and d) acute necrotizing bronchiolitis (NS) and
peri bronchiolitis as well as neutrophilc infitrates in the interstitium. e) W-infected LCMV-
immune mouse lungs had significantly increased BAL T around the airways and no alveolar
edema; f) BAL T surrounded an airway with bronchiolitis obliterans (BO), and also present
was perivascular (PV) lymphocyic cuffng. Bars = 100 
Table 10. Altered immunopathology in the i.n. W-infected LCMV-immune
mouse lungs
Lung % Mice with lung involvement
Pathological Control+W LCMV-imm + 
Compartments Features (n=7)# (n=5)#
+++ +++
Alveoli Edema
BALT Extent of
BALT
Airways Necrotizing
bronchiolitis
Peribronchial 100
AMlt
Bronchioliis 100
obliterans
Interstitium CMlt 100
AMI
Pleura CMI 100 100
Vasculature Lymphocytic 100
cuffing
Necrotizing
vasculitis
Edema + AMI 100
\ Seven days after VV infection the mouse lungs were harvested , sectioned and
; stained (H+E), as described in Materials and Methods. These data are
representative of 5 similar experiments.
:i. t, AMI
, acute mixed infiltrate (polymorphornuclear and mononuclear cells);
:j, CMI , chronic mononuclear infiltrate (lymphocytes and macrophages);
J; Grading of the pathological changes in the lung: based on the distribution and
the severity of disease from 0 to +++ (0, within normal limit; +, 1-9%, ++ , 10-
.'. 49%, and +++ 50% involvement of the lung parenchyma).
f #, the number of mice in each group.
(CMI) with lymphocytes and macrophages was present in the interstitium and pleura of
almost all the W- infected LCMV-immune mouse lungs.
In addition, 60% of the LCMV-immune lungs had perivascular lymphocytic
cuffng, as defined by lymphocye accumulation around the vessels (Figure 12f and
Table 10). LCMV-immune mouse lungs challenged with W also showed the less
common pathology of necrotizing vasculitis (60%) and bronchiolitis obliterans (40%)
(Figure 12f), which, in humans, are thought to be immune-mediated diseases of
unknown etiology. By 7 days after W infection, lungs from both groups showed
necrotizing bronchiolitis, one of the main lesions of the disease (Figure 12d,f), as
defined by the presence of necrotic bronchiolar epithelium with PMNs and debris. Thus
altered immunopathological features were seen in the W- infected LCMV-immune mice
lungs, which showed a prominent lymphocytic response, whereas the W-infected
control mouse lungs mainly had acute neutrophilc infiltrates and severe edema.
Bronchiolitis obliterans and BAL T persist in the LCMV-immune mouse
lungs long after W challenge
To further study the effect of prior immunity to LCMV on the altered lung
immunopathology upon W infections
, I examined lung histopathology in LCMV-immune
mice at later time points after the W challenge. As shown above, 7 days after W
challenge, some of the W-challenged LCMV-immune mouse lungs developed
"','
bronchiolitis obliterans (Figure 12f and Table 10). By day 14 and 30 post W
postinfection, moderate bronchiolitis obliterans was still present in 4 out of 5 
challenged LCMV- immune lungs (Table 11a).
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Another interesting finding was persistence of prominent BAL T in the lungs of
W-challenged LCMV-immune mice. Expansion of BAL T occurred in the W-infected
LCMV-immune lungs as early as day 5 postinfection (see Chapter V Table 20). The
extensive BALT tended to persist, as there was stil a substantial BALTin W-challenged
LCMV-immune lungs 30 days after W infection (Table 11a) and even 43 days after 
infection (not shown). As shown in Table 11a, enhanced BALT developed but only late
(greater than 14 days) after W infection in the control mouse lungs. Thirt days after
W infection, only very mild BAL T presented in the W-challenged control mouse lungs
(Table 11a).
To define whether the persistent BALT is a unique feature in the LCMV-immune
mouse lungs with heterologous W infection, I also examined histology in LCMV-, and
immune mouse lungs after homologous secondary viral challenge. The secondary
LCMV infection induced a transient mild to moderate BAL T, and 30 days after the
secondary LCMV infection, only very mild BAL T persisted in, the LCMV-challenged LCMV-
immune mouse lungs (Table llb). The secondary W infection induced moderate BAL T
as early as 7 days after challenge, and BAL T persisted in the lung even 69 days after
secondary challenge (Table llb). Therefore, expansion and persistence of BALT
observed in the lungs of W-challenged LCMV- immune mice were more like the changes
occurring in the lungs of W-challenged W-immune mice. This suggests that may be
a good inducer of BAL T with a high frequency of memory T cells in the immune mouse
lungs and there' may be a distinct mechanism to control the size of BAL T, which is an
inducible lymphoid tissue. In one experiment with day 14-W-infected LCMV-immune
mice, I found that C08+ T cell clusters (Figure 13b) and scattered C04 T cells (Figure
, II
Figure 13. The predominant infiltrates in the BAL T of the
LCMV-immune mouse lung challenged with W are T cells.
Fourteen days after W challenge, lungs from LCMV-immune mice were
harvested, and frozen sections (5 mm) were cut and fixed, then
undergone immunohistochemistry staining. (a) shows hematoxylin and
eosin staining. The serial sections which show similar pulmonary
architecture, were incubated with biotin-labeled mAbs to C03 (clone
145-2C11), (b) C08 (clone 53-5. 8), (C) C019 (Clone 103), or (d) C04
(clone RM4-5). Sections were then stained with streptavidin-HRP and
DAB solution. The sections were counterstained with. Magnification:
SOx of the objective of the digital light-microscope.
.,'
-, 
13d) surrounded a bronchiolar and vascular bundle, while no C019+ B cells were found
in the BALT (Figure 13c). These results suggested that the predominant infiltrates in the
BAL T of the W-challenged LCMV- immune mouse lung were T cells.
In vivo depletion of IFN- results in severe pulmonary edema and no
induction of BAL T in W-infected LCMV-immune mice
Because the LCMV-specific memory C08+ T cells produced IFN-y in the lung of
, W-challenged mice, we questioned whether IFN-y played a role in the altered lung
pathology. Compared to the W- infected LCMV-immune mice treated with control IgGl
(Figure 14a), in vivo depletion of IFN-y in the W-infected LCMV-immune mice by
intravenous (Lv.) and Lp. injection of anti-IFN-y resulted in severe edema and no
induction of BALT (Figure 14b). This pathology was similar to the changes observed in
the W-infected control mouse lungs (Figure 12c), which suggested that IFN-y might
playa role in recruiting the lymphocyes to the lungs and thus alter the pathology in the
infected LCMV-immune mouse lungs. This is consistent with studies showing that
IFN-y participates in inducing chemokines to recruit activated lymphocyes to the liver
uterus and ovary, the sites of W replication (Mahalingam et aI. , 2000). Therefore, the
enhanced IFN-y response in immune mice may play role in the induction of
immunopathology.
.,'
---- 
Figure 14. Severe edema and impaired lymphocic infiltration in the lungs of
infected LCMV-immune mice upon treatment with anti-IFN-y mAb. Lung
sections from mice that had been infected with W 7 days previously were stained with
hematoxylin and eosin. (a) W- infected LCMV-immune mice were treated with control
IgG1. (b) In vivo depletion of.IFN-y in W- infected LCMV-immune mice by daily Lv. and
p. injection of anti-IFN-y for 6 days resulted in severe pulmonary edema and no
induction of BALT. Bars=100 
-,.
II 'r
Detecting in situ LCMV-specific CDS T cells in BAL T of W-infected
LCMV- immune mouse lung by using MHC tetramer and confocal laser scanner
microscopy
In order to determine if the BAL T in the lungs of LCMV-immune mice acutely
infected with W was composed of LCMV-specific memory C08 T cells, I stained lung
sections in situ with LCMV epitope-specific MHC tetramers. I chose NP396-specific
tetramers, which were easily made because NP396-404 peptide binds to H20 at lOOO-fold
higher affnity than other LCMV epitope peptides (Gairin et al., 1995). Because BAL T is not
prominent in W-infected control mouse lungs, there were few clusters of C08 T cells in
those lungs (Figure 15b) as compared to the LCMV-immune lungs, which had prominent
BALT (Figure 15a). Those few C08 T cells present in the W-infected control mouse lungs
did not co-stain with NP396 tetra mer (Figure 15b). In contrast, in the LCMV-immune lungs
after W challenge there were many C08 T cells which co-stained with NP396 tetra mer
(Figure 15a), demonstrating that LCMV-specific C08 cells were recrui ed to and
contributed to the formation of the prominent BAL T, one of the hallmarks of the 
altered
pathology present in these mice. A similar stining pattem was also found in the W-
infected LCMV-immune mouse lung frozen sections by using NP396-specific IgG-MHC I
dimers (not shown).
Brief summary
I have shown in this chapter that mice with respiratory infection with LCMV can
clear the virus in the lung and enter a resting immune healthy state. When these LCMV-
immune mice are challenged intranasally with W prior immunity to LCMV provides
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protection against a lethal W challenge, and the decrease in mortality in the W-infected
LCMV- immune mice is associated with a decreased W load throughout the course of the
infection. Moreover, I provide data that this protective heterologous immunity
against W is dependent on LCMV- immune leukocyes.
In this chapter, I systematically examined what impact heterologous virus
challenge had on memory C08+ T cell populations. This impact resulted in: (i) the up-
regulation of C069 expression, the activation of cyotoxic function and IFN-y production
of LCMV-specific C08 memory T cells upon W challenge; (ii) the selective expansion
and modulation of the original LCMV-specific memory C08 T cell repertoire; and (ii) the
distinct organ-dependent redistribution of these defined antigen-specific heterologous
memory T cell populations. These responses were associated with IFN- dependent
enhanced protective immunity and greatly altered immunopathology. Taken together
prior immunity to LCMV has a profound effect on the disease induced by W. This
heterologous immunity can be another important factor influencing the severity and
ultimate outcome of viral infections.
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CHAPTER IV
THE MECHANISMS INVOLVED IN ACTIVATION AND MODULATION OF
MEMORY CDS T CELLS DURING THE HETEROLOGOUS VIRAL
INFECTIONS
The next logical question is what are the mechanisms involved in activation and
modulation of memory C08 T cells during the acute heterologous viral challenge. One
possible mechanism is cross-reactive stimulation through TCR engagement. A TCR that
recognizes a given MHC-presented peptide might also recognize other peptides that fit the
appropriate MHC motif and have, projecting from the antigen-binding groove, amino acid
side chains that are able to stimulate the TCR. Another possible mechanism for activation
and modulation of memory C08 T cells is Ag- independent bystander activation by
cytokines. During viral infection, there is an induction of type I IFN, which can then
induce IL-15. Memory C08 T cells can be induced into cell cycle by IL-15 (Tough et aI.
1999). IL- , another important cytokine controlling many viral and mycobacterial
infections, has recently been reported to drive memory C08 T cells into cell division 
vivo and this effect is IFN- dependent (Tough et aI., 2001). A third potential
mechanism involved in modulation of memory CD8 T cells during the heterologous viral
infection is the migration of memory T cells, which express distinct chemokine receptors
(Mahalingam et aI. , 2000), into areas of inflammation in a non-specific manner. Studies
have shown that putatively non-cross-reactive OVA-specific memory-phenotype
transgenic T cells migrate into the lung early during influenza A virus infection and
thereafter disappear instead of expanding in number (Topham et aI. , 2001).
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In this chapter, I wil show that upon heterologous W challenge there is
preferential expansion in number of LCMV-specific memory C08 T cells with discrete
specificities. This selectivity suggests that cross-reactive responses played a role in this
expansion. W peptides partially homologous to LCMV NP205 stimulate LCMV NP205-
specific C08 T cells, suggesting that NP205 may be a cross-reactiveepitope. Results
from poly I:C treatment of LCMV-immune mice and W challenge of IL-12KO mice
suggest that the cytokines produced during W infection may assist in the initial
recruitment of LCMV-specific memory C08+ T cells into the lung and MLN and that IL-12
enhances IFN-y production by LCMV-specific memory C08+ T cells.
Alteration of LCMV-specific memory CDS, cell repertire after W
challenge
To examine whether there was some selectivity to the accumulation of LCMV-
specific C08+ T cells in W-infected LCMV- immune mice, I analyzed the number and
proportion of each epitope-specific C08+ T cell population in the total LCMV-specific
pool. Figure 4a shows that 12 days after W infection, there were selective 6- and 80-
fold expansions of GP-33- (day 0: 4.0 x 10 cells; day 12: 2.4 x 10 cells) and NP205-
(day 0: 3.9 x 10 cells; day 12: 3. 1 x 10 cells) specific C08 T cells, respectively, in the
W-challenged LCMV- immune mouse lungs as compared to the lungs of LCMV-immune
mice without W challenge. There also were 3- to- fold increases of three other
epitope-spedfic C08 T cells. When I analyzed the proportion of each epitope-specific C08
T cell population within the total LCMV-specific pool (Figure 16), there was a seven-fold
selective expansion of the NP205-specific population, retention of the GP33-specific
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LCMV-Immune
NP205 GP92
LCMV-lmmune+W d12
GP92
NP396 NP205
GP276
Figure 16. Alteration of LCMV-specific CDS memory T cell
repertoire in W-infected LCMV-immune mouse lung. This is
Figure 6 presented in a new way.
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population, but a 50-67% loss of the NP396-, GP276- and GP92-specific populations.
Overall , these data indicated thatW infection in an LCMV- immune mouse can markedly
alter the LCMV-specific memory T cell hierarchy, with selective expansion of some
epitope-specific C08 T cell populations. This result is suggestive of cross-reactive
responses.
It is noteworthy that experiments varied in the relative amount of gp33-specific
vs. NP205-specific T cells stimulated. Some experiments showed LCMV-immune mice in
which only the NP205 response was significantly amplified, but other experiments
showed mice in which the gp33 response was marginally higher than the NP205
response and considerably higher than the normally strong NP396 response. Therefore,
upon heterologous W challenge there was preferential expansion of LCMV-specific
memory C08 T cells with discrete specificities. This selectivity suggests that cross-
reactive responses may playa role in this expansion.
NP20S-cross-reactive Wpeptides stimulate LCMV NP20S-specific CDS
T cells
Since NP205-specific C08 T cells were selectively expanded upon W challenge of
LCMV-immune mice, our laboratory pursued a study to search for NP205 cross-reactive
epitopes. Using ONASIS softare to scan the whole W genome sequence based on
two criteria , partial homology to LCMV NP205 and an appropriate MHC K binding motif,
we found three peptides designated as pi, p10 and p24 (Sheridan and Selin
unpublished data). As schematically shown in Figure 17 pI and p24 have
about 50% homology to LCMV NP205. They also have H2K binding residues at the fifth
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LCMV NP205 YTV KYP
Wp1
Wp10
VV p24
LYP
STLN
AI VNYAN
Figure 17. NP205-crossreactive peptides. Three 
peptides designated as p1 , p10 and p24 were found to have
partial 38% to 50% homology to LCMV NP205 and the
appropriate MHC K binding motif based on scanning of the
whole genome sequence with the DNAsis program.
Homologous residues are shown in balded letters. They also
have the H2K binding residue at the fifth Y or F and the eighth
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Y and the eighth V or L. W pl0 has about 38% homology to LCMV NP205 and H2K
binding residues at the fifth F and the eighth L. Preliminary experiments by others in the
lab showed that LCMV acute infection can induce low numbers of COB T cells
recognizing W pi and p24, whereas W acute infection can induce p10- and p-24-
specific C08 T cells. In W- infected LCMV-immune mice, there were increases in those
three W peptide-specific C08 T cells.
To directly examine whether LCMV-NP205-specific C08 T cells can be stimulated by
peptides to produce IFN-y, I incubated cells with individual W peptides for 5 hrs and
then stained cells with NP205 tetramer or dimer and anti-IFN-y mAb. As shown in Figure
18, in the resting LCMV-immune mouse lungs, 29% of NP205 dimer+ cells synthesized
IFN-y in response to W pl stimulation. Twelve days after W infecton, 17% of NP205
dimer+ cells were IFN- + in response to W pl stimulation. After calculating the cell
number, there was actually a 16-fold increase in NP205-specific C08 T cells recognizing
Wpl in the LCMV-immune lungs 12 days after W challenge, in addition to a 98-fold
increase in NP205-specific C08 T cells and a 100-fold increase in total C08 T cells in
response to W pi (Table 12 Exp. 1). Although 1.1% and 1.3% of C08 T cells responded to
WplO and p24 stimulation, respectively, in the resting LCMV-immune lungs, no significant
binding of NP205 tetramer was seen in those populations (Figure 18). By day 12 of acute
infection of LCMV-immune mice, there were 77- and 91-fold increases in CD8 T cells
responding to W pl0 and p24 stimulation, respectively, but no significant binding of NP205
tetramer w s again seen in those populations (Rgure 18 and Table 12 Exp. 1). In the MLN
a 7. fold increase in NP205-specific C08 T cells in response to Wp1 stimulation was also
observed in W-infected LCMV-immune mice (Table 12 Exp. 2). In splenocyes, 43% of
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Peptide NP205
stimulation (no tetramer) NP205
a. Lung , 0,8 0,54 0,
LCMV -irn ,
;:,
(CD8: 10%)
VVpl
06 0.
VVplO VVp24
1. 0,02 1. 
:I::
1.0
LCMV -imm' '
'!'
+ VV day 1
(CD8: 77%)
b. Spleen
LCMV - irn '
~~~
(CD8: 15%) 
.,.,
0.1 0.3 0.1
LCMV -imm 
+ VV day 12 
;::,
(CD8: 14%) 
IFNy t ' I 1. NP205 tetramer (Gated on CD8+)
Figure 18. W peptides cross reactivate LCMV NP20S-specific
CD8 T cells. LCMV-immune ( 12 months after LCMV Ln. infection)
mice were challenged i.n. with W. Leukocytes were isolated from the
(a) lungs and (b) spleens, stimulated with individual peptides for 5 hrs
and stained with NP205 tetra mer and anti-IFN-y mAb. Cells from
groups of three mice each were pooled before staining. The total
C08+ T cell frequencies are given in parentheses. The number in
each quadrant is the percentages of C08+ T cells with a particular
staining pattern. The percentage of IFN- producing C08+ T cells with
no peptide stimulation was below 0.01%. Data are representative of
three similar experiments, and in two other experiments NP205 dimer
was used instead of NP205 tetra mer.
..,
,
"
.
Ta
bl
e 
12
. I
FN
-
pr
od
uc
in
g 
CD
S 
T 
ce
lls
 in
 re
sp
on
se
 to
 V
V
 p
I, 
pl
0,
 a
nd
 p
24
 s
tim
ul
at
io
n 
an
d 
LC
M
V 
NP
20
5-
sp
ec
ifc
 C
D
S
T 
ce
lls
 in
 re
sp
on
se
 to
 V
V
 p
I s
tim
ul
at
io
n 
a
ft
er
 V
V 
ch
al
le
ng
e 
o
f L
CM
V
-im
m
un
e 
m
ic
e
N
P2
05
IF
N
-
+
 
1
IF
N
-
+
 
1
IF
 
Ex
p
N
P2
05
-
O
rg
an
G
ro
up
s
sp
ec
ifi
c
IF
- t 
2 
(V
Vp
l
(V
pl
(V
V 
pI 
0
(V
Vp
24
st
im
ul
at
io
n)
st
im
ul
at
io
n)
st
im
ul
at
io
n)
st
im
ul
at
io
n)
Lu
ng
LC
M
V
-im
m
7x
l0
2.
4x
l0
2x
l0
1.
4x
l0
1.
6x
 1
 0
LC
M
V
-im
m
+V
V
 d
ay
 1
2
5x
10
8x
10
2x
 1
0
1.
lx
l0
l.4
x 
10
LC
M
V
-im
m
2x
l0
5x
l0
5x
10
1.
 7
x 
10
2.
2x
l0
LC
M
V
-im
m
+V
V
 d
ay
 1
2
1.
8x
 1
0
2x
l0
3x
l0
6x
l0
6x
l0
LC
M
V
-im
m
0x
l0
5x
l0
8x
10
8x
l0
5x
l0
LC
M
V
-im
+V
V
 da
y 
12
8x
 1
 0
2x
l0
2x
 1
0
5x
10
6x
l0
M
LN
LC
M
V
 -i
m
m
7.
3x
l0
1.
3x
l0
1.
4x
l0
6x
l0
1.
1x
l0
LC
M
V
-im
m
+V
V
 d
ay
 1
2
4.
4x
l0
LO
x 
10
1.
0x
l0
1.
6x
 1
0
1.
0x
 1
 0
LC
M
V
 -i
m
m
9x
l0
9x
l0
1.
5x
l0
5x
10
9x
 1
0
LC
M
V
-im
+V
V
 da
y 
12
1 
x 
10
3x
10
5x
10
1.
1 
x 
1 
0
1.
7x
 1
0
Sp
le
en
LC
M
V
-im
m
2x
10
2.
4x
l0
2x
l0
7x
l0
9x
 1
0
LC
M
V
-im
+V
V
 da
y 
12
7x
l0
0x
l0
7x
l0
1.
3x
10
7x
10
LC
M
V
 -i
m
m
8x
10
0x
10
0x
 1
0
1.
7x
10
1.
5x
10
LC
M
V
-im
+V
V
 da
y 
12
3.
3x
10
1.
5 
x 
10
1 
x 
10
3.
4x
10
1x
10
,
 
de
te
rm
in
ed
 b
y 
in
tra
ce
llu
la
r I
F-
y 
sta
in
in
g 
fo
llo
w
in
g 
in
di
ca
te
d 
in
di
vi
du
al
 p
ep
tid
e 
sti
m
ul
at
io
n;
 2
,
 
de
te
nn
ne
d 
by
 in
tra
ce
llu
la
r
IF
N
- y
 st
ai
ni
ng
 a
fte
r V
V
p1
 p
ep
tid
e 
sti
m
ul
at
io
n 
fo
llo
w
ed
 b
y 
sta
in
in
g 
w
ith
 N
P2
05
-s
pe
ci
fic
 M
H
C 
te
tra
m
er
 o
r d
im
m
er
. 3
,
 
N
P2
05
-
sp
ec
ifi
c 
te
tr
er
s 
w
er
e 
u
se
d.
 4
,
 
N
P2
05
-s
pe
ci
fic
 d
im
er
s w
er
e u
se
d.
109
NP205 dimer+ cells also were IFN- + in response to W pi stmulation. Twelve days after
W infection, 33% of NP205 dimer+ cells were IFN- + in response to W pl stimulation
although there was no increase in the absolute numbers of both 
NP20S-specific and Wp1-
specific C08 T cells before and after W challenge (Figure 18 and Table 12). No significant
binding of NP205 tetramer was seen in Wp10 and p24-
specific C08 T cells in the spleen
(Figure 18). These results suggest that Wpl can stimulate LCMV NP205 C08 T cells in a
cross-reactive manner, but cross-reactvity with WplO and p24 is less defined.
Of note, when cells were stimulated with NP205 peptide for 5 hrs and then
stained with NP205 tetramer, IFN-y+ C08 T cells responding to NP205 peptide stained
with NP205 tetramer to a very low level
, presumably because the TCRson NP205-
specific C08 T cells were down-regulated (Figure 18). The staining patterns with anti-
IFN-y mAb for NP205-specific cells were only slightly different in the absence or
presence of NP205 tetramer following NP205 peptide stimulation (Figure 18). Therefore
because of this caveat of the technique used here
, the results shown in Figure 18 could
be underestimates of cross-reactive cells
, arguing for the possibilty that WplO and p24
are cross-reactive with LCMV NP205-specific memory C08 T cells. Since W encodes
about 200 proteins
, it is highly possible that there are more W epitopes cross-reactive
with other LCMV epitope-specific C08 T cells.
Poly I:C induces up-regulation of CD122 and CD69 on CDS T cells and a
transient increase in LCMV-specific CDS T cells in LCMV-immune mouse lungs
To assess the role of cytokines in modulation of memory C08 T cells during
heterologous virus infection
, I first examined the effect of a cyokine inducer
, poly I:C
110
on activation and accumulation of LCMV-specific memory C08 T cells. Memory C08 T
cells have receptors for IL- , a cytokine that regulates their homeostasis (Ku et aI.
2000; Sprent et aI., 1999). During viral infections, there is an induction of type I IFN
which can then induce IL-15. In turn, IL-15 can enhance the division of memory C08 
cells (Ku et aI. , 2000; McNally et aI. , 2001; Tough et aI., 1996). Poly I:C, which mimics
viral dsRNA, is a potent inducer of type I IFN and other cyokines such as IllS (in both
type I IFN-dependent and independent manners) (Mattei et aI. , 2001). To examine how
memory T cells respond to cytokines induced by poly I:C, I first assessed the expression
of C0122 (IL-15Rp and IL-2RP) on C08 T cells in LCMV- immune mouse lungs upon
intranasal poly I:C treatment. As shown in Figure 19a, C0122 was expressed on C08 T
cells in resting LCMV-immune mouse lungs. By day 3 poly I:C treatment, there was an
up-regulation of C0122 expression on the total C08 T cell population in the LCMV-
immune mouse lung. A slight up-regulation of C0122 was also observed on CD8 T cells
from the lungs of W-infected LCMV- immune mice by day 3 postinfection. Similarly, poly
I:C-induced up-regulation of C0122 was also observed on C08 T cells in the MLN of
LCMV-immune mice at day 3 post treatment (not shown). It is not clear whether 100 /-g
poly I:C induces equivalent levels of cytokines to the amount of cyokines induced by W
infection. Nonetheless, these results suggest that both poly I:C and infection could
lead to up-regulation of C0122 on C08 T cells in LCMV- immune mouse lungs, enabling
these C08 T cells to respond to IL-15 induced in those mice.
I also examined C069 expression on C08 T cells in LCMV-immune mouse lungs
after poly I:C treatment. As shown in Figure 19b, in resting LCMV-immune mouse lungs
a very low level of C069 was expressed on C08 T cells. A dramatic up-regulation of
a. CD122+/CD8
.. 90
co 80
LCMV- im m LCMV+polyl:C LCMV+VV d3
b. CD69+/CD8
I- 30
ct 100-.
LCMV-imm LCMV+poly I:C LCMV+VV d3
Figure 19. Poly I:C-induced up-regulation of
CD122 and CD69 on CDS T cells in LCMV-immune
mouse lungs. LCMV- immune (::12 months after LCMV
Ln. infection) mice were inoculated Ln. with 100 
poly I:C. Leukocyes were isolated from the lungs
, and
stained with anti-CDS, anti-CD122 and anti-CD69 mAbs.
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C069 was observed on C08 T cells from the lungs of W-infected LCMV-immune mice 3
days after W infection (Figure 19b), as also shown in Chapter III. However
, three days
after poly I:C treatment, there was only a slight increase in C069 expression on the total
C08 T cell population in the LCMV-immune mouse lung (Figure 19b). Type I IFN has
been known to up-regulate MHC class I complex expression on APCs (Bukowski and
Welsh, 1985; Rhodes et aI. , 1986); thus it is possible that poly I:C-induced cyokines
such as type I IFN might up-regulate MHC class I charged with endogenous self-ligands
for TCRs on APCs. These increased endogenous self-ligands could trigger TCRs on T
cells, leading to C069 expression.
Summing intracellular IFN-y responses to 5 individual LCMV-specific epitopes,
there were 9- and 18-fold increases in LCMV-specific C08 T cells in the lung and MLN of
LCMV-immune mice, respectively, 4 days after poly I:C treatment
, as compared to
resting LCMV- immune mice (Figure 20). However, by 12 days after treatment, there was
no further increase but instead a decrease in LCMV-specific C08 T cells as compared to
the cell number at day 4 post treatment (Figure 20). This 
contrasts with the infection
of LCMV-immune mice, where there were significant increases in the numbers of LCMV-
specific T cells at later time points (Figure 5). Therefore, the poly I:C-induced increase
, of LCMV-specific C08 T cells was transient.
Poly I:C causes no alteration of LCMV-specific CDS T cell repertoire and
no in vivo IFN-y production in LCMV-immune mice
To examine whether there was a poly I:C-induced nonspecific bystander
accumulation of all LCMV-specific C08+ T cells or whether there was some selectivity to
LUNG
2E+06
0E+05
OE+05
OE+OO
LCMV-inm LCM+polylC day4 LCMV +poly Ie day 12
MLN
0E+05
0E+05
0E+05
OE+OO
LCMV- imm LCMV+polylC day4 LCMV+pofylC
day12
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Figure 20. Poly I:C-induced transient increase in
LCMV-specific CDS T cells in LCMV-immune mice.
LCMV- immune (::12 months after LCMV i. n. infection) mice
were inoculated Ln. with 100 1-9 poly I:C. Lymphocyes
were isolated from the (a) lungs and (b) MLNs, stimulated
with 5 individual LCMV peptides and stained for intracellular
IFN-y. Lymphocytes from groups of three mice each were
pooled before staining. The sum of the total numbers for
each of five LCMV epitopes are shown in y-axis. Dat are
representative of two similar experiments.
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this accumulation, I analyzed the proportion each epitope-specific C08+ T cell population
represented in the total LCMV-specific pool (Figure 21). In both the lung and MLN, there
were no significant alterations of the LCMV-specific C08 T cell repertoire by day 4 and
day 12-post treatment with poly I:C, suggesting that there was a poly I:C-induced
nonspecific bystander accumulation of all LCMV-specific C08+ T cells that was equal.
This contrasts with the W-induced alteration of LCMV-specific C08 cell repertoire
observed in LCMV- immune mouse lungs and MLN at day 12 after challenge (Figure
6).
To examine if poly I:C can cause a functional activation of memory T cells in
terms of in vivo IFN-y production, I examined in vivo intracellular IFN-y production by
memory T cells 3 days after poly I:C treatment. As shown in Table 13, no 
in vivo IFN-
production was found by LCMV epitope-specific CD8 T cells in poly I:C-treated LCMV-
immune mice. This contrasted with C08 T cells specific for 4 LCMV epitopes from 
infected LCMV- immune mouse lungs, which accounted for 59% (6.5/11.0) of IFN-
producing C08 T cells in the lung. These results imply that the selective accumulation
and alteration as well as functional activation of LCMV-specific C08 T cells in the lung of
W-infected LCMV-immune mice were not simply due to a non-specific bystander
process caused by W-induced cyokines.
Frequency and repertoire of LCMV-specific CDS T cells in IL-12KO
LCMV-immune mouse lungs
Vv induces a potent IL-12 response (Slezak et aI., 2000). I decided to examine
the role of IL-12 in activation of C08 T cells in W-infected LCMV-immune mouse lungs,
-',
115
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GP33
50%
CJ GP276
40% ri NP205
30% GP92
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LCMV-imm LCMV+polylC LCMV+polyIC
day4 day12
70%
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40%
30%
20%
10%
LCMI-imm LCMI+polyIC day4 LCMI+polyIC day12
Figure 21. Poly I:C causes no alteration of LCMV-specific
CDS T cell repertoire in LCMV-ilnmune mice. Data were
derived from intracellular the IFN-y staining analysis in Figure 20 a
(: b with five known LCMV-specific epitbpes and are
representative of two similar experiments.
Table 13. No in vivo IFN-y production by LCMV-specifc CDS T cells
in poly I:C-treated LCMV-immune mice
Specificity ofT cells % Dimer+ IFN- + cells out of total CD8+ T cells
No dimer
LCMV -imm + poly I:C
day3
LCMV-imm + 
day3
11.0
NP396
GP33
GP34
NP205
1.1
1.9
0.3
Total dimer+
IF- cells
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using IL- 12KO mice. I observed a similar frequency and repertoire of LCMV-specific C08
T cells in resting IL-12KO LCMV-immune mouse lungs as compared to the wild-type
mice (Figure 22a). Similar results were obtained in the spleens of resting IL-12KO LCMV-
immune mice as compared to the wild-type controls (LCMV-immune IL-12KO: 2.0x10
cells/spleen; LCMV-immune WT: 1.7x cells/spleen). In the MLN, there was no
significant difference in the frequency of LCMV-specific memory C08 T cells between the
IL-12KO and wild-type LCMV- immune mice. However, the GP33-specific memory C08 T
cell population was no longer predominant in the MLN of resting IL- 12KO LCMV-immune
mice (WT: 59:110%; IL-12KO: 46:113%; 23%,J, p=0. , n = 3 experiments). This
phenomenon contrasts with GP-33 dominance in the MLN of resting wild-type LCMV-
immune mice (Figure 22b). Nonetheless, a relatively normal LCMV-specific memory C08
T cell pool was detected in the resting LCMV- immune IL-12KO mice.
Up-regulation of CD69 and CD44 but not CD122 on CDS T cells in
LCMV-immune IL-12KO mice
To examine how memory T cells respond to W infection in IL-12KO mice, I
assessed C069 and C044 expression. As shown in Figure 23, three days after 
challenge, there was a dramatic increase in C069 expression and a moderate up-
regulation of C044 expression on the total C08 T cell populations from the lung of both
LCMV- immune WT and IL-12KO mice.
However, the expression of C0122 (one subunit of IL-15R and IL"'2R) on C08 T
cells was different in LCMV- immune WT and IL-12KO mouse lungs upon W challenge. It
was noted that in both groups, all C0122+ C08 T cells were C044+ (not shown). As
a. Lung
60%
50%
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20%
6 10%
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:2 ,JO%
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Figure 22. Frequency and repertoire of LCMV-specific
memory CDS T cells in the lung (a) and MLN (b) of
resting LCMV- immune IL-12KO mice. Data were
derived from intracellular IFN-y staining analysis with four
known LCMV-specific epitopes and are representative 
three similar experiments. The numbers below the bar
graphs were the sums of the numbers of 4 individual LCMV
ep!tope-specific COB T cell populations.
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shown in Figure 23, by day 3 W postinfection, there was a 2-fold increase in the
percentage of C0122+ C08 T cells in LCMV-immune WT mouse lung. This was not
observed on C08 T cells from the lungs of W-infected LCMV- immune IL-12KO mice.
Similar patterns of phenotypic changes were observed on C08 T cells in the MLN of
LCMV-immune WT and IL-12KO mice at day 3 post infection (not shown). It is not
clear why the up-regulation of C0122 expression on C08 T cells early in infections
was impaired in the LCMV-immune IL-12KO mice. I postulate that IL-12 might playa
role in up-regulation of C0122 expression on C08 T cells; then, IL-15 secreted by APCs
or IL-2 produced by C04 cells could modulate functions of these C08 T cells.
Accumulation of LCMV-specific CDS T cells in W-infected LCMV-
immune IL-12KO mice.
To examine if IL-12 plays a role in accumulation of LCMV-specific C08 T cells 
infected LCMV-immune mice, I used intracellular IFN-y staining to quantify LCMV-
specific C08 T cells at day 0, day 7 and day 12 post W infection. Data were analyzed by
calculating the ratios of the numbers of LCMV-specific C08 T cells in the wild-type mice
versus IL-12KO mice at each time point after challenge (Figure 24). In resting
immune mice, there were a slightly lower number of LCMV-specific C08 T cells in the
lung, and MLN of wild-type mice than those in IL-12KO mice. Seven days after 
challenge, the numbers of LCMV-specific C08 T cells in the lung and MLN of wild-type
mice were 2. 1- and 1.8-fold higher than those in the lung and MLN of IL- 12KO mice
respectively. By day 12 post W infection, the numbers of LCMV-specific C08 T cells in
the MLN of wild-type mice were 3. fold higher than those in the MLN of IL-12KO mice.
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Figure 24. Accumulation of LCMV-specific CDS T cells in
the W-infected LCMV-immune IL- 12KO mice. Data
represent the means of the ratios of the numbers of LCMV-
specific COB T cells in the wild-type mice and IL-12KO mice
after challenge from three similar experiments (Lung and
MLN).
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These results suggest that a decreased accumulation of LCMV-specific CD8 T cells
occurred in both the lung (day 7) and MLN (day 12) of LCMV- immune IL-12KO mice as
compared to the wr controls upon W infection.
The role of IL-12 in IFN- production by LCMV-specific CDS T cells upon
antigenic stimulation
When I examined in vivo IFN-y production by LCMV-specific C08 T cells in W-
infected LCMV- immune IL- 12KO mouse lungs using the modified intracellular IFN-
assay, I found that there was a remarkable 6.25-fold reduction in in vivo IFN-
production by LCMV-specific C08 T cells in W-infected LCMV-immune IL-12KO mouse
lungs as compared to the wr controls 3 days after W challenge (Figure 25). Only 6.5%
of the LCMV-specific C08 T cells were producing IFN-y in W-infected LCMV-immune IL-
12KO mice, while 42% of the LCMV-specific C08 T cells were producing IFN-y in W-
infected LCMV-immune wr mice. Therefore, IL-12 played a role in the functional
activation of LCMV-specific C08 T cells to produce IFN- in vivo during heterologous W
infection.
To further examine whether the IL-12-mediated enhancement of IFN-
production by LCMV-specific memory C08 cells is dependent on TCR triggering,
leukocyes from the lung, MLN and spleen of LCMV- immune mice were stimulated with
LCMV peptides in the absence or presence of mouse recombinant IL- 12 in vitro for 5
hrs. Cells were then analyzed by intracellular IFN-y assays. As shown in Figure 26 and
Table 14 from one of two representative experiments, no IFN-y production by memory
C08 T cells from LCMV-immune mice was observed without cognate peptide stimulation
.. 1.
"t 0.
CI 0.
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Figure 25. Reduced in vivo IFN-y production by LCMV-
specific CDS T cells in W-infected LCMV-immune IL-
12KO mouse lungs. Mice were infected as indicated.
Lymphocyes isolated from mouse lungs were immediately
placed at 4 oC and stained with anti-CDS mAb, 4 of 6 potential
LCMV epitope-specific MHC dimers (NP20S, NP396, GP33 and
GP34) for which we had functioning dimers and anti-IFN-y mAb
without any stimulation in vitro. The data presented in this
figure have been gated on CDS+ T cells. Y-axis indicates the
percentage of CDS T cells stained with the indicated MHC
dimer and intracellular IFN-
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in the presence of exogenous IL-12. If cells were stimulated with individual LCMV
epitope-specific peptides, there was a 2- to 3-fold increase in IFN-y mean fluorescent
intensity (MF!) for each epitope-specific C08 T cell population after addition of
exogenous IL- , even though the frequency of IFN-y producing cells specific for each
LCMV epitope did not significantly increase, suggesting that IL-12 could enhance IFN-
production by LCMV-specific memory C08 T cells, but only after their TCRs were
triggered by peptide stimulation.
Brief summary to Chapter IV
In this chapter, I have shown that upon heterologous W challenge, there are
preferential expansions of LCMV-specific memory C08 T cells with discrete specificities.
This selectivity suggested that cross-reactive responses played a role in this expansion.
Moreover, I have shown that W peptide pi , which is partially homologous to LCMV NP
205, stimulated LCMV-NP205-specific C08 T cells, suggesting that NP205 may be a
cross-reactive epitope. I have provided evidence that poly I:C treatment of LCMV-
immune mice results in a transient increase but no repertoire alteration of LCMV-
epitope-specific C08 T cells. These cells do not produce IFN- in vivo. Finally, W
challenge of LCMV- immune IL-12KO mice results in activation and slightly decreased
accumulation of LCMV-specific C08 T cells. Here, there is a dramatic reduction of in vivo
IFN-y production by LCMV-specific C08 T cells in the lung of LCMV-immune IL-12KO
mice. Overall, the cytokines and, possibly, chemokines produced during W infection
may assist in the initial recruitment of LCMV-specific memory C08+ T cells into the lung
127
and MLN. However, cross-reactive T cell responses most likely participated in their
activation and selective expansion in the lung and MLN upon W challenge.
" ..
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CHAPTER V
THE SEQUENCE OF INFECTIONS WITH DIFFERENT VIRUSES
DETERMINES THE PATTERN OF ANTIVIRAL IMMUNITY AND
IMMUNOPATHOLOGY IN THE LUNG
Prior heterologous immunity to a virus can alter the course of disease caused by a
second virus. In the previous two chapters, a model of the respiratory W infection of
LCMV- immune mice was examined. In this chapter
, I wil demonstrate some new
insights on heterologous immunity using other virus combinations. Using four unrelated
viruses (LCMV, W, influenza A virus and MCMV), I took two different approaches. First,
I examined the effect of immunity to three different viruses
, LCMV, MCMV and influenza
A virus had on the outcome of acute W infection. Second, I examined the effect of
immunity to one virus, influenza A virus, had on the acute responses to LCMV MCMV
and W. I focused my assessment of disease outcome on three major features: virus
titers, cytokine profiles and lung immunopathology. These studies demonstrate that the
specific sequence of infections with different viruses controls the outcome of disease by
influencing viral clearance, early cytokine responses and immunopathology.
Respiratory infection of CS7BL/6 mice with LCMV, influenza A virus or
MCMV
I first examined the kinetics of viral clearance after an i.n. inoculation of naiVe
C57BLj6 mice with LCMV, influenza A virus or MCMV. As shown previously, LCMV was
cleared in the lungs and spleens (Table 2). During an acute influenza A virus infection
129
influenza A virus could be detected in the infected-mouse lungs by plaque assays (Table
2). By day 10 postinfection , influenza A virus was no longer detectable in the lung.
These results were comparable to other studies (Dohert et al., 1992), and influenza A
virus-immune mice remained healthy during the rest of their life time unless they were
subsequently infected with pathogens.
When mice were immunized with a low dose of MCMV (400 PFU), there was no
discernible clinical illness during the course of the infection. MCMV titers in the lung
were not examined. When mice were challenged with a much higher dose of MCMV (1 x
PFU), MCMV PFU were detected in the lung (Table 16). In mice given 10 PFU of
MCMV intranasally, the course of virus replication was virtually identical to that noted
with 100 PFU of virus (Jordan, 1978). In that study, peak titers were reached in the
lungs on day 7 (5 x 10 PFUjlung) and gradually declined over the next 2 weeks.
Therefore, during an respiratory infection of C57BLj6 mice with these selected
doses of LCMV, influenza A virus, or MCMV, these viruses were cleared from the lung,
and infections with these viruses could be used to study the effect of prior immunity to
one virus on immunity against a second unrelated virus.
The sequence of heterologous virus infecions determines whether
viral clearance is enhanced or impeded
The effects of immunity to LCMV, MCMV, or influenza A virus on 
infection. Adult C57BLj6 mice were intranasally immunized with either LCMV MCMV or
influenza A virus. More than 6 weeks after the acute response had resolved, and when
the host was in a resting immune state, the mice were challenged with a second virus
130
Table 15. Previous heterologous viral infections protect against W
Immunizing Challenge Days after Virus Titer (log p value (Immune 
virus virus challenge PFU/lung)b ControjC
control (3) 2 :t 0.
LCMV 5.5 :t 0.4 P= 0.
Control (1) 5:t0.
MCMV 0 :t 0. P = 0.004
Control (2) 2 :t 0.
Flu 5.4 :! 0.4 P = 0.
The infection of mice was done as described in Materials and Methods. a, The
number in parentheses represents the number of experiments that were done.
b. Data are presented as mean
:! 
SEM 10glOPFU/lung from a representative
experiment. There were three to five mice per treatment group. c. Statistically
significant difference between the control and immunized groups of mice (t-test).
d. LCMV- immune mice (12 weeks afteriCMV infection) acutely infected with W
were NK cell-depleted by i.p. injection of 100 III (200 Ilg) of anti-NK1.1 (clone
PK136) on day 0 and 4 after infection. e, Flu- immune mice were challenged with
W 6 weeks after initial infection with influenza virus.
, ..
Table 16. Prior immunity to Flu can enhance or impede viral clearance
Immunizing Challenge Days after Virus Titer (log P value (Immune
virus virus challenge PFU/lung)b vs. Control
Control W (2) 5:t 0.
Flu 1 :t 0. , P = 0.
Control LCMV (2) 1 :t 0.
Flu 7:t 0. t, P .c 0.
Control LCMV (3) 5 :t 0.
Flu 3 :t 0. t, P .c 0.
Control LCMV (3) 5.4 :t 0.4
Flu 0 :t 0. t, P = 0.
Control MCMV (7) 0 :t 0.3
Flu 9 :t 0. 1, P = 0.
Control MCMV (7) 7 :t 0.4
Flu 5 :t 0.3 , P = 0.
The infection of mice was done as described in Materials and Methods. a , The number in
parentheses represents the number of experiments that were done. b. Data are
presented as mean :t SEM 10glOPFU/lung from a representative experiment. There were
three to five mice per treatment group. c. Statistically significant difference between the
control and immunized groups of mice (t-test). d , e, f, g, and h, Flu-immune mice were
challenged: with a second unrelated virus 12, 24, 11, 10, and 6 weeks after initial
infection with influenza virus, respectively.
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as seen in Table 15 and Table 16, which show viral titration data. Two distinct patterns
emerged on how prior infections could influence viral clearance in the lung. The first
pattern was that prior immunity to LCMV MCMV or influenza A virus resulted in 80%,
68% and 84% reductions in W titers, respectively, in the lung at 5-6 days after W
infection (Table 15). This protective effect of prior immunity lasted for long periods of
time after the original virus infection, as mice either 12 (Table 15) or 30 weeks
(Control+W: 6.9:t O. lloglOPFU/lung; LCMV-immune+W: 6.3 :t O. lloglOPFUjlung; 86%
-1, poeO.05, n = 3 mice/group) after LCMV infection demonstrated comparable effciency
at resisting W challenge as did mice either 6 (Table 15) or 12 (Table 16) weeks after
influenza A virus infection challenged with W. Therefore, prior immunity to LCMV
MCMV or influenza A virus provided significant protection against infection.
The enhanced replication of LCMV or MCMV in influenza A virus-
immune mice. In contrast to the protection against in influenza A virus-immune
mice, prior immunity to influenza A virus was not always protective. The second pattern
I observed was that immunity to influenza A virus resulted in a significant 6. fold
increase in LCMV and 8-fold-increase in MCMV titers in the lungs when compared to
controls 7 days after challenge with LCMV or MCMV (Table 16). Within this same group
of influenza A virus-immune mice there was stil a 60% decrease in W titers as
compared to controls. Enhanced LCMV titers were seen in the lungs of influenza A virus-
immune mice as early as 5 days after challenge, but the increase was not as big as the
one observed 7 days after LCMV infection (Table 16). Moreover, significantly increased
LCMV titers were also found in the spleens of influenza A virus-immune mice compared
with control mice 7 days after LCMV challenge (for instance, control: 3.7 :t 0.3
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10glOPFU/spleen; influenza A virus-immune mice: 4.7 :t 0.5 10glOPFU/spleen; 10-fold
increase, P = 0.009; n = 4 mice/group). For MCMV challenge, the kinetics of the
increase in virus titer varied between the two stocks of MCMV preparations used.
Significant increases in MCMV titers were mostly observed at day 7 postinfection for one
stock, while in some cases significant increases in MCMV titers were found at day 9
postinfection for the other stock. The reason for this variation is unclear. These
experiments were carried out 6 - 24 weeks after influenza A virus infection (Table 16),
indicating that this enhanced LCMV or MCMV replication appeared to be independent of
the time after initial immunization with influenza A virus. These studies suggest that
exposure to heterologous viruses can be beneficial , resulting in protective immunity, but,
depending on the infection sequence, can also result in enhanced virus replication.
In addition to the sequential heterologous viral infections shown in Table 15 and
16, I also assessed virus titers in the lungs of influenza A virus- or MCMV-infected LCMV-
immune mice and LCMV- or influenza A virus-infected MCMV-immune mice. In a few
pilot experiments no significant changes in challenge virus titers were observed in the
lungs of those heterologous virus- immune mice when compared with control mice
(Table 17), so no more experiments have been performed with these combinations since
then. These studies suggest that immunity between heterologous viruses is a common
occurrence, but it is not universal to all virus combinations, as there is a selective effect
dependent on the sequence of virus infections.
If'
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Table 17. Heterologous immunity between viruses in the lung
Challenge virus
Immunizing
LCMV Flu MCMVvirus
LCMV
- 0. 1 (1)
- 0. 1 (1)
- 0.9 (4)*
Flu + 0. 6 (3)* + 0.7 (7)*
- 0.6 (2)*
MCMV + 0. 1 (2) + 0. 1 (1)
- 0.5 (1)*
Naive mice or mice that were immune to various heterologous viruses were
challenged intranasally with these viruses
, and the PFU titers were assessed in
lungs 5-9 days after infection. Data are presented as average of mean 
changes
of titers in multiple experiments. The number in parentheses represents the
number of experiments that were done to derive the mean 
IOg10 changes in virus
titers. There were three to five mice per treatment group. This table shows the
degree of either protective immunity, as determined by the reduction of viral
titer, or decreased immunity, as determined by the increase in viral titer
, in
heterologous virus-immune mice compared with control mice. ND homologous
virus challenges were not done. +
, increased titer; -, reduced titer. *
, P-:0.05.
'." "
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The sequence of heterologous virus infections determines the cyokine
profile
I questioned whether prior immunity to heterologous viruses affected the
cytokines induced during the subsequent virus infection. Lungs of LCMV-immune mice
early after W challenge or of influenza A virus-immune mice early after W or MCMV
challenge were assessed for their cytokine mRNA levels by RNase protection assay
(Figure 27). IFN-y is a prototypic T l cytokine with antiviral activity. IL-12 is a cyokine
with multiple functions, including induction of differentiation of THl T cells. IL-l, IL-
and TNF-a are three major proinflammatory cytokines inducing neutrophilic infiltration
and synthesis of acute phase proteins.
The cyokine profile in W-infected LCMV-immune mice. Consistent with
my early study on W-infected LCMV- immune mouse lungs, there were 4-fold higher
levels of IFN-y mRNA in LCMV immune mice lungs 3 days after W infection (Figure
27a). At the same time, there was also a 50% reduction in the mRNA levels of the pro-
inflammatory cytokine IL-6 in the LCMV-immune mouse lungs as compared to the
controls. Altogether these results suggested that stronger acute inflammatory cytokine
responses occurred in the W- infected control mice as compared to LCMV-immune mice.
Previous immunity to LCMV markedly enhanced a Th1 type cyokine response to W
infection but appeared to suppress pro-inflammatory cytokine responses.
The cytokine profile in W-infected influenza A virus-immune mice.
Cytokine profiles upon W infection of influenza A virus-immune mice mirrored the ones
observed in LCMV-immune mice. There was a 60% higher level of IFN-y mRNA
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expression in the lungs at day 3 after infection in influenza A virus-immune mice as
compared to controls (Figure 27b). Concomitantly, these same influenza A virus-immune
mice showed a 50% reduction in mRNA levels of the pro-inflammatory cyokine IL- ll3,
although IL-6 levels remained similar to control mice (Figure 27b). It would appear in
situations where prior immunity resulted in protective immunity against W infection
there were enhanced Thl type responses with increased IFN-y associated with
suppression of some pro-inflammatory responses upon W challenge.
The cyokine profile in MCMV-infected influenza A virus-immune mice.
When I examined the cytokine profile in influenza A virus-immune mouse lungs
challenged with MCMV, where prior immunity appeared to have a negative impact on
the second virus infection , I observed that a very different cyokine profile was induced
by MCMV as compared to W. There was a very striking 12-fold increase in IFN-y mRNA
level when compared to control mice 3 days after MCMV challenge (Figure 27c).
However, unlike the influenza A virus or LCMV-immune mice challenged with W, the
MCMV-infected influenza A virus- immune mice had significantly increased levels of pro-
inflammatory cyokines, including 11-, 4- and 4-fold increases in IL- , IL- lp' and IL-
12p40, respectively (Figure 27c). It is not clear what mechanism accounts for the
increased MCMV load in influenza A virus- immune mice. It is possible that the increased
virus load is driving the production of these cyokines, or it is also consistent to assume
that the presence of these pro-inflammatory cyokines may mediate the enhanced virus
replication.
",-,
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Distinctive lung pathology during acute respiratory infection of non-
immune mice with LCMV, MCMV, influenza A virus, or 
I questioned whether it is a general phenomenon that prior infections with
heterologous viruses could influence lung pathology on subsequent infections; thus, 
needed to document baseline data on lung pathology during acute infection in non-
immune mice. Mouse lung tissues were harvested, sectioned and stained with
hematoxylin and eosin. Each acute virus infection in naive mice at the selected doses
induced a distinct lung pathology, which returned to essentially normal architecture in
the resting immune state (Figure 28). Figure 28a shows a naive mouse lung section,
characterized by flat pleura, clean and open bronchioles, clean and open alveoli with
very thin septa, as well as normal vasculature. Acute LCMV and MCMV infections
induced relatively mild lung disease composed predominantly of chronic mononuclear
(MN) infiltrates in the interstitium (Figure 28b, c; and Table 18). Acute LCMV infection
could induce mild to moderate transient SALT. BALT is not normally visible but can be
induced by infection (Figure 28b and Table 18). MCMV only induced BAL T at very high
doses of infections (Table 18). MCMV also is known to infect endothelial cells (Staczek,
1999) and thus it was not too surprising to observe endothelial activation (Table 18)
upon infection with this virus.
Influenza A virus and W infections at much lower doses of virus than LCMV and
MCMV caused much more severe lung damage, with some residual changes in the lung.
'-'
Influenza A virus induced severe acute inflammation with many mixed
polymorphonuclear (PMN) and MN cells around airways, in the alveolar spaces and
interstitium. This severe acute inflammation frequently developed into consolidation.
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Acute Immune Immune + VV
Figure 28. Lung immunopathology varies depending on the infecting virus and can be
further dramatically altered by prior immunity to heterologous viruses. Lung sections
from mice were stained with H+E. First column: na"ive control (a) and single virus acute infection
(day 7) (b-LCMV, c-MCMV, d-Flu); second column: single virus immune (e- , f-LCMV
, g-
MCMV
h-Flu); third column: immune mice infected with W (i-na"ive+W day 7, j-LCMV-immune+W day
, k-MCMV-immune+W day 5, I-Flu-immune+W day 5). Magnification: 4x of the objective of
the digital light-microscope.
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Consolidation in influenza A virus- infected mouse lungs was reported previously in an
early study on influenza pneumonia (Loosli et aI., 1975). Moderate edema, necrotizing
vasculitis and perivascular acute mixed PMN and MN infiltrates were also present in the
influenza A virus-infected mouse lungs (Figure 28d and Table 18). After the acute
influenza A virus infection resolved, the lung architecture was relatively normal. There
were some residual consolidated areas and mild BAL T persisting in the influenza A virus-
immune mouse lung. Also occasionally, very mild bronchiolization occurred in the
influenza A virus- immune mouse lung (Figure 28h and Table 20). Bronchiolization is a
damage-repairing process where the alveolar walls are lined by cells resembling, but not
necessarily identical with , bronchiolar epithelium. Bronchiolization can be observed after
a variety of insults such as respiratory infection, exposure to chemical irritants and
carcinogens, and even circulatory disturbances involving the lung (Nettesheim and
Szakal, 1972).
During acute W infection, the mouse lungs developed necrotizing bronchiolitis
and severe alveolar edema (Figure 28i, 29a and Table 18). This accumulation of
extravascular fluid in the air spaces could significantly disturb gas exchange. In addition
the W- infected mouse lungs mainly showed acute mixed inflammatory infiltrates (AMI)
with PMN and MN cells in the peribronchial areas and interstitium, as well as in the
perivascular areas, shown at higher magnifications in Figure 29 (Figure 29a , b and Table
18, 20). Enhanced BALT could develop but only late, i.e. greater than 14 days, after W
infection (Table 11). Mild BALT persisted for at least 3 months in the W-immune mouse
lung (Figure 28e).
144
The findings described above are consistent with previous studies (Jakab et 
1983; Jordan, 1978; Lemercier et aI. , 1979; Loosli et aI. , 1975; Mackenzie et a!., 1989;
Martinez Peralta et aI., 1990; Staczek, 1999; Walker and Murphy, 1987; Yap et aI.
1979).
Alterations in W-induced lung pathology is dependent on the specific
history of heterologous virus exposure
The effec of immunity to LCMV on W-induced immunopathology.
When the LCMV- MCMV- or influenza A virus-immune mice were challenged with W
the immunopathology varied dramatically not only from the W-infected controls but also
from each other, depending on the specific heterologous virus exposure. During the
acute W infection, lungs from W- infected control and LCMV- MCMV- or influenza 
virus-immune mice all showed one common pathology, necrotizing bronchiolitis (Figure
29b, e, g and Table 19), which is defined by the presence of necrotic bronchiolar
epithelium with PMNs and debris. However, compared to the controls, the lungs of
LCMV-immune mice challenged with W showed very little alveolar edema and had a
very prominent lymphocytic response, instead of an acute inflammatory response. Most
strikingly, the LCMV-immune mouse lungs had very prominent BALT as early asS and 7
days after W infection (Figure 28j, 29c d and Table 19). Also, prominent chronic MN .
infiltration (CMI) with lymphocytes and macrophages was present in the interstitium and
pleura of' almost all the LCMV-immune mouse lungs. In addition, the LCMV-immune
lungs had perivascular lymphocytic cuffng, as defined by a significant lymphocyte
accumulation around the vessels (Figure 28j, 29c d and Table 19). Interestingly, by day
145
Figure 29
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Figure 29. Patterns of chronic mononuclear infiltrates in
VV-infected mouse lungs vary depending on prior
heterologous virus exposure. Higher magnifications (lOx: a,
, e, and g; 40x: b, d, f, and h) of the lung sections shown in
panel i , j, k and I of Figure 28 demonstrated in more detail the
alteration in lung pathology of na"ive mice (a, b) as compared to
LCMV-immune (c, d), MCMV-immune (e, f) and Flu-immune (g,
h) upon W challenge. A: alveoli; B: bronchiole; V: vessel; AMI
acute mixed inflammation with PMN and MN infiltrates; BO,
bronchiolitis obliterans; NB, Necrotizing bronchiolitis.
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149 ':\:r! u
7 of W infection LCMV-immune mouse lungs also showed the less common pathology of
bronchiolitis obliterans (Figure 29c, d and Table 19).
The effects of immunity to MCMV or influenza A virus on W-induced
immunopathology. Following W challenge, the lungs of MCMV- and influenza A virus-
immune mice, like LCMV- immune mice, showed a more prominent chronic mononuclear
response (Figure 28k
, \
, 2ge, g and Table 19), unlike the acute W-infected controls that
had acute neutrophilic infiltrates (Figure 29b and Table 19). Interesting, in both MCMV-
and influenza A virus-immune mice there was a more dramatic accumulation of
mononuclear cells around the vessels with less dramatic increases in BALT, while the
reverse was true in LCMV-immune mice (Figure 28j, k I, 29c, e, g and Table 19).
Although alveolar edema was diminished in MCMV- and influenza A virus- immune mice
this was less so than in LCMV-immune mice (Table 19). The major differences between
influenza A virus-immune mice and MCMV-immune mice upon W challenge was the
presence of mild residual areas of consolidation in W- infected influenza A virus-immune
mouse lungs, whereas W- infected MCMV-immune mouse lungs demonstrated greater
endothelial activation (Table 19). Clearly, prior immunity to anyone of these three
viruses led to dramatic alterations in W-induced pathology in the lung. Although the
common feature in this altered pathology was enhanced chronic mononuclear infiltrates,
immunity to each virus resulted in a different pattern of pathology in the various
compartments of the lung.
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Figure 30. Prior immunity to Flu markedly enhances the usual mild 
mononuclear
infiltrates in the lung upon LCMV- and MCMV- infection. 
Lung sections from mice were
stained with H+E. Acute Flu infection (day 7) caused consolidation with AMI, composed of 
PMN
and MN infiltrates (a), and Flu-immune lungs were essential normal with 
residual consolidated
areas (b). As compared with a LCMV-infected lung (day 7) with mild lymphocyic response
around airways and in the interstitium (c), LCMV-infected Flu- immune mouse lung interstitium
showed slightly enhanced lymphocytic response and pneumonic consolidation composed of MN
cells (d, day 7). Acute MCMV infection (day 7) induced interstitial disease with MN infitrates and
vascular lymphocyic tufting (e). Very strikingly, MCMV-infected Flu- immune lungs had increase in
BALT and pneumonic consolidation of the interstitium (f). B: Bronchiole; V: vessel. 
Magnification:
4x of the objective of the digital light-microscope.
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Figure 31. Unique immunopathology in MCMV-infected
mouse lungs induced by prior immunity to Flu. 
Lung sections
shown here were the same as the ones in panel a, b, and f of
Figure 30 but were at higher magnifications. (a and b): an Flu-
infected lung section at lOx and 40x magnification respectively 7
days after challenge. (c and d) a Flu- immune mouse lung
section. (e and f) a MCMV-infected Flu- immune mouse lung
section , showing very prominent chronic MN inflammation in a
large densely consolidated area. (g and h) another MCMV-
infected Flu-immune mouse lung section, showing an
enhancement of alveolar bronchiolization.
~~~":,
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Prior immunity to influenza markedly enhances the usual mild chronic
mononuclear responses in the lung upon acute LCMV or MCMV infection
I was particularly interested in the influence that immunity to influenza A virus
had on lung pathology upon challenge with MCMV or LCMV, as prior immunity to
influenza A virus appeared to have a detrimental effect on clearance of these viruses.
The most prominent feature of acute influenza A virus infecion is severe
pneumonic consolidation of the lung, which is associated with acute neutrophilic
infiltration (Figure 30a, 31a , b and Table 20). When this resolves, the mouse is left with
some minimal residual areas of consolidation (Figure 30b, 31c
, d, and Table 20), which
appear to be present for the lifetime of the animals as they were observed even 24
months after infection (not shown).
The effects of immunity to influenza A virus on MCMLrinduced
immunopathology. When influenza A virus-immune mice were infected with MCMV
the lung pathology was very different than W infection of influenza A virus- immune
mice but also very different than acute MCMV infection in control mice. Acute MCMV
infection resulted in no pneumonic consolidation, but did induce a chronic mononuclear
infiltration around bronchioles and vessels and in the interstitium (Figure 30e). Upon
MCMV infection of influenza A virus-immune mice, the MCMV-induced lymphocyic
response seen in the lung of non-immune mice was even further enhanced, with a
dramatic increase in both BAL T and a very striking pneumonic consolidation of the
interstitium, but this consolidation was composed of chronic mononuclear infiltration
rather than the acute neutrophilic infiltration observed during acute influenza A virus
infection (Figure 30f, 31e, f and Table 20). There was also an enhancement of alveolar
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bronchiolization, which did occasionally appear in a very mild form in influenza A virus-
immune mouse lungs (Figure 3 Of, 31c 9, h and Table 20). Thus, prior immunity to
influenza led to an overwhelming chronic mononuclear response, which was associated
with decreased ability to clear MCMV (Table 16).
The effec of immunity to influenza A virus on LCM induced
immunopathology. Interestingly, prior immunity to influenza A virus had a similar
effect on the immunopathology in response to another virus, LCMV. Like MCMV, acute
infection with LCMV in control mice results in predominantly mild mononuclear
infiltrate in the interstitium of the lung (Figure 30c and Table 20). However, in influenza
A virus-immune mice LCMV infection induced an increase in chronic mononuclear
infiltration around airways and vessels increased bronchiolization, and some
enhancement of pneumonic consolidation composed of chronic mononuclear cells
(Figure 30d and Table 20). Prior immunity to influenza A virus was also associated with
decreased abilty to clear LCMV (Table 16). Thus, prior immunity to influenza A virus
resulted in marked enhancement of the usually mild mononuclear infiltration that occurs
upon LCMV or MCMV infection.
Brief summary and discussion
I have shown in this chapter that mice with respiratory infection with LCMV
MCMV or influenza A virus can clear the virus in the lung and enter a resting immune
healthy state. When these immune mice are challenged intranasally with an unrelated
virus, previous exposure to LCMV MCMV and influenza A virus can result in protective
immunity against W, but prior immunity to influenza A virus can lead to enhanced
J: 
,.able 21. Sequence of heterologous virus infections influences viral clearance, early
cyokme profiles and histopathology in the lung
Virus Cytokine profile Histopathology
titer
LCMV-immune + 
IFN-y t Dramatically decreased edema
vs. Acute W IL-
Increased chronic lymphocytic
and MN responses
Decreased acute inflammatory
(PMN) responses
Early increased prominent BAL 
(Iym phocyic)
Bronchiolitis obliterans
MCMV-immune + 
Decreased edema
vs. Acute W
Increased chronic lymphocytic
and MN responses, especially
around vessels
Decreased acute inflammatory
(PMN) responses
Moderate BAL T
Endothelial activation
Flu-immune + IFN-y t
Decreased edema
vs. Acute W
Increased chronic lymphocytic
IL- and MN responses
Decreased acute inflammatory
(PMN) responses
Mild BALT
Mild consolidation
Flu-immune + LCMV
Slightly increased BAL 
vs. Acute LCMV
Slightly increased MN response
in the interstitium and around
vessels
Moderate consolidation
Increased bronchiolization
Flu-immune + MCMV IFN-
Increased prominent BAL T (in
vs. Acute MCMV IL-
the consolidated areas)
IL- Increased consolidation with
IL- massive lymphocyic and 
infitrates
Increased bronchiolization
1. day 5-7 postinfection; 2. day 3 postinfectio ; 3. NO, not done.
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replication of LCMV and MCMV. No enhanced virus replication was observed among
tested heterologous viruses in previous systemic Lp. infection studies (Selin et a\.
1998). Therefore, respiratory mucosal infections with heterologous viruses might be a
good model system to study the profound effect, either beneficial or detrimental, of one
history of a virus infection on immunity and immunopathology upon a subsequent
challenge with an unrelated virus (Table 21).
I also show that, in situations where prior immunity to LCMV or influenza A virus
results in protective immunity against W infection, there were enhanced Th1 type
responses with increased IFN-y and suppression of some pro-inflammatory responses
upon W challenge. However, the presence of pro-inflammatory cytokines in MCMV-
infected influenza A virus-immune mice is associated with enhanced MCMV replication.
I have shown in this chapter that an acute respiratory infection of C57BL/6 mice
with LCMV, W, MCMV or influenza A virus causes distinct immunopathological changes
in the lung and that, in the resting immune state, virus-challenged mouse lungs return
to essentially normal architecture. When the LCMV-, MCMV- or influenza A virus-
immune
mice are challenged with W, the immunopathology varies dramatically not only from the
infected controls but also from each other, depending on the prior heterologous virus
exposure. The enhanced accumulation of mononuclear cells appears to be 
associated
with the ability to decrease W titers. I also show that prior immunity to influenza leads
to an overwhelming chronic mononuclear response and ultimately decreased ability to
clear MCMV. Similar to MCMV infection, LCMV infection of influenza A virus-
immune mice
induces a more prominent chronic mononuclear response, associated with enhanced
LCMV replication in the lung th?\n LCMV infection of non-immune mice.
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Taken together, the sequence of infections with different viruses determines the
consequences of heterologous antiviral immunity and immunopathology in the lung
(Table 21).
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CHAPTER VI
DISCUSSION
This thesis examines the activation and role of virus-specific memory C08 T cells
in heterologous antiviral immunity and immunopathology in the lung. A heterologous
virus-induced modulation of memory C08 T cells specific for a previously encountered
virus is explored here in terms of the phenotypic and functional activation status of
memory C08 T cells, the kinetics of accumulation of these cells in lymphoid (the MLN
and spleen) and non-lymphoid (the lung) organs, as well as the memory T cell
repertoire alteration upon the heterologous viral infection. The roles of cross-reactivity
and cyokines in activation of the heterologous memory C08 T cells are also pursued.
Associated with this modulation of virus-specific memory C08 T cells by a heterologous
virus, mortality upon a high dose challenge, the viral load, early cyokine profiles and
lung immunopathology are examined.
In this thesis, I have provided evidence that the activation and modulation of
LCMV-specific memory C08 T cells occur in an organ-dependent manner upon infection
with Wand that this activation and modulation process is associated with IFN-
mediated heterologous antiviral immunity and immunopathology in the lung. I also
provide data suggesting that cross-reactive T cell responses and initial recruitment by
virus-inducediocytokines playa role in modulation of LCMV-specific memory CD8 T cells
upon W infection. Finally, I have made observations implying that the sequence of
infections with different viruses determines the consequences of heterologous immunity
and immunopathology. This is evidenced by the findings showing beneficial enhanced
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clearance in LCMV, MCMV, or influenza A virus-immune mice and detrimental
increased LCMV and MCMV replication in influenza A virus-immune mice. Taken
together, the data presented in this thesis provide a better understanding of the
immunity and pathogenesis to a pathogen in the natural environment as the host is
exposed to multiple different pathogens over a lifetime. Below is an in depth discussion,
of the major points made in this thesis.
The frequency and hierarchy of virus-specific memory CDS T cells in
lymphoid and non-lymphoid organs of mice with a respiratory viral infecion
The results that showed a high frequency of LCMV-specific memory CD8 T cells
in the resting immune mice after resolution of respiratory LCMV-infection are consistent
with contemporary studies on influenza A virus infection (Hogan et aI., 2001a; Marshall
et aI., 2001), VSV infection (Masopust et aI. , 2001), and RSV infection (Ostler et aI.
2001). Using LOAs and intracellular IFN-y assays, I have shown that a high frequency of
LCMV-specific memory C08 T cells is present in the lung of LCMV-immune mice with a
very slow decline over 1 year after resolution of LCMV infection. The proportion 
LCMV-specific C08+ T cells in the MLNs of these same mice remained stable (around 2%
of C08 T cells), and in the spleen it was also relatively stable but higher than in the
MLNs. There are several possibilities accounting for this pattern. First, lymphocyes and
Iymphoblasts from the lung vascular pool differ from peripheral blood or splenic
.,,'
lymphocytes in their migration pattern (Binns et aI., 1992). Once the activated C08+ T
cells have been recruited to the lung, they may not have easily re-circulated (Harris et
aI. , 2002), whereas between secondary lymphoid organs long-lived memory T cells can
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re-circulate. Secondly, T cells which localize to non-lymphoid organs have an increased
abilty to survive, as a recent study with annexin V (a pro-apoptotic cell surface marker)
and TUNEL staining (for apoptotic cells) has shown much less susceptibilty to apoptosis
in memory C08 T cells in peripheral organs such as the lung than cells in secondary
lymphoid organs such as spleen and MLN (Wang, 2002). Third, once C08 T cells migrate
into the lung, these cells are unable to divide (Harris et aI., 2002). Recently published
studies identified two distinct populations of memory C08 T cells in the lung airway
lumina following recovery from a respiratory Sendai virus infection (Cauley et al. , 2002;
Hogan et aI., 2002). A large population (90%) of Ag-specific C08+ T cells persists in a
functional state for several weeks with minimal further division after acute infection
while only a smaller population (10%) of Ag-specific C08+ T cells is maintained in the
lung airways by homeostatic proliferation and migration to lung airways from the
lymphoid organs after viral clearance. All these features for memory T cells in the lung
may explain why the frequency of memory C08 T cells in the lung is high but wanes
gradually.
The long-term persistence of memory C08 T-cell populations in lymphoid organs
mayqe due to homeostatic turning over at a slow, yet steady, pace (Razvi et al. , 1995;
Sprent et aI., 1999). Since memory cells remain in a higher activation state than na ive
cells, these memory cells can respond to stimulatory cytokines such as IL-15 and IL-
(Goldrath et aI. , 2002; Ku et aI. , 2000; Schluns et aI. , 2000; Tan et a!., 2002).
Meanwhile, TCRs of memory C08 T cells may also be stimulated by endogenous self-
ligands, low-affnity cross-reactive ligands, or in some cases possibly by persisting
cognate viral antigens (not necessary in infectious forms) (Gray, 2002). Two new mouse
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models in which TCRs can undergo conditional deletion have been developed
(Labrecque et aI., 2001; Polic et aI., 2001). The first model allows the inducible ablation
of the TCR on mature T cells 
in vivo by Cre recombinase-mediated TCR Ca gene deletion
(Polic et aI., 2001). Since the Cre recombinase is under the control of type-I IFN
promoter, this model is not suitable for a viral infection system which induces IFN. The
, second model exploited the binary transgenic strategy in which the first transgene
encodes a tetracycline (tet)-sensitive transactivator and the second transgene encodes
OVA257-264-specific OT-l a chain and is controlled by the transactivator. Tet inhibits
the transactivator binding to and activating the second transgene (Labrecque et aI.
2001). These mice can first be primed with an antigen. After the primed T cells enter
the memory phase, TCRs on those memory T cells can undergo deletion with an
inducing agent. Then, the memory T cells with no TCRs can be tracked to examine their
survival and functions. This strategy wil help further, clarify the role of TCR on memory
T cell maintenance.
Another interesting but unexpected observation was that the specificity of the
C08+ T cell response to acute LCMV infection between MLN and lung differed , while the
spleen tended to have a similar repertoire to the lung. There may be several possibilties
accounting for this. During the priming phase, there could be differential expression of
viral proteins in different organs, resulting in different magnitudes of expansion of
different epitope-specific C08 T cells. Recently, the functional heterogeneity of dendritic
cell subsets has also been recognized in the spleen and MLN (Reis e Sousa et al., 1999;
Shortman et aL 1997), so it is possible that different DC subsets prime C08 T cells with
different specificity distinctively in the spleen and MLN. Moreover, different tissue
:,. ' .
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adhesion molecules could possibly lead to different thresholds of TCR signaling.
Alternatively, in different organs some virus-induced epitope-specific T cell populations
may respond to cross-reactive tissue-specific self-antigens. Of note, and for unknown
reasons, a lower proportion of GP33-specific cells bound Annexin-V than NP396- and
NP205-specific cells (Wang, 2002), and this difference was more dramatic for T cells in
the MLN than in the lung. This suggests that GP-33 cells in the MLN survived better than
the cells with other specificities. This might be one of reasons for the difference in
repertoire between the lung and MLN. The definitive evidence that explains this
difference in repertoire between the lung and MLN has not yet been found. Nonetheless
heterologous W infection modified the LCMV-specific repertoire differently in both these
two organs in such a manner that it further enhanced the difference between these two
sites, as discussed below.
Dynamic modulation of memory CDS T cell repertire specific to one
virus during a heterologous viral infection.
Memory T cells exist in a dynamic network, and re-infection with homologous
viruses can activate these memory T cells and modulate the original repertoire. For
example, a recent study on adoptively transferred LCMV-immune leukocytes showed
that homologous LCMV re- infection caused more than seven divisions of T cells specific
for each epitope, with dramatic increases in number and slight changes in LCMV-specific
epitope hierarchy with a better NP396- than gp33-specific response in the spleen (Kim 
aI. , 2002; Selin et aI., 1999). Another example was an alteration of the repertoire of
influenza A virus-specific memory C08 T cells following secondary challenge, and a
'.'''-
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H20 -restricted epitope PA224-233 prominent in the primary influenza A virus-specific
C08 T-cell response was found much less apparent (Belzet aI., 2000).
Heterologous viruses can also modulate the original memory C08 T cell pool
specific for a previously encountered virus. Since the replication of a heterologous virus
is not constrained by neutralizing antibody, if this heterologous virus can activate
memory T cells that are specific for a previously encountered pathogen, the high antigen
load might lead to profound T-cell activation. Indeed, in this thesis, I observed that
upon Ln. challenge with heterologous W, (i) LCMV epitope-specific memory CD8 T cells
were activated by W early in infection and were producing IFN- in vivo and
cytolytically active; (ii) there was a selective expansion and modulation of the original
LCMV-specific memory C08 T cell repertoire; and (ii) there was also a selective organ-
dependent redistribution of these defined antigen-specific heterologous memory T cell
populations. Of interest, at day 3 post W challenge, there was no significant number of
C04 T cells producing IFN- in vivo in both LCMV-immune and control mouse lungs.
Since C04 T cells was required to mediate heterologous immunity and altered
immunopathology (Selin et aI., 1998), future studies should further examine the
dynamics of modulation of LCMV-specific memory C04 T cells at later time points after
infection. C08+ T cells from LCMV-immune mice were found to be cytolytically
activated by infection with heterologous viruses (Selin et aI., 1999; Selin et aI., 1996;
Yang et al., 1989). The recent study on adoptive transfer of splenocytes from LCMV-
immune mice into Thy-congenic mice also showed that infections with the heterologous
W caused more than seven divisions and increases in number of T cells specific to some
putatively cross-reactive (e.g. GP33 and NP205-specific C08 T cells) but not other
c- 1
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epitopes and resulted in substantial changes in the hierarchy of the LCMV-specific T cells
(Kim et aI. , 2002). In another system with heterologous virus infections, LCMV and PV
encode cross-reactive C08+ T-cell epitopes (LCMV NP205 and PV NP205), which are
subdominant in each infection. However, if LCMV-immune mice are infected with PV, or
if PV- immune mice are infected with LCMV, the T-cell responses to these NP205-specific
peptides become dominant, involving more than 20% of the C08 T cells. Meanwhile
C08 T cell responses to major immunodominant epitopes are significantly decreased in
both cases upon heterologous viral challenge (Brehm et aI. , 2002). This new epitope
hierarchy remains in the resting double immune state (LCMV and PV-immune or PV and
LCMV-immune).
Of note, in some experiments (Figure 10), the percentage of LCMV-specific
memory C08 T cells in the lung was lower at day 3 post infection than that prior to
challenge. This might be due to bystander apoptosis of memory T cells early in W
infection (McNally et aI., 2001). At this early time point, chemokine-induced nonspecific
recruitment and cytokine or cross-reactivity-driven proliferation of LCMV-specific
memory C08 T cells in the lung might not offset the loss of the cells. Nonetheless
LCMV-specific memory C08 T cells in the lung were activated producing IFN- in vivo 
day 3 post W infection. Actually, the accumulation of LCMV-specific memory CD8 T cells
in the lung was found to occur relatively slowly upon W challenge, as it took
approximately 12 days. Our laboratory previously showed that after acute LCMV
infection Qf IFN-yR KO mice the C08 T cell response returned to homeostasis, but with
delayed kinetics (Lohman and Welsh, 1998). This suggests that IFN-y influences the
contraction phase after the peak of C08 T cell response to LCMV. One recent report
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further showed a delayed contraction of secondary effector C08+ T cells as compared to
the contraction of primary effector C08 T cells (Badovinac et aI. , 2002). The authors
hypothesized that impaired IFN- signaling-whether by receptor modulation or
induction of inhibitory molecules in secondary C08+ effector T cells-could account for
the delayed contraction of these populations. Is it possible that upon heterologous W
challenge, LCMV-specific memory C08 T cells underwent a pseudo-secondary response
with both a delayed expansion phase ( due to a lower affnity interaction between W
antigens and LCMV-specific C08 T cells as compared to homologous LCMV infection) and
a delayed contraction phase, resulting in slow accumulation in the lung?
Modulation of memory CD8 T cells specific to one virus during heterologous viral
infections is not a rare event. A study from another group showed that there was an
increase in CTLp frequency, analyzed by LOA, of Sendai virus-specific memory C08 T
cells in the lung and spleen upon influenza A virus infection (Tripp et aI., 1995a).
Another study from the same group also showed that the relative prevalence of divided
influenza A virus NP366-specific memory C08 T cells (defined by BrdU+ , which was used
as a indicator for DNA synthesis) increased significantly in the mouse spleens 8 days
after Lv. exposure to LCMV and that the prevalence of BrdU LCMV NP396-specific
memory C08 T cells also increased significantly in the spleens 8 days after influenza A
virus infection (Flynn et aI., 1999). In a mouse model of RSV infection, if mice were
infected with influenza A virus before the recombinant W-RSV immunization and
subsequent RSV challenge, there was an accumulation of influenza A virus NP366-specific
C08 T cells in the lung upon RSV challenge (Walzl et al. , 2000).
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The roles for T cell cross-reactivity and cytokine and chemokine mileu
in activation and modulation of virus-specific memory CDS T cells during
heterologous viral infections.
There may be several factors driving or assisting activation and modulation of
virus-specific memory C08 T cells following the heterologous 
viral challenge. The first
factor is the activation of memory C08 T cells by a cross-reactive antigen. In this thesis,
I provide several pieces of evidence suggesting that W cross-reactive epitopes may play
an important role in activation and modulation of LCMV-specific memory C08 T 
cell
populatio . Upon heterologous W challenge, there were preferential expansions of
LCMV-specific memory C08 T cells with discrete specificities (GP33- and lor 
NP205-
specific). W infection can thus markedly alter the LCMV-specific memory cell
hierarchy, suggestive of cross-reactive responses. Our previous study showed that 
and W infections of LCMV-immune mice induced the reactivation of memory CTL
specific to LCMV. LOAs demonstrated that at least part of this reactivation of 
memory
cells in LCMV-immune mice related to cross-reactivity at the clonal level (Selin et aI.
1994). Studies on adoptively transferred CSFE-
labeledLCMV-immune donor T cells into
Thy- l congenic hosts inoculated with also found that W often 
induced preferential
expansions in NP20S- and gp33-specific T cells (Kim et aI., 2002). In another system, a
well-characterized cross-reactivity between LCMV NP205 and PV NP205 dramatically
influenced the immunodominance in LCMV- or PV-immune mice upon PV or LCMV
heterologous challenge (Brehm et al. , 2002). In this thesis, I have shown that W 
pl, a
peptide partially homologous to LCMV NP, 205 , stimulated LCMV-
NP205 specific C08 T
cells, suggesting that NP20S may be the cross-reactive epitope. However, the
7t.
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percentage of NP205-specific C08 T cells that recognized W pi did not increase 12 days
after W challenge, suggesting the unknown cross-reactive W epitopes other than W pi
might be responsible for activation and selective expansion of NP205 T cells. Moreover
because of the caveat of the technique used (double stains of cells with anti-IFN-y mAb
for W-peptide-induced intracellular IFN-y and NP205 dimer/tetramer for NP205-specific
TCRs), the results could not negate the possibility that Wp10 and p24, the two other
peptides with partially homology to LCMV NP 205, also cross-reactivate LCMV NP205-
specific memory C08 T cells. Furthermore, since W encodes about 200 proteins, it is
highly possible that there are more W epitopes cross-reactive with other LCMV epitope-
specific C08 T cells. In some experiments (Figure 6), a more dramatic increase in
NP205-specific C08 T cells was observed in the lung than in the MLN 12 days after 
challenge. This might be due to the fact that W stil presented in the lung while W was
cleared in the MLN by day 12 postinfection. The cells recruited to the lung might
undergo further proliferation upon continuously encountering their cross-reactive
antigens.
Future studies should use new strategies to identify cross-reactive epitopes. For
instance, cross-reactive epitopes can be defined by assessment of epitope-specific dimer
or tetra mer-sorted fresh C08 T cells for their ability to respond to potentially cross-
reactive antigens. The sorted cells will be used only after a defined rest period allowing
bound dime
,s or tetramers to fall off the cell surface, because their presence on the cell
surface may block the interaction of that cell with the potentially cross-reactive antigens.
If the frequency of the cross-reactive T cells is so low, then the sorted cells will need to
be plated into LOAs to obtain a cross-reactive frequency. Then defined peptide-specific
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cross-reactive C08 T cell clones will be generated to assess the effect of these clones in
generating immunity to heterologous viruses. Alternatively, the role of cross-reactivity in
heterologous immunity can be tested by examining the 
effect of immunization with
cross-reactive peptides or minigenes that encode the cross-reactive epitopes (Rodriguez
et aI., 1997) on generating immunity to heterologous viruses.
Several issues should be considered in terms of cross-reactivity. 
First, a cross-
reaction that involves the same determinants on the TCR might be easier to predict by
searching for similar amino-acid side chains at positions of peptides that engage the
TCR. This method has been used for the calculation of potential frequencies of cross-
reactivity (Mason , 1998). Second, if different determinants on the TCR cross-react with
different' peptide-MHC structures, it would be very diffcult to predict when such cross-
reactivity would occur. A way to overcome the diffculty in 
defining this type of cross..
reactivity may be a peptide-induced intracellular cyokine assay, which has an advantage
of sorting out the cross-reactive epitope since a large pool of peptides 
can be tested
within the same assay. The 
third issue about cross-reactivity is that a given T cell may
express two different TCRs. This could happen due to incomplete allelic exclusion 
of the
second TCR a-chain (Alam and Gascoigne, 1998). Although the extrapolated 
frequency
of these cells present in the normal repertoire ranges from 7-
21% (with an average of
15%), the frequency of antigen-responsive cells expressing two surface 
chains is
relatively loW (0(1%) (Heath et aI., 1995). This raises the possibilty that dual a 
chain T
cells may have a selective disadvantage in responding to specific antigen. A simple way
to test the role of dual receptor T cells in heterologous immunity would be to make a F1
hybrid of a TCRa KO (B6 background) and 86 mice. This mouse would only express one
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a-chain. A study on C08 T cells from PV- infected LCMV-immune F1 offspring of a TCRa
KG B6 and normal B6 mice still showed a high degree of cross-reactivity between LCMV
NP205 and PV NP205 (Brehm et ai , unpublished), suggesting that cross-reactivity is not
due to dual TCRs. The fourth issue about cross-reactivity is that possibly only a
subpopulation of the T cells that are specific for a peptide will recognize the cross-
reactive peptide, making T cell cross-reactivity more diffcult to define. Because the TCR
usage differs from host to host and stochastic elements might determine clonal
dominance (Un et aI., 2000; Un and Welsh, 1998), the proportion of peptide-specific T
cells that cross-react with another peptide might differ from one host to another. This
may be the reason why there was some variabilty in the alteration of the LCMV-specific
memory C08 T cell repertoire upon W challenge between the experiments I have done.
In the lung there was always a marked change in the selective specificities, with either
the GP33- or NP205-specific responses dominating the repertoire. Adoptive transfer of T
cells from a single LCMV- immune host into na"ie donors should make the repertoire
alteration less variable between different recipient mice upon W challenge. By this
method, potential cross-reactive epitopes between these two viruses will be defined
more easily than studying the cells pooled from individual mice.
The second factor that may assist activation and modulation of memory C08 T
cells during the heterologous viral infection is the non-specific activation by cytokines 
and potentially chemokines- induced by the virus. The cyokine milieu induced by any
particular virus can be altered by prior exposure to other pathogens. In this thesis, I
have shown that the respiratory infection of LCMV-immune mice with stimulates in
the lung a significantly higher production of the T type cytokine IFN-y but a lower
- ;,
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production of the pro- inflammatory cytokine IL-6 at days 3 postinfection than did non-
immune controls. Moreover, the respiratory infection of infiuenza A virus-immune mice
with MCMV results in greatly enhanced T 1 type and proinflammatory cytokines. These
altered cyokine profiles may have a impact on heterologous memory C08 T cells, since
memory C08 T cells express or can rapidly up-regulate receptors for those cytokines.
Poly I:C, presumably through induced cytokines, can have a limited transient
effect on memory C08 T cells. I have provided evidence that both poly I:C and 
infection could lead to up-regulation of C0122 (IL-15R and IL- ) on C08 T cells in
LCMV- immune mouse lungs, enabling these C08 T cells to respond to IL-15 or IL-
induced in those mice. Currently, it is unclear whether C0122+ C08 T cells are true
antigen-specific memory cells or memory-phenotype (C044 ) cells. There is one recent
study showing that in the primed TCR transgenic mice at least two subsets of memory
phenotype C08 T cells coexist: C0441ntC0122- C08 cells, which are generated only
following antigenic peptide priming; and C044highC0122+ C08 T cells, which are
heterogeneous in terms of antigenic specificity but can contain a fraction of Ag-specific
memory cells (Walzer et aI., 2002). A recent study showed that IL-15 was required for
bystander proliferation induced by IFN, basal homeostatic proliferation, and survival of
C044hlgh C0122+ C08+ cells (Judge et aI. , 2002). Poly I:C treatment of LCMV-immune
mice resulted in a transient increase but no repertoire alteration of LCMV-epitope-
specific C08 T cells. These cells did not produce IFN- in vivo. Examining adoptively
transferred CSFE- Iabeled LCMV-immune donor T cells into Thy-l congenic hosts found
that poly I:C stimulation caused a limited synchronized division of memory C08 T cells
specific to each of five LCMV epitopes, with no increase and sometimes a loss in
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number, and no change in their epitope hierarchy (Kim et aI., 2002). Of note
stimulation of mice with the type- IFN inducer poly I:C induces first apoptosis and a
substantial loss (:: 50%) of memory C08+ T cells. Then, it seems that IL-15 stimulates
the division of the remaining C08+ T cells, such that they restore the C08+ T-cell pool
(McNally et aI. , 2001). Since poly I:C is a potent inducer of type I IFN and IL- 15, type I
IFN and IL- 15 might playa partial role in increasing LCMV-specific C08 T cells upon W
challenge. In the case of heterologous W infection , LCMV-specific memory CD8 T cells
may be induced into cell cycle by IL-15. This is a homeostatic process (Zhang et al.,
1998) that is necessary because of attrition of memory C08 T cells during the early
virus-induced T cell and IFN responses (McNally et aI. , 2001).
However, it is diffcult to exclude a role for TCR triggering in this process. I have
shown that, after poly I:C treatment, there was a slight increase in C069 expression on
the total CD8 T cell population in the LCMV-immune mouse lung. Rapid transient up-
regulation of C069 has been linked to engagement of the TCR on T cells (Testi et a!.
1994). There is one report showing that proliferation of C044 C08+ T cells followed by
injection of poly I:C was not associated with significant up-regulation of C069 or C025
expression, which implies that TCR signaling was not involved (Tough et a!., 
1996).
However, the type I IFN induced by immunostimulatory CpG ONA/OONs (a 
mimic of
microbial DNA and used as an adjuvant for immunization) can induce partial activation
of naive T cells, leading to up-regulation of CD69 and other molecules but no 
entry into
cell cycle (Sun et al., 2000). The receptors for dsRNA (poly I:C) and CpG ONA/OONs,
Toll-like receptor (TLR)- and TLR-9, respectively, on APCs have been found
(Alexopoulou et aI. , 2001; Kaisho et al. , 2001). It is possible that poly I:C itself or
' 1 
- -
.t""!'
""'
174
cytokines induced by poly I:C might activate APCs, whose upregulated MHC-self peptide
complexes could trigger TCRs on T cells, leading to C069 expression, because all TCRs
have some low level of reactivity' against endogenous MHC-self peptide complexes.
Therefore, it is diffcult to exclude a role for TCR triggering following poly I:C treatment.
Nonetheless, cytokines induced by poly I:C alone could only cause transient effect on
C08 T cell responses without proper antigenic stimulation.
IL-12 may playa role in modulation of memory C08 T cells following the
heterologous viral challenge. First, I observed that there was a slight increase in the
frequency of LCMV-specific memory C08 T cells in the IL-12KO LCMV-immune mice.
This might be due to higher antigen load-driven stronger expansion of LCMV-specific
C08 T cells in IL-12KO mice than in normal B6 mice during acute LCMV infection.
Moreover, since IL-12 enhances IFN-y synthesis in activated T and NK cells (Trinchieri
1995), and IFN-y influences the contraction phase after the peak of C08 T cell response
to LCMV (Lohman and Welsh, 1998), the contraction of LCMV-specific C08 T cells after
the peak of the response was slightly impaired in IL-12KO mice, leading to a slight
increase in the frequency of LCMV-specific memory C08 T cells. I also observed that the
GP33-specific memory C08 T cell population was no longer predominant in the MLN of
IL-12KO LCMV-immune mice. This observation may be explained by some report
stating that apoptosis of T cells via the Fas-FasL system can be suppressed by IL-
(Fuss et al. 1999; Li et aI., 2001; Marth et aI., 1999; Neurath et aI., 2001). The
mechanism by which IL- 12 counteracts the Fas pathway is not yet fully understood
although it is known that it does not involve the induction of the anti-apoptotic proteins
Bcl-2 or BcI-xL, and thus may act on mitochondria-independent apoptosis signaling
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events (Neurath et aI. , 2001). Moreover, a lower proportion of pro-apoptotic Annexin-
binding GP33-specific cells was seen than of other specificities (e.g. NP396 and NP205),
particularly in the MLN. This phenomenon might be associated with a Fas-FasL
interaction (Wang, 2002). The above observations suggest that in the MLN of LCMV-
immune IL- 12KO mice, GP-33 specific cells and cells with other specificities undergo
similar levels of apoptosis, given that the repertoire in the resting immune state reflect
the hierarchy of LCMV-specific C08 T cells at the peak of T cell response to acute LCMV
infection. Therefore, GP33-specific cells no longer predominate in the MLN of LCMV-
immune IL-12KO mice.
Secondly, upon W infection, there was an increase in both C069 and C044
expression on the total C08 T cell populations from LCMV-immune IL-12KO mice,
suggesting activation of memory C08 T cells in the absence of IL-12. However, the up-
regulation of C0122 expression on C08 T cells early in W infection was impaired in the
LCMV-immune IL-12KO mice. I postulate that IL-12 might playa role in up-regulation of
C0122 expression on C08 T cells early (day 3) after viral challenge. Since C0122 is
shared by IL-15R and IL- , IL-15 secreted by APCs or IL-2 produced by memory C04
cells early after viral challenge could modulate functions of C08 T cells. Indeed, I found
that W challenge of LCMV-immune IL-12KO mice results in a slightly decreased
accumulation of LCMV-specific C08 T cells 7 days after W challenge. Recently, IL-
has been reporjed to drive memory C08 T cells into homeostatic cell division in vivo
(Kieper et aI. , 2001) and this effect is IFN-y or IL-18-dependent and possibly mediated
by IL-15 signaling (Tough et aI., 2001). Bystander proliferation of memory CD8 T cells
was also observed upon NKT or T cell activation by superantigens, and this process
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could be induced by an IFN- independent, but IL-12- or IFN- dependent pathway
(Eberl et aI., 2000). It is possible that the slightly decreased accumulation of LCMV-
specific C08 T cells in W-challenge of LCMV-immune IL-12KO mice may be due to lack
of IL-12-assisted proliferation of W-activated LCMV-specific memory C08 T cells. Since
IL-12 is not a major growth factor forT cell proliferation (Trinchieri , 1995), the decrease
of LCMV-specific C08 T cells in W-infected LCMV-immune IL-12KO mice was modest.
Thirdly, there was a dramatic reduction of in vivo IFN-y production by LCMV-
specific C08 T cells in the , lung of the W-challenged IL-12KO mice. This suggests, as
would be expected, that IL -12 is important to induce IFN-y production in memory C08 T
cells. It is diffcult to exclude a role for TCR triggering in this process, since I found no
exogenous IL- 12-induced enhancement of IFN-y production by LCMV-specific C08 T
cells from LCMV-immune mice in the absence of any in vitro peptide stimulation in the
hour culture. There is one report showing that bystander activation of C08 T cells by
a combination of IL-12 and IL-18 (in a 48 -hr in vitro culture of splenocyes) contributed
to the rapid production of IFN-y (Lertmemongkolchai et aI., 2001). These authors
concluded that this was TCR-independent, but even here, it is hard to rule out that TCR
engagement by endogenous self-antigens occurs during the 2-day culture process. The
definitive approach to test this hypothesis would be study those two mouse models in
which TCRs can undergo conditional deletion (Labrecque et aI., 2001; Polic et al. , 2001).
The memory"cells from those primed mice can be treated with the inducing agents, and
TCRs on those memory T cells will undergo conditional deletion. Then, the memory T
cells with no TCRs can be examined for IFN-y production in the presence of exogenous
IL- 12 and lor IL-18. Although there was a dramatic reduction of in vivo IFN-
);'
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production by LCMV-specific C08 T cells in the lung of the W-challenged IL-12KO mice
two preliminary experiments showed no decrease in the heterologOl,ls immunity against
Win LCMV- immune IL-12KO mice when compared to normal LCMV-immune mice upon
infection. This result suggests that cytokines other than IL-12 may playa role in the
heterologous immunity against W during the respiratory infection.
Memory T cells express distinctive chemokine receptors and can migrate into
areas of inflammation in a non-specific manner (Kunkel and Butcher, 2002). This non-
specific migration might account for the increase in each LCMV epitope-specific C08 T
cell population early in W infection. Moreover, some cyokines can influence cell
migration by affecting expression of chemokines or chemokine receptors. There is one
study showing a critical role for IL-12 in CCR5 (a chemokine receptor implicated in T cell
migration to inflammatory sites) induction on TCR-triggered mouse C08 T cells (Iwasaki
et al. , 2001). LCMV-specific C08 T cells in W- infected LCMV- immune IL-12KO mice may
not migrate effciently from the secondary lymphoid tissue such as the spleen into the
inflamed lung, hence decrease in their number compared to normal mice. IFN-y is a
cytokine that can participate in inducing chemokines to recruit activated lymphocytes to
the site of inflammation (Mahalingam et aI. , 2000). In my study, the early enhanced
IFN-y production may further recruit activated LCMV-specific memory C08 T cells into
areas of inflammation in a non-specific manner. This increases the probabilty that a
memory T cell , will encounter its up-regulated endogenous or cross-reactive ligands and
become activated with the assistance of cyokines.
Three other cyokines might also potentially playa role in modulation of memory
C08 T cells during the heterologous viral infection. IL -18, originally called IFN- inducing
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factor, exhibits pleiotropic immunomodulatory activities. IL-18 possesses biochemical
similarities to IL-1 and functional similarities to IL-12 (Oinarello, 1999). First, IL-18, in
synergism with IL-12, has been recently reported to drive memory C08 T cells into
homeostatic cell division (Tough et aI., 2001). Secondly, IL-18 mRNA and the precursor
form of its protein are found in normal rat lung and they can be up-regulated in acutely
inflamed lungs (Jordan et al., 2001). IL-18 was showed to be required for optimal IFN-
release in the mouse lung during respiratory viral infection (Xing et aI., 2000). Thirdly,
one recent study showed that the IL-18-elicited anti- effect in the acute phase of
infection of BALB/c mice was mediated by the sum of various host defense mechanisms
including NK cells and CTL (Tanaka-Kataoka M, 1999), and another study showed
selective IL-18 requirements for induction of local IFN-y responses during MCMV
infection (Pien et al., 2000). Therefore, IL-18 may be a good candidate for studying the
role of cytokines in heterologous immunity in the future. In addition, a recently
described IFN- inducing cytokine, IL-23, which is produced by monocyes
/macrophages, acts primarily on memory T cells (Oppmann et al., 2000). Like IFN-
TNF-a is rapidly generated after T cells encounter viral peptides bound to the MHC
(Slifka et aI., 1999). The roles for IL-18, IL-23 and TNF-a in modulation of virus-specific
memory C08 T cells during heterologous viral infections should be investigated in future
studies.
Taken together, the activation and modulation of memory T cells by
heterologous' agents is a very complex issue. It may be that some combination of cross-
reactive memory T cells and the appropriate cytokine environment as well 
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recruitment by chemokines results in activation and modulation of heterologous memory
T cell populations.
Altered pathogenesis to a virus in association with virus-induce
modulation of memory CDS T cells specific for another unrelated virus
The modulations of memory C08 T cells specific for a previously encountered
virus may alter the pathogenesis of unrelated viral infections. These memory CD8 T cells
activated by heterologous viruses may influence viral clearance, cytokine responses and
virus- induced immunopathology. In this thesis, I have shown that memory CD8+ T cells
specific to LCMV were activated in vivo by W to produce IFN-y in the lungs of LCMV-
immune mice as early as 3 days after W challenge. Then, there was a selective
accumulation of these functionally activated LCMV epitope-specific C08 T cells and a
repertoire alteration in the lung. These modulations of LCMV-specific memory C08 T
cells were associated with protection against a lethal W challenge and a decreased 
load throughout the course of the acute W infection. In contrast with the W-infected
control mouse lungs that mainly showed severe edema and acute inflammatory
infiltrates with PMN and MN cells, the W- infected lungs of LCMV-immune mice had an
altered immunopathology, characterized by prominent mononuclear infiltrates and the
accumulation of LCMV-specific memory C08+ T cells in the expanded BAL T. This
contributed to a marked change in the architecture of the lung during W infection of
LCMV-immune. mice. I postulate that the accumulation of LCMV-specific memory C08+ T
cells in the lung may also lead to more rapid viral clearance, thus decreasing the acute
edema and inflammatory infiltration. Since W is sensitive to IFN-y (Muller et aI., 1994),
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elevated levels of IFN-y, which were detected in LCMV- immune mice and enhanced by
IL-12, played an important role in mediating the protective heterologous anti-viral
immunity and altered lung immunopathology. C08 T cells were shown to be a source of
IFN-y, but involvement of C04 T cells is also possible. The previous studies have shown
that protection against W in LCMV-immune mice depends on both C08+ and C04+ T
cells in the systemic infection model (Selin et aI., 1998). Even through NK cells made
IFN-y in response to W infection , they did not contribute to the protective heterologous
immunity against W in LCMV-immune mice. The role of B cells in heterologous antiviral
immunity should be examined in the future.
It was noted that the reduction of W titer in the MLNs was more striking than
the reduction of titer in the lungs of mice adoptively reconstituted with LCMV-
immune splenocyes. There are some possibilities accounting for this result. First, LCMV-
immune splenocyes may home better to lymphoid tissues like lymph nodes than to the
peripheral tissues such as the lung. Generally, via Lv. adoptive transfer, cells isolated
from lymphoid organs home better to lymphoid organs than to the peripheral tissues
(Reinhardt et aI. , 2001; Rodolfo et aI., 1990). A different approach using intratracheal
adoptive transfers of bronchoalveolar lavage (BAL) cells isolated from the Sendai virus-
immune mice into na ive mice observed a significant protection against a challenge with
Sendai virus (Hogan et aI., 2001b). The intratracheal route of cell transfer worked in
that system "because Sendai virus infection induces potent lymphocytic infiltrates in
bronchiolar and alveolar spaces, and thus transferred BAL cells could home effciently
into the lung via the trachea. However, my research system is different from this study
in that LCMV infection induces mainly mononuclear interstitial infiltrates, and
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lymphocytes are seldom seen in airways (Figure 28b). Thus, intratracheal transfer of
LCMV-immune cells isolated from the lung might not provide better protection than i.
adoptive transfer did. Secondly, W is cleared more rapidly in lymphoid tissues (Table 2).
Thirdly, it is easy for a virus to infect permissive bronchiolar and alveolar epithelia cells
and spread infectious viral particles through open air spaces within a short incubation
period (Wright, 1997). During an i.p. infection with 10 PFU W, W is cleared in the
spleen 5 days after infection and in peripheral tissues (fat pads and liver) by day 7
postinfection (Selin et aI. , 2001). In contrast, since W replicated very well in the lung,
the W dose used for Ln. inoculations had to be decreased about 100-fold. The
differences in W titers between the immune group and the control group following Ln.
challenges were also smaller than the ones observed in previous studies with systemic
p. infections (Selin et aI., 1998). Since mice are very sensitive to respiratory W
infection and W replicates very well in the lung, the limited numbers of splenic LCMV-
specific C08 T cells homing to the lung after i.v. adoptive transfer of LCMV-immune
splenocytes may not control W effciently. Nonetheless, adoptive transfer studies
showed that the protective heterologous immunity against acute respiratory infection
with W was dependent on LCMV- immune splenocytes.
Two features of altered immunopathology observed in the lung of W-infected
LCMV- immune mice have significant implications for studying immune responses and
immune-mediated diseases in the human lung. One was the dramatic expansion of
BAL T, implying that an individual's past history of infections may influence whether
there would be an induction of BALT in response to an additional antigenic challenge. In
human and mouse lungs BALT is not a constitutive structure, but BALT can be initiated
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and vigorously expanded upon infection to become a highly integrated mucosal immune
system along the respiratory tract (Pabst, 1992; Tschernig and Pabst, 2000). Another
important feature observed in W-infected LCMV-immune mouse lung was the
development of bronchiolitis obliterans an obstruction of the bronchiole by plugs of
fibrin and inflammatory cells (Schlesinger et al., 1998) in some mice. In humans, the
etiology of this condition is not well understood, and it is thought to be immune-
mediated and to occur in association with viral and intracellular bacterial infections or in
response to some drugs (Schlesinger et aI. , 1998). Bronchiolitis obliterans also remains
the most significant cause of morbidity and mortality following lung transplantation
(McKane et aI., 2001). Acute rejection is the main risk factor for the development of
bronchiolitis obliterans and is characterized by a perivascular/bronchiolar leukocye
infiltration. One recent study showed that recruitment of CXCR3-expressing
mononuclear cells plays an important role in the recruitment of mononuclear cells
(Belperio et al. , 2002). Our mouse model suggests that an individual's past history of
infections may influence whether they develop bronchiolitis obliterans in response to an
additional antigenic challenge. Since there are few mouse models of bronchiolitis
obliterans available, studying this type of model might provide further insights into this
poorly understood condition.
The sequence of infections with different viruses determines the
consequences of antiviral immunity and immunopathology in the lung
The study presented in this thesis also examined what effect, if any, prior
immunity to a virus other than LCMV had on immunity and immunopathology 
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response to a heterologous virus challenge. The study clearly demonstrates that the
specific sequence of heterologous virus infections can alter the course of subsequent
virus infections. First, mice were immunized to three different viruses, LCMV MCMV or
influenza and I examined the impact immunity to each of these viruses had on the
outcome of acute W infection. Second, the mice were immunized with one virus, i.e.
influenza A virus, and I examined the impact of immunity to influenza A virus on the
acute responses to three different viruses LCMV, MCMV and W.
These studies clearly indicate that each individual response to acute W infection
can be strongly influenced by that individual's past history of infections. There were
many common features in the manner in which each of these viruses influenced the
acute W response, but immunity to each different virus also brought unique changes.
Interestingly, immunity to any of the three viruses, LCMV MCMV or influenza A virus
resulted in significantly decreased W titers in the lung compared to a non-immune host.
In LCMV and influenza A virus-immune mice , this protective immunity to was
associated with enhanced T 1 type responses, with increased IFN-y, and suppressed
pro-inflammatory responses, with decreased IL-6 or IL-lf3. A preliminary experiment
also showed that there was no increase in T 2 type cytokines (IL-4 and IL-5) in LCMV-
immune mouse lungs upon W infection. The fact that immunity to any of these three
viruses was protective is most likely due to the fact that W is very sensitive to IFN-
(Muller et aI., 1994). Upon examining the pathology there was a decrease in alveolar
edema in all three groups of mice (Table 21). However, in the W-infected MCMV- and
influenza A virus-immune mice there was a less effect on edema than in LCMV-immune
mice. Prior immunity to anyone of these three viruses did not result in the usual 
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induced acute inflammatory response in the lung, but rather a predominantly
mononuclear infiltrate (Table 21). However, the pattern of the lymphocyic infiltrates
dramatically differed between the groups. In the LCMV-immune mice there was a
pronounced lymphocytic accumulation in the BAL T and around the airways while in
MCMV and influenza A virus-immune mice there was more lymphocytic accumulations
around the vessels. The major difference between influenza A virus-immune and MCMV-
immune mice upon W challenge was the presence of mild residual areas of
consolidation in W-infected influenza A virus- immune mouse lungs and the endothelial
activation in W-infected MCMV-immune mouse lungs. Therefore, immunity to LCMV
MCMV and influenza A virus resulted in enhanced chronic mononuclear infiltrates in the
infected mouse lungs; however, depending on prior immunity to different viruses,
these were distinct patterns of pathology in those mouse lungs as summarized in Table
21.
Immunity to influenza A virus had a significant impact on the outcome of
subsequent acute infections with any of three viruses, W LCMV and MCMV. Although
immunity to influenza A virus resulted in some common features in the subsequent
infection such as enhanced mononuclear infiltrates in the lung and increased early IFN-
production , immunity to influenza A virus had a very different impact on subsequent
infections, depending on the specific virus infection. As noted above, upon heterologous
W challenge, there was the beneficial effect of enhanced W clearance in the lung. This
was associated with an enhanced T Hi type cytokine response with increased IFN-
y and
suppressed pro-inflammatory cytokine responses when compared to the non-immune
control mice. In marked contrast, influenza A virus-immune mice demonstrated
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decreased abilty to clear either MCMV or LCMV. Interestingly, the 
influenza A virus-
immune mice infected with MCMV, had enhanced both T H
i type cyokines such as,
IFN-y and pro-inflammatory cyokines such as IL- lj3, IL-12 and IL-
6. This contrasts with
the cytokine profile induced in W- infected influenza A virus-
immune mice. Upon LCMV
or MCMV infection of influenza A virus- immune mice there was a dramatic enhancement
of the mononuclear infiltration of the lung; which normally 
occurred in mild form in non-
immune lungs (Table 21). MCMV infection pathology differed from 
LCMV induced
pathology in that there was an increase in consolidation 
observed in MCMV-infected
influenza A virus-immune lung. This consolidation was 
composed of dramatically
increased chronic mononuclear infiltrations. It is interesting 
to note that when prior
immunity to influenza A virus further 
enhances what would normally be a mild
lymphocyic response in a MCMV- or LCMV-infected non-
immune host, this enhancement
of the lymphocyic response has a 
detrimental impact on MCMV or LCMVdearance
(Table 21). However, when prior immunity transforms an acute inflammatory 
response
to a predominant lymphocyic response as in 
influenza A virus-, LCMV- or MCMV-
immune mice challenged with W, there is an enhanced clearance of W. Thus, it is clear
that the specific sequence of virus infections controls the 
outcome of disease and
depending on the infection sequence, exposure to 
heterologous viruses can be either
beneficial, resulting in protective immunity or detrimental
, leading to enhanced virus
replicati6h.
Two features of the altered immunopathology 
observed in the lungs of mice with
heterologous viral infections have significant implications for our better 
understanding of
immune-mediated diseases in the human lung. The first 
important feature was the
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dramatic increase in pneumonic consolidation in MCMV-infected influenza A virus-
immune mouse lungs. Viral infection-induced lung consolidation has been mainly seen in
mice with influenza A virus infection and occasionally parainfluenza virus infection
(Yamaguchi et aI. , 1988) and lethal W infections (Smee et aI. , 2001). The consolidation
observed in MCMV-infected influenza A virus-immune mouse lung consisted of chronic
mononuclear infiltration rather than the acute neutrophilc infiltratfon observed during
acute influenza A virus infection. It is possible that an individual's past history of
influenza A virus infections may influence whether they develop more severe chronic
consolidation in response to a future infection with a second pathogen. The second
feature of interest was the enhanced bronchiolization in MCMV-infected influenza A
virus- immune mice. Bronchiolization is a damage-repairing process where the alveolar
walls are lined by cells resembling bronchiolar epithelium. This can be observed after a
variety of insults such as respiratory infection, exposure to chemical irritants, and even
circulatory disturbances involving the lung (Nettesheim and Szakal, 1972). If such
modified alveolar tissues are exposed to carcinogens, bronchiolar carcinoma could
develop (Nettesheim and Szakal, 1972). The influence of pathogenic viruses such as
influenza virus on lung cancers has been indicated (Chang et al.
, 1984; Kotin, 1966;
Nettesheim et aI. , 1971). Our mouse model suggests that an individual's past history of
infections may influence whether they have risk in developing bronchiolar carcinoma in
response to an " additional antigenic challenge especially in the presence of
environmental carcinogens. Studying this type of model might provide further insights
into these conditions.
.:,
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What is the mechanism of heterologous immunity observed in influenza A virus-
immune mice? Since W and MCMV are large viruses and encode about 200
polypeptides, I hypothesize that Wand MCMV might have epitopes cross-reactive with
influenza A virus and those cross-reactive epitopes may stimulate influenza A virus-
specific memory T cells upon W or MCMV infection. Wand MCMV infections also induce
potent cytokine responses such as IL-12 and IFN-y (Biron and Orange, 1995; Cousens
et aI. , 1999; Slezak et al., 2000). In this W- or MCMV-induced cytokine mileu, it is
possible that influenza A virus-specific memory T cells activated by W or MCMV-
encoded cross-reactive epitopes could result in either protective immunity against W or
enhanced MCMV replication. The future studies should be designed to test this
hypothesis.
The enhancement of MCMV and LCMV titers in influenza A virus-immune mice is
an interesting aspect of heterologous immunity. Antibody-mediated immune
enhancement of virus replication, caused by increased uptake of virus through virus-
specific antibody complexes by FcyR+ cells, has b en observed in some viral infections
in humans and animal models (Battegay et aI. , 1993a; Gould et aI. , 1987; Littaua et aI.
1990). The enhanced initiation of viral replication cycles by cyokines such as IL-2 and
TNF-a has also been reported in human HIV infection (Kinter and Fauci
, 1996; Kitaura
et aI. , 2001a; Kitaura et aI. , 2001b). Various cytokines such as TNF-
, IL- , IFN-y, IL-8
and IL- 13 can augment CMV replication in human cells in vitro as well as in rat and
mice in vivo (Haagmans et aI., 1994a; Haagmans et aI., 1994b; Hatch et aI.
, 1997;
Murayama et aI., 1998; Mutimer et aI., 1997; Yerkovich et aI., 1997). In the present
study, the early elevated cyokines such as IFN-y, IL-lj3, and IL-6 may have contributed
-=.
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to the enhanced MCMV replication observed in the lungs of MCMV-infected influenza A
virus- immune mice. Although the mechanisms involved in cytokine-induced increased
MCMV replication are unclear, NF- , which can be activated by pro-inflammatory
cytokines such as IFN-y, IL-1, and TNF-a (Baud and Karin , 2001; Christman et aI.
1998), has been shown to activate the CMV enhancer through a viral transactivator
(Sambucetti et aI. 1989). Furthermore, MCMV replicates in lymphocyes and
macrophages (Pottathil et aI., 1986; Shanley and Pesanti, 1983). It is conceivable that
the massive infiltration with mononuclear lymphocytes and macrophages in MCMV-
infected influenza A virus-immune mice lungs might support enhanced replication of
MCMV.
Currently, there are few report available in terms of enhanced V replication:
High doses of IL-12 inhibit the development ,of LCMV-specific CTL; thus they are
detrimental to resistance against LCMV (Orange et aI., 1994). In future studies
examining the cyokine levels in LCMV-infected influenza A virus-immune mice wil clarify
the role of cyokines in enhancement of LCMV replication by influenza A virus-immunity.
In the current study, the observed enhanced mononuclear infiltrates in the lung of
influenza A virus- immune mice upon LCMV (clone 13) challenge may result in enhanced
LCMV-replication, because clone 13 has an increased abilty to replicate in macrophages
(Matloubian et al. 1993). In order to study the mechanism involved in this
phenomenon, l examined the LCMV-specific C08 cell response in LCMV-infected
influenza A virus-immune mice. The results from the preliminary experiments showed
that the number of LCMV-specific C08 T cells in LCMV-infected influenza A virus-immune
mouse lungs was only half as many as the number of LCMV-specific C08 cells in
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LCMV- infected control mouse lungs. Future studies should further define whether this
altered LCMV-specific C08 T cell response in LCMV-infected influenza A virus-immune
mice contributed to enhancement of LCMV replication and what effector mechanisms
were involved in this process.
Heterologous immunity is a new research area and only a few models have been
studied. In one study, persistent alveolitis, patchy consolidation and collagen deposition
(associated with increased hydroxyproline), upon resolution of virus infection, were
reported in Sendai or influenza A virus-infected mouse lungs (Jakab, 1990). Mice that
were infected with Sendai virus followed 30 days later by influenza A virus infection had
an increase in the persistent alveolitis and hydroxyproline 90 days after the initial
infection. Although the author claimed that Sendai virus infection did not alter the
replication of influenza virus in the lungs during the acute influenza infection stage
there were around 1 IOg10 lower influenza virus titers in the lungs of influenza A virus-
infected Sendai-immune mice than influenza A virus-infected non-immune mice at each
time point they checked. This partial protection is comparable to the heterologous
immunity we define. There is one recent paper reporting the successful heterologous
protection of C57BL/6 mice from a lethal A/HK/156/97 (H5N1) influenza A virus infection
by immunizing first with a serologically distinct H9N2 isolate (O' Neill et al., 2000). This is
another example of so-called anti-influenza A virus heterosubtypic immunity (Liang et
al., 1994), which is consistent with the concept of heterologous immunity. If a pre-
existing pool of memory T cells is activated during infection with a heterologous agent
the T 1 or T 2 bias of the memory response might affect the T l or T 2 bias of the
primary response to the heterologous agent. In a murine model of RSV infection, if mice
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are infected with influenza A virus before the W-RSV immunization and RSV challenge,
the immune response to RSV is altered and the infection resolves quickly without a
strong T 2 response and serious eosinophila (Walzl et al.
, 2000).
The sequence of heterologous virus infections determines the consequences of
antiviral immunity and immunopathology. For example
, studies with systemic Lp.
infections have showed many instances of significant, but not necessarily reciprocal
partial protection. Infection with LCMV, PV or MCMV conferred a considerable level 
protection against infection with W, while W-immune mice did not have resistance to
any of the other viruses (Selin et aI. , 1998). Similarly, LCMV protected against PV better
than PV protected against LCMV (Selin et aI., 1998). The lack of reciprocal protection
might also relate to whether the potentially cross-reactive T-cell epitope is suffciently
dominant to generate a sizeable pool of memory T cells. In this thesis, I also observed
unexpectedly that prior immunity to influenza A virus led to enhanced MCMV and LCMV
replication while immunity to influenza A virus still conferred protection against W. 
that murine mouse of RSV infection, prior exposure to influenza A virus reduced lung
eosinophilia but did not affect RSV viral load in the lung of rW-G-primed mice upon RSV
challenge (Walzl et aI. , 2000).
New aspec of heterologous immunity in mouse and human diseases
The mice ,with heterologous virus infections used in this thesis had only been
previously exposed to a single virus. The one previous exposure enabled us to relatively
easily sort out events occurring during the heterologous viral infection and the possible
roles for the factors contributing to heterologous immunity. Our laboratory s ongoing
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study has been using the mice that have undergone multiple exposures to several
unrelated viruses (with at least 6 week intervals between infections). Those multiple
virus-:immune mice were then challenged with a virus. Distinct patterns were observed
on antiviral immunity against the challenging virus, depending on the history of prior
infections with heterologous viruses (Selin et ai, unpublished data). For example, As
compared to PV challenge of naive mice, immunity to LCMV (single virus-immune) alone
protected mice against PV in the spleen. However, immunity to LCMV+PV (double-
immune) did not protect mice better against PV than did immunity to LCMV alone.
Interestingly, prior immunity LCMV+PV+W (triple-immune) and
LCMV+PV+W+MCMV (four-virus-immune) resulted in further reductions of PV titers
compared immunity LCMV-immune whereas the spleen
LCMV+PV+W+MCMV+V5V- immune mice (five-virus-immune), there was an increase in
PV titers when compared to the mice immune to three and four viruses. Therefore, the
sequence of infections with different viruses determines the consequences of
heterologous immunity. Theoretically, these distinct patterns of heterologous immunity
in mice immune to multiple viruses may be due to continuous dynamic modulation of
the memory T cell pool after each infection.
These observations from experimental models further imply that heterologous
immunity in humans might be the determining factor between a clinical and subclinical
or between a lethal and non- lethal, infection. Many viruses in humans-such as Epstein-
Barr virus (EBV), and varicella-zoster-cause much more severe infections in teenagers
and young adults than they do in younger children (Rickinson and Kieff, 1996; Weinstein
and Meade, 1956). Such a difference could be due to immunopathology occurring as a
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consequence of the reactivation of memory cells
, which may be more diverse and
prominent in a more immunologically mature individual. An example of sequential
infections in humans inducing severe disease is that of dengue hemorrhagic fever
where different strains of dengue virus express distinct neutralizing antibody epitopes
but share highly cross-reactive T cells epitopes (Halstead
, 1988). A potent activation of
memory T cells by heterologous viruses may result in this enhanced 
immunopathology
(Mathew et aI., 1998). Similarly, cross-reactive memory T-cell responses to influenza A
virus variants may also become pathogenic to a human population immune to an
influenza A virus (Dohert et aI.
, 1997; Jameson et al., 1998). Work in our laboratory
has indicated that some T cells that are specific for the HLA-A2-restricted
immunodominant BMLF1 peptide of EBV cross-react with the main HLA-A2-restricted
immunodominant M1 peptide of influenza A virus even though the peptides have only
three amino acids in common. Does such a strong presence of influenza A virus-induced
Ml-specific T cells in the memory T cell pool predispose the host to severe
mononucleosis on EBV infection? Such cross-reactive T cells might also provide
enhanced resistance to infection (Welsh and Selin
, 2002). A cross-reactive epitope
between HCV and influenza A virus was found when individuals that were HCV
seronegative were found to generate a putative 'HCV-specific
' T-cell response
(Wedemeyer et aI.
, 2001), indicating that cross-reactivity may enable a host to
generate memory T-cell pools that are speci
c for a particular pathogen that the host
has never experienced. Such a phenomenon could relate to recent findings of HIV-
specific T cells in HIV-seronegative individuals who show no 
signs of harboring HIV
(Kaul et aI. , 2001). It is possible that these cross-reactive HIV-specific T cells may confer
,,-
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a state of immunity. The field of heterologous immunity is stil very new
, but the more
investigators look, the more examples may be found.
Conclusions
Studying heterologous viral infections inoculated via the i.n. mucosal route, I have
provided insights into a better understanding of virus-induced activation and modulation
of memory C08 T cells specific for a heterologous virus and their association with
heterologous immunity and altered immunopathology in the lung. I have taken
advantage of the LCMV and W, as well as influenza A virus and MCMV systems, and
made several novel observations on heterologous antiviral immunity and
immunopathology:
1. High frequencies of LCMV-specific memory C08 T cells, otherwise quite stable, are
modulated during a respiratory heterologous W infection, resulting in (i) an early
activation in vivo by W to produce IFN-y, (ii) a selective expansion and alteration of
the original LCMV-specific memory C08 T cell repertoire, and (Hi) distinct organ-
dependent redistribution of these LCMV-specific memory T cells.
2. TCR cross-reactivity plays an important role in activation and modulation of LCMV-
specific memory C08 T cells during heterologous W infections.
3. Virus-induced cytokines playa role in the initial recruitment of LCMV-specific memory
C08 T cells during heterologous W infections.
4. These modulations of LCMV-specific memory CD8 T cells are associated with
protection against a lethal W challenge and a decreased W load throughout the
course of the acute W infection. There are altered cyokine profiles and altered lung
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immunopathology characterized by prominent lymphocytic and mononuclear
infiltrates and the accumulation of LCMV-specific memory C08+ T cells in the
expanded BAL 
5. Elevated levels of IFN-y produced by activated LCMV-specific memory CD8 T cells
and enhanced by IL -12 play an important role in mediating the protective
heterologous immunity and altered lung immunopathology in W-infected LCMV-
immune mice.
6. The sequence of infections with different viruses determines the outcomes of
heterologous viral infections. Upon W infection, prior exposure to heterologous
viruses such as LCMV, MCMV and influenza A virus can be beneficial, resulting in (i)
protective immunity against W, (ii) elevated levels of IFN-y but suppressed levels of
IL-6 or IL- lf), and (Hi) increased lymphocyic and mononuclear responses in the lung.
7. Depending on the infection sequence, prior immunity to influenza A virus can be
detrimental , resulting in (i) enhanced MCMV and LCMV replication , (ii) elevated levels
of IFN-y, IL-6, IL-lf), and IL-12 (upon MCMV infection), and (Hi) dramatically
enhanced consolidation with prominent lymphocyic and mononuclear infiltrates in
the MCMV-infected influenza A virus- immune mouse lungs.
8. Bronchiolitis obliterans in W-infected LCMV- immune mouse lung and enhanced
bronchiolization in MCMV- or LCMV-infected influenza A virus-immune mouse lung
may be ed as animal models for related human diseases.
The mechanisms that underline some of these important observations remain to
be identified. However, this thesis provides a foundation for further examining the role
195
of memory C08 T cells in heterologous immunity and immunopathology during
respiratory viral infections.
196
CHAPTER VII
REFERENCES
Ahmed, R. , Butler, L. D. , and Bhatti, L. (1988). T4+ T helper cell function in vivo:
differential requirement for induction of antiviral cyotoxic T-
cell and antibody responses.
J Virol 62, 2102-2106.
Akira, S. (2000). The role of IL-18in innate immunity. Curr Opin Immunol12, 59-63.
Alam , S. M. , and Gascoigne, N. R. (1998). Postranslational regulation of TCR Valpha
allelic exclusion during T cell differentiation. J Immunol16O, 3883-3890.
Alexopoulou, L. , Holt, A. e. , Medzhitov, R. , and Flavell, R. A. (2001). Recognition of
double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413,
732-738.
Altman, J. D., Moss, P. A. H. , Goulder, P. J. R. , Barouch, O. H. , McHeyzer-Williams, M.
, Bell, J. 1. , McMichael, A. J. , and Davis, M. M. (1996). Phenotypic analysis of antigen-
specific T lymphocyes. Science 274, 94-96.
Alwan , W. H. , Kozlowska, W. J. , and Openshaw, P. J. (1994). Distinct types of lung
disease caused by functional subsets of antiviral T cells. J Exp Med 179, 81-89.
Anderson , R. W. , Bennink, J. R. , Yewdell, J. W. , Maloy, W. L. , and Coligan, J. E. (1992).
Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific
cytotoxic T lymphocyes. Mol Immunol 29, 1089-1096.
197
Avery, A. C. , Zhao, Z. S. , Rodriguez, A. , Bikoff, E. K., Soheilian, M. , Foster, e. S. , and
Cantor, H. (1995). Resistance to herpes stromal keratitis conferred by an IgG2a-derived
peptide. Nature 376, 431-434.
Bachmann, M. F. , Barner, M. , Viola, A. , and Kopf, M. (1999). Distinct kinetics of cyokine
production and cyolysis in effector and memory T cells after viral infection. Eur J
Immunol 29, 291-299.
Bachmann, M. F. , and Zinkernagel , R. M. (1996). The influence of virus structure on
antibody responses and virus serotype formation. Immunol Today 17, 553-558.
Badovinac, V. P., Porter, B. B., and Hart, J. T. (2002). Programmed contraction of
C08( +) T cells after infection. Nat Immunol .1 619-626.
Barry, S. M. , Johnson, M. A. , and Janossy, G. (2000). Cytopathology or
immunopathology? The puzzle of cyomegalovirus pneumonitis revisited. Bone Marrow
Transplant 26, 591-597.
Battegay, M. , Bachmann, M. F., Burhkart, C. , Vivile, S. , Benoist, C. , Mathis, D.
Hengartner, H. , and Zinkernagel, R. M. (1996). Antiviral immune responses of mice
lacking MHC class II or its associated invariant chain. Cell Immunol167, 115-121.
Battegay, M. , Kyburz, D. , Hengartner, H. , and Zinkernagel, R. M. (1993a). Enhancement
of disease by neutralizing antiviral antibodies in the absence of primed antiviral 
cyotoxic
T cells. Eur J Immunol 23, 3236-3241.
..'.,',
198
Battegay, M. , Moskophidis, D. , Waldner, H. , Brundler, M. A. , Fung-Leung, W. P. , Mak, T.
, Hengartner, H. , and Zinkernagel , R. M. (1993b). Impairment and delay of
neutralizing antiviral antibody responses by virus-specific cyotoxic T cells. J Immunol
151, 5408-5415.
Baud, V. , and Karin, M. (2001). Signal transduction by tumor necrosis factor and its
relatives. Trends Cell Bioi 11, 372-377.
Belperio, J. A. , Keane, M. P. , Burdick, M. D., Lynch, J. P. , 3rd, Xue, Y. Y., Li, K., Ross, O.
, and Strieter, R. M. (2002). Critical role for CXCR3 chemokine biology in the
pathogenesis of Bronchiolitis obliterans syndrome. J Immunol169
, 1037-1049.
Belz, G. T., and Dohert, P. C. (2001). Virus-specific and bystander C08+ T-cell
proliferation in the acute and persistent phases of a gammaherpesvjrus infection. J Virol
75, 4435-4438.
Belz, G. T. , Xie, W. , Altman , J. D., and Dohert, P. C. (2000). A previously unrecognized
20(b )-restricted peptide prominent in the primary influenza A virus-specific C08( +) T-
cell response is much less apparent following secondary challenge. J Virol 74, 3486-
3493.
Bender, B. S. , Croghan , T. , Zhang, L., and Small, P. A. , Jr. (1992). Transgenic mice
lacking class I major histocompatibilty complex-restricted T cells have delayed viral
clearance and increased mortality after influenza virus challenge. J Exp Med 175, 1143-
1145.
,. "' , .,,
199
Bienenstock, J. , Johnston
, N. , and Perey, O. Y. (1973a). Bronchia/lymphoid tissue. 
Morphologic characteristics. Lab Invest 28, 686-692.
Bienenstock, J. , Johnston, N. and Perey, O. Y. (1973b). Bronchial lymphoid tissue. II.
Functional characterisitics. Lab Invest 28, 693-698.
Binns, R. M. , Licence, S. T. , and Pabst, R. (1992). Homing of blood
, splenic, and lung
emigrant Iymphoblasts: comparison with the behaviour of lymphocyes from 
these
sources. Int Immunol 4, 1011-1019.
Biron, e. A. (1994). Cytokines in the generation of immune responses to
, and resolution
, virus infection. Curr Opin Immunol 6, 530-538.
Biron, e. A. , and Orange, J. S. (1995). IL12 in acute viral infectious disease. Res
Immunol 146, 590-600.
Bot, A., Reichlin, A. , Isobe, H. , Bot, S. , Schulman, J., Yokoyama, W. M. , and Bona, C. A.
(1996). Cellular mechanisms involved in protection and recovery from influenza virus
infection in immunodeficient mice. J Virol 70, 5668-5672.
Bousso, P. , and Kouri/sky, P. (1999). A clonal view of ar3 T cell responses. Semin
Immunol 11, 423-431.
Braciale, T. J. , Andrew, M. E. , and Braciale, V. L. (1981). Simultaneous expression of H-
restricted and alloreactive recognition by a cloned line of influenza virus-specific
cytotoxic T lymphocytes. J Exp Med 153, 1371-1376.
200
Bradley, L. M. , Croft, M. , and Swain , S. L. (1993). T-cell memory: new perspectives.
Immunol Today 14, 197-199.
Bray, M. , Martinez, M. , Smee, O. F. , Kefauver, D. , Thompson, E. , and Huggins, J. W.
(2000). Cidofovir protects mice against lethal aerosol or intranasal cowpox virus
challenge. J Infect Ois 181
, 10-19.
Brehm , M. A., Pinto, A. K. , Daniels, K. A. , Schneck, J. P. , Welsh, R. M. , and Selin, L. K.
(2002). T cell immunodominance and maintenance of memory regulated by
unexpectedly cross-reactive pathogens. Nat Immunol 3, 627-634.
Buchmeier, M. J. , Elder, J. H. , and Oldstone, M. B. (1978). Protein structure of
lymphocyic choriomeningitis virus: identification of the virus structural and cell
associated polypeptides. Virology 89, 133-145.
Bukowski, J. F. , and Welsh, R. M. (1985). Interferon enhances the susceptibilty 
of virus-
infected fibroblasts to cyotoxic T cells. J Exp Med 161 257-262.
Bukowski, J. F. , Woda, B. A. , and Welsh, R. M. (1984). Pathogenesis of murine
cytomegalovirus infection in natural kiler cell-depleted mice. J Virol 52, 119-128.
Burnet FM, F. F. (1949). The production of antibodies. (New York
, Macmilan), pp. 157-
182.
Burrows, S. R. , Khanna, R. , Burrows, J. M. , and Moss, O. J. (1994). An alloresponse in
humans is dominated by cyotoxic T lymphocyes (CTL) cross-reactive with a single
201
Epstein-Barr virus CTL epitope: implications for graft-versus-
host disease. J Exp Med
179, 1155-1161.
':-
Burrows, S. R. , Khanna
, R. , Silins, S. L. , and Moss, O. J. (1999). The influence of
antiviral T-cell responses on the alloreactive repertoire. Immunol Today 
20, 203-207.
---
Butz, E. A, and Bevan
, M. J. (1998). Massive expansion of antigen-specific C08+ T cells
during an acute virus infection. Immunity 8, 167-175.
, Byrne, J. A , and Oldstone, M. B. (1984). Biology of cloned 
cyotoxic T lymphocytes
specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol 51
, 682-
686.
Cao, W. , Henry, M. D. , Borrow, P. , Yamada, H. , Elder, J. H. , Ravkov, E. V., Nichol, S. T.
Compans, R. W. , Campbell, K. P. , and Oldstone, M. B. (1998). Identification of alpha-
dystroglycan as a receptor for lymphocyic choriomeningitis virus and 
Lassa fever virus.
Science 282, 2079-2081.
Cao, W. , Tykodi, S. S. , Esser, M. T. , Braciale, V. L. , and Braciale, T. J. (1995). Partial
activation of C08+ T cells by a self-derived peptide. Nature 378, 295-298.
Carding, S. R. , Allan, W. , Kyes, S. , Hayday, A , Bottomly, K., and Dohert, P. C. (1990).
Late dominance of the inflammatory process in murine influenza by gamma/delta + 
cells. J Exp Med 172, 1225-1231.
Cauley, L. S. , Hogan, R. J. , and Woodland, O. L. (2002). Memory T-cells in non-lymphoid
tissues. Curr Opin Investig Drugs 3, 33-36.
-=,
202
Chang, L. W. , Menna, J. H. , Wang, P. M. , Kalderon, A. E. , Sorenson, J. R. , and
Wennerstrom, O. E. (1984). The potential oncogenic activity of influenza A virus in lungs
of mice. Exp Pathol 25, 223-231.
Cherukuri, A. , Dykstra , M. , and Pierce, S. K. (2001). Floating the raft hypothesis: lipid
raft playa role in immune cell activation. Immunity 14, 657-660.
Christinck, E. R. , Luscher, M. A. , Barber, B. H., and Willams, O. B. (1991). Peptide
binding to class I MHC on living cells and quantitation of complexes required for CTL
lysis. Nature 352, 67-70.
Christman, J. W. , Lancaster, L. H. , and Blackwell, T. S. (1998). Nuclear factor kappa B: a
pivotal role in the systemic inflammatory response syndrome and new target for
therapy. Intensive Care Med 24, 1131-1138.
Clark, 1. A. (2001). Heterologous immunity revisited. Parasitology 122 
Suppl, S51-59.
Clark, I. A. , Allson , A. C. , and Cox, F. E. (1976). Protection of mice against Babesia and
Plasmodium with BCG. Nature 259, 309-311.
Clark, I. A. , Wils, E. J. , Richmond, J. E. , and Allson, A. C. (1977). Suppression of
babesiosis in BCG-infected mice and its correlation with tumor inhibition. Infect Immun
17, 430-438.
Corr, M. , Sianetz, A. E. , Boyd, L. F. , Jelonek, M. T. , Khilko, S. , al-Ramadi
, B. K. , Kim , Y.
, Maher, S. E. , Bothwell, A. L. , and Margulies, O. H. (1994). T cell receptor-MHC class I
peptide interactions: affnity, kinetics
, and specificity. Science 265, 946-949.
'.' . ,
203
r--
Cousens, L. P. , Peterson, R. , Hsu, S. , Dorner, A., Altman, J. D. , Ahmed, R. , and Biron, C.
1'' A. (1999). Two roads diverged: interferon alphajbeta- and interleukin 12-mediated
pathways in promoting T cell interferon gamma responses during viral infection. J Exp
Med 189, 1315- 1328.
Cox, F. E. G. (1970). Protective immunity between malaria parasites and piroplasms in
mice. Bulletin of the World Health Organization 43, 325-336.
Oal Porto, J., Johansen, T. E. , Catipovic, B., Parfit, O. J., Tuveson , D., Gether, U.
Kozlowski, S. , Fearon , O. T., and Schneck, J. P. (1993). A soluble divalent class I major
histocompatibilty complex molecule inhibits alloreactive T cells at nanomolar
concentrations. Proc Natl Acad Sci USA 90, 6671-6675.
Daniel, c. , Horvath , S., and Allen , P. M. (1998). A basis for alloreactivity: MHC helical
residues broaden peptide recognition by the TCR. Immunity 8, 543-552.
Daniels, M. A. , Devine, L., Miller., J. D. , Moser, J. M., Lukacher, A. E. , Altman, J. D.
Kavathas, P., Hogquist, K. A. , and Jameson, S. C. (2001). C08 binding to MHC class I
molecules is influenced by T cell maturation and glycosylation. Immunity 15, 1051-1061.
De St Groth, F. , and Webster, R. (1966). Disquisitions on original antigenic sin. II. Proof
in lower creatures. J Exp Med 124, 347-361.
Oinarello, C. A. (1999) Interleukin-18. Methods 19, 121-132.
Dohert, P. c. , and Ahmed, R. (1997). Immune responses to viral infection. In Viral
pathogenesis, N. Nathanson, Ahmed, R. , Gonzalez-Scarano, F. , Griffn, O. , Holmes
/:' -- 
204
, Murphy, F. , and Robinson, H.L., ed. (Philadelphia, Lippincott-Raven Publishers),
pp. 143-161.
Dohert, P. c. , Allan, W. , Eichelberger, M. , and Carding, S. R. (1992). Roles of alpha
beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol1D, 123-151.
Dohert, P. c. , and Christensen , J. P. (2000). Accessing complexity: the dynamics 
virus-specific T cell responses. Annu Rev Immunol18, 561-592.
Dohert, P. c. , Topham, O. J. , Tripp, R. A. , Cardin, R. D. , Brooks, J. W., and Stevenson,
P. G. (1997). Effector C04+ and C08+ T-cell mechanisms in the control of respiratory
virus infections. Immunol Rev 159, 105-117.
Dohert, P. c. , and Zinkernagel , R. M. (1974). T-cell-mediated immunopathology in viral
infections. Transplant Rev 19, 89-120.
Dutton , R. W. , Bradley, L. M., and Swain, S. L. (1998). T cell memory. Annu Rev
Immunol16, 201-223.
Eberl, G. , Brawand, P. , and MacDonald, H. R. (2000). Selective bystander proliferation of
memory C04+ and C08+ T cells upon NK T or T cell activation. J Immunol165, 4305-
4311.
Ehl, S. , Hombach, J. , Aichele, P. , Hengartner, H. , and Zinkernagel , R. M. (1997).
'-'
Bystander activation of cyotoxic T cells: studies on the mechanism and evaluation of in
vivo significance in a transgenic mouse model. J Exp Med 185, 1241-1251.
205
f1-
Falk, K. , Rotzschke, 0. , Stevanovic, S. , Jung, G., and Rammensee, H. G. (1991). Allele-
specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
Nature 351, 290-296.
Fenner, F. , Henderson , O. A. , Arital, I. , Ladnyi, I. D. , and Jezek, Z. (1988). Smallpox and
Its Eradication (Geneva, World Health Organization).
Fields, B. A. , and Mariuzza, R. A. (1996). Structure and function of the T-cell receptor:
insights from X-ray crystallography. Immunol Today 17, 330-336.
Flynn, K. J., Belz, G. T. , Altman , J. D. , Ahmed, R. , Woodland, O. L., and Dohert, P. C.
(1998). Virus-specific C08+ T cells in primary and secondary influenza pneumonia.
Immunity 8, 683-691.
Flynn, K. J., Riberdy, J. M. , Christensen, J. P. , Altman, J. D. , and Dohert, P. C. (1999).
In vivo proliferation of naive and memory influenza-specific C08( +) T cells. Proc Natl
Acad Sci USA 96, 8597-8602.
Fuss, I. J. , Marth, T. , Neurath, M. F. , Pearlstein, G. R. , Jain , A. , and Strober, W. (1999).
Anti- interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in
mice. Gastroenterology 117, 1078-1088.
Gairin, J. E. , Mazarguil , H. , Hudrisier, D. , and Oldstone, M. B. (1995). Optimal
lymphocyic chori.9meningitis virus sequences restricted by H- 20b major
histocompatibility complex class I molecules and presented to cytotoxic T lymphocyes. J
Virol 69, 2297-2305.
206
Gairin, J. E., and Oldstone, M. B. (1992). Design of high-affnity major histocompatibility
complex-specific antagonist peptides that inhibit 
cyotoxic T-Iymphocyte activity:
implications for control of viral disease. J Virol 66, 6755-6762.
Goldrath, A. W. , Sivakumar, P. V. , Glaccum, M. , Kennedy, M. K. , Bevan, M. J. , Benoist,
c., Mathis, D. , and Butz, E. A. (2002). Cytokine requirements for acute and Basal
homeostatic proliferation of naive and memory C08+ T cells. J Exp Med 195, 1515-
1522.
Gould, E. A. , Buckley, A. , Groeger, B. K. , Cane, P. A., and Ooenhoff, M. (1987). Immune
enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms
involved. J Gen Virol 68 ( pt 12), 3105-3112.
Graham, M. B. , and Braciale, T. J. (1997). Resistance to and recovery from lethal
influenza virus infection in B lymphocye-deficient mice. J Exp Med 186, 2063-2068.
Gray, O. (2002). A role for antigen in the maintenance of immunological memory. Nat
Rev Immunol 2, 60-65.
Grayson , J. M. , Murali-Krishna, K. , Altman, J. D. , and Ahmed , R. (2001). Gene
expression in antigen-specific C08+ T cells during viral infection. J Immunol166, 795-
799.
Greten, T. F. , Siansky, J. E./ Kubota, R. , Soldan, S. S. , Jaffee, E. M. , Leist, T. P., Pardoll,
O. M., Jacobson, S. , and Schneck, J. P. (1998). Direct visualization of antigen-specific T
cells: HTLV- l Taxl1-19- specific C08(+) T cells are activated in peripheral blood and
207
accumulate in cerebrospinal fluid from HAMrrSp patients. Proc 
Natl Acad Sci USA 95,
7568-7573.
Grewal, !. S. , and Flavell , R. A (1998). C040 and C0154 in cell-mediated immunity.
Annu Rev Immuno/l6, 111-135.
Haagmans, B. L. , Stals, F. S. , van der Meide, P. H., Bruggeman, C. A , Horzinek, M. c.
and Schijns, V. E. (1994a). Tumor necrosis factor alpha promotes replication and
pathogenicity of rat cytomegalovirus. J Virol 68, 2297-2304.
Haagmans, B. L., van der Meide
, P. H. , Stals, F. S., van den Eertegh, A. J. , Claassen
E., Bruggeman, C. A. , Horzinek, M. C. , and Schijns, V. E. (1994b). Suppression of rat
cytomegalovirus replication by antibodies against gamma interferon. J Virol 68, 2305-
2312.
Haanen, J. B. , Wolkers, M. c., Kruisbeek, A M. , and Schumacher, T. N. (1999). Selective
expansion of cross- reactive C08( +) memory T cells by viral variants. J Exp Med 190,
1319-1328.
Halstead, E. S. , Mueller, Y. M., Altman, J. D. , and Katsikis, P. O. (2002). In vivo
stimulation of C0137 broadens primary antiviral C08+ T cell responses. Nat Immunol 3,
536-541.
Halstead, S. B. (1988). Pathogenesis of dengue: challenges to molecular biology.
Science 239, 476-481.
208
Halstead, S. B. (1989). Antibody, macrophages
, dengue virus infection, shock, and
hemorrhage: a pathogenetic cascade. Rev Infect 
Ois 11 Suppl4, S830-839.
Harris, N. L. , Watt, V. , Ronchese
, F. , and Le Gros, G. (2002). Differential T cell function
and fate in lymph node and nonlymphoid tissues. J Exp Med 195, 317-326.
Hatch, W. c. , Freedman, A. R. , Boldt-Houle, O. M. , Groopman, J. E. , and Terwillger, E.
F. (1997). Differential effects of interleukin-13 on cytomegalovirus and human
immunodeficiency virus infection in human alveolar macrophages. 
Blood 89, 3443-3450.
Heath, W. R. , Carbone, F. R. , Bertolino, P., Kelly, J., Cose, S., and Miler, J. F. (1995).
Expression of two T cell receptor alpha chains on the surface of normal murine 
T cells.
Eur J Immunol 25, 1617-1623.
Hogan, R. J. , Cauley, L. S., Ely, K. H. , Cookenham, T., Robert, A. D., Brennan, J. W.
Monard, S. , and Woodland, O. L. (2002). Long-term maintenance of virus-specific
effector memory C08( +) T cells in the lung airways depends on proliferation. J Immunol
169, 4976-4981.
Hogan, R. J. , Usherwood, E. J. , Zhong, W. , Robert, A. D. , Dutton, R. W. , Harmsen, A.
, and Woodland, O. L. (2001a). Activated Antigen-Specific C08( +) T Cells Persist in
the Lungs Following Recovery from Respiratory Virus Infections. J Immunol166, 1813-
1822.
r -
-,.
If'
. 
Hogan R. J. , Zhong, W. , USherwood
, E. J. , Cookenham , T., Robert, A. D. , and
Woodland, O. L. (2001b). Protection from respiratory virus infections can be mediated
by antigen-specific C04( +) T cells that persist in the lungs. J Exp Med 193, 981-986.
Holtappels, R. , Pahl-Seibert, M. F. , Thomas, D. , and Reddehase, M. J. (2000a).
Enrichment of immediate-early 1 (m123f-pp89) peptide-specific C08 T cells in a
pulmonary C062L(/0) memory-effector cell pool during latent murine cytomegalovirus
infection of the lungs. J Viroj 74, 11495-11503.
Holtappels, R. , Podlech, J. , Geginat, G. , Steffens, H. P. , Thomas, D. , and Reddehase, M.
J. (1998). Control of murine cytomegalovirus in the lungs: relative but not absolute
immunodominance of the immediate-early 1 nonapeptide during the antiviral cyolytic T-
lymphocye response in pulmonary infiltrates. J Viral 72, 7201-7212.
Holtappels, R. , Podlech, J. , Grzimek, N. K. , Thomas, D. , Pahl-Seibert, M. F. , and
Reddehase, M. J. (2001). Experimental preemptive immunotherapy of murine
cytomegalovirus disease with C08 T'celilines specific for ppM83 and pM84, the two
homologs of human cytomegalovirus tegument protein ppUL83 (pp65). J. Virol 75, 6584-
6600.
Holtappels, R. , Thomas, D. , Podlech, J. , Geginat, G. , Steffens, H. P. , and Reddehase, M.
J. (2000b). The putative natural kiler decoy early gene m04 (gp34) of murine
cytomegalovirus encodes an antigenic peptide recognized by protective antiviral C08 T
cells. J Virol 74, 1871-1884.
209
210
Holtappels, R. , Thomas, D. , Podlech , J. , and Reddehase, M. J. (2002). Two antigenic
peptides from genes m123 and m164 of murine cyomegalovirus quantitatively dominate
C08 T-cell memory in the H-2d haplotype. J Virol 76, 151-164.
Holtappels, R. , Thomas, D. , and Reddehase, M. J. (2000c). Identification of a K(d)-
restricted antigenic peptide encoded by murine cytomegalovirus early gene M84. J Gen
Virol 81, 3037-3042.
Homann, D. , Teyton, L. , and Oldstone, M. B. (2001). Differential regulation of antiviral
T-cell immunity results in stable C08+ but declining C04+ T-cell memory. Nat Med -7
913-919.
Hudrisier, D. , Oldstone, M. B. , and Gairin , J. E. (1997). The signal sequence of
lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope
that is restricted by both H-20(b) and H-2K(b) molecules. Virology 234, 62-73.
Iwasaki, M. , Mukai , T. , Gao, P. , Park, W. R. , Nakajima, c., Tomura , M. , Fujiwara, H.
and Hamaoka , T. (2001). A critical role for IL-12 in CCRS induction on T cell receptor-
triggered mouse C04(+) and C08(+) T cells. Eur J Immunol 31, 2411-2420.
Jakab, G. J. (1990). Sequential virus infections, bacterial superinfections, and
fibrogenesis. Am Rev Respir Ois 142 374-379.
Jakab, G. J. , Astry, C. L. , and Warr, G. A. (1983). Alveolitis induced by influenza virus.
Am Rev Respir Ois 128, 730-739.
::-
211
Jameson , J., Cruz, J. , and Ennis, F. A. (1998). Human cytotoxic T-Iymphocye repertoire
to influenza A viruses. J Viro' 72, 8682-8689.
Jonjic, S. , Mutter, W. , Weiland, F. , Reddehase, M. J. , and Koszinowski, U. H. (1989).
Site-restricted persistent cytomegalovirus infection after selective long-term depletion of
C04+ T lymphocytes. J Exp Med 169, 1199-1212.
Jordan, J. A. , Guo, R. F. , Yun, E. C. , Sarma, V., Warner, R. L. , Crouch, L. D. , Senaldi, G.
Ulich, T. R. , and Ward, P. A. (2001). Role of IL-18 in acute lung inflammation. J
Immunol167, 7060-7068.
Jordan , M. C. (1978). Interstitial pneumonia and subclinical infection after .intranasal
inoculation of murine cyomegalovirus. Infect Immun 21
, 275-280.
Judge, A. D. , Zhang, X., Fujii, H. , Surh, C. D. , and Sprent, J. (2002). Interleukin 15
Controls both Proliferation and Survival of a Subset of Memory-Phenotype C08( +) T
Cells. J Exp Med 196, 935-946.
Kaech , S. M. , and Ahmed, R. (2001). Memory C08+ T cell differentiation: initial antigen
encounter triggers a developmental program in naive cells. Nat Immunol 2, 415-422.
Kaech, S. M. , Wherry, E. J. , and Ahmed , R. (2002). Effector and memory T-cell
differentiation: implications for vaccine development. Nat Rev Immunol 2, 251-262.
Kaisho, T. , Takeuchi, 0. , Kawai, T. , Hoshino, K. , and Akira , S. (2001). Endotoxin-induced
maturation of My088-deficient dendritic cells. J Immunol166, 5688-5694.
212
Kane, L. P., Lin, J. , and Weiss, A. (2000). Signal transduction by the TCR for antigen.
Curr Opin Immunol 12, 242-249.
Kanegane
, H. , and Tosato, G. (1996). Activation of naive and memory T cells by
interleukin-15. Blood 88, 230-235.
Kaul, R. , Dong, T. , Plummer
, F. A. , Kimani
, J. , Rostron , T. , Kiama, P. , Njagi, E./ Irungu
, Farah, B. , Oyugi, J. et aJ. (2001). C08( +) lymphocyes respond to different HIV
epitopes in s ronegative and infected subject. J 
Clin Invest 107, 1303-1310.
Khali, N. , and Greenberg, A. H. (1989). Natural killer cell regulation of murine
embryonic pulmonary fibroblast survival in vivo. Cell Immunol12o, 439-449.
Kieper, W. c., Prlic, M. , Schmidt, C. S. , Mescher, M. F. , and Jameson, S. C. (2001). I'-12
enhances C08 T cell homeostatic expansion. J ImmunOl166, 5515-5521.
Kim, S. K. , Brehm , M. A. , Welsh, R. M. , and Selin, L. K. (2002). Dynamics of memory T
cell proliferation under conditions of heterologous immunity and bystander stimulation. J
Immunol 169, 90-98.
Kinter, A. , and Fauci, A. S. (1996). Interleukin-2 and human immunodeficiency virus
infection: pathogenic mechanisms and potential for immunologic enhancement.
Immunol Res 15, 1- 15.
Kitaura
, H. , Ohara, N. , Kobayashi
, K. , and Yamada, T. (2001a). TNF-alpha-mediated
activation of HIV-l LTR in monocyoid cells by mycobacteria. 
FEMS Immunol Med
Microbiol 31, 97-103.
213
Kitaura, H. , Ohara, N. , KObayashi
, K. , and Yamada , T. (2001b). TNF-alpha-mediated
multiplication of human immunodeficiency virus in chronically infected monocytoid cells
by mycobacterial infection. Apmis 109, 533-540.
Klenerman, P. , and Zinkernagel , R. M. (1998). Original antigenic sin impairs cytotoxic T
lymphocyte responses to viruses bearing variant epitopes. Nature 394, 482-485.
Koszinowski, U. H. , Reddehase
, M. J., Keil, G. M. , Volkmer, H. , Jonjic, S. , Messerle, M.
del Val , M. , Mutter, W. , Munch, K. , and Buhler, B. (1987). Molecular analysis of
herpesvjral gene product recognized by protective cyolytic T lymphocyes. Immunol
Lett 16, 185-192.
Kotin , P. (1966). The influence of pathogenic viruses on cancers induced by inhalation.
Proc Can Cancer Conf 6, 475-498.
Ku, C. C. , Murakami, M. , Sakamoto, A., Kappler, J. , and Marrack, P. (2000). Control of
homeostasis of C08+ memory T cells by opposing cytokines. Science 288, 675-678.
Kulkarni, A. B. , Morse, H. C. d., Bennink, J. R. , Yewdell, J. W. , and Murphy, B. R. (1993).
Immunization of mice with vaccinia virus-M2 recombinant induces epitope- 
specific and
cross-reactive Kd-restricted C08+ cyotoxic T cells. J Virol 67, 4086-4092.
Kunkel , E. J. , and Butcher, E. C. (2002). Chemokines and the tissue-specific migration of
lymphocytes. Immunity 16, 1-4.
T:. - ''':f"
214
Kuwano
, K. , Reyes V. E. , Humphreys
, R. E., and Ennis
, F. A. (1991). Recognition of
disparate HA and NSl peptides by an H-2Kd-
restricted
, influenza specific CTL clone. Mol
Immunol28, 1-7.
Labrecque
, N. , Whitfeld
, L. S. , Obst
, R. , Waltzinger, c. , Benoist
, C. , and Mathis
, D.(2001). How much TCR does a T cell need? Immunity 15, 71-82.
Lanzavecchia
, A , and Sallusto
, F. (2001). Antigen decoding by T lymphocytes: from
synapses to fate determination. Nat Immunol .2 487-492.
Lee, K. H. , Holdorf, A D., Dustin
, M. L. , Chan, A c. , Allen, P. M. , and Shaw
, A. S.(2002). T cell receptor signaling precedes immunological 
synapse formation. Science
295, 1539-1542.
Lehmann-Grube
, F. (1986). Lymphocyic choriomeningitis 
virus. In Infectious Diseases
and Medical Microbiology, A L. Braude
, Davis
, C. , and Fierer
, J. , ed. (Philadelphia
B. Saunders Co.), pp. 1076.
Lehmann-Grube
, F. , Lohler, J. , Utermohlen
, 0. , and Gegin
, C. (1993). Antiviral immune
responses of lymphocyic choriomeningitis virus-infected mice lacking C08+ T
lymphocytes because of disruption of the beta 2-
microglobulin gene. J Virol 67, 332-339.
Leist, T. P. , Kohler, M. , and Zinkernagel
, R. M. (1989). Impaired generation of anti-
viralcytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with
C04-specific monoclonal antibody. Scand J Immunol 
30, 679-686.
rt'
If:,
215
Lemercier, G. , Ponsot, J. F. , Mouretin, G. , Mavet, S. , and Fontanges, R. (1979).
Morphometric study of the bronchopulmonary lymphoid system in the normal mouse
and the mouse infected with influenza virus. Ann Anat Pathol (Paris) 24, 301-304.
Lertmemongkolchai, G. , Cai, G. , Hunter, C. A. , and Bancroft, G. J. (2001). Bystander
activation of C08+ T cells contributes to the rapid production of IFN-gamma in response
~~~\ .
to bacterial pathogens. J Immunol166, 1097-1105.
, W., Lu, L. , Wang, Z. , Wang, L. , Fung, J. J., Thomson , A. W. , and Qian, S. (2001). 11-
12 antagonism enhances apoptotic death of T cells within hepatic allograft from Flt3
ligand-treated donors and promotes graft acceptance. J Immunol166, 5619-5628.
.'.r
Liang, S. , Mozdzanowska, K. , Palladino, G. , and Gerhard, W. (1994). Heterosubtypic
immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J
Immunol 152, 1653-1661.
, M. Y., Selin, L. K. , and Welsh, R. M. (2000). Evolution of the C08 T-cell repertoire
during infections. Microbes Infect 2, 1025-1039.
, M. Y. , and Welsh , R. M. (1998). Stabilty and diversity of T cell receptor repertoire
usage during lymphocyic choriomeningitis virus infection of mice. J Exp Med 188, 1993-
2005.
Littaua, R. , Kur , I., and Ennis, F. A. (1990). Human IgG Fc receptor II mediates
antibody-dependent enhancement of dengue virus infection. J Immunol 144 3183-3186.
1D'-
1'7
!I;
..':'
216
Lohman, B. L. , and Welsh , R. M. (1998). Apoptotic regulation of T cells and absence of
immune deficiency in virus-infected gamma interferon receptor knockout mice. J Virol
=:-
, 7815-7821.
LO?SIi, C. G. , Stinson , S. F., Ryan, O. P. , Herteck, M. S. , Hardy, J. D. , and Serebrin, R.
(1975). The destruction of type 2 pneumocyes by airborne influenza PR8-A virus; its
, ;'
:\1
lie
lit
?..;'- '
effect on surfactant and lecithin content of the pneumonic lesions of mice. Chest 67, 7S-
14S.
Lucin , P. , Pavic, 1., Polic, B. , Jonjic, S. , and Koszinowski , U. H. (1992). Gamma
interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol
66, 1977-1984.
Mackenzie, C. D. , Taylor, P. M. , and Askonas, B. A. (1989). Rapid recovery of lung
histology correlates with clearance of influenza virus by specific C08+ cytotoxic T cells.
Immunology 67, 375-381.
. ,
Mahalingam , S., Foster, P. S. , Lobigs, M. , Farber, J. M. , and Karupiah , G. (2000).
Interferon-inducible chemokines and immunity to poxvirus infections. Immunol Rev 177,
127- 133.
'.
Marrie, T. J. , and Saron , M. F. (1998). Seroprevalence of lymphocyic choriomeningitis
virus in Nova Scotia. Am J Trop Med Hyg 58, 47-49.
';1,
'-'J.
E-,
82,
8'-"
,.-
217
Marshall, O. R., Turner, S. J. , Belz, G. T. , Wingo, S. , Andreansky, S. , Sangster, M. Y.
Riberdy, J. M. , Liu, T. , Tan , M. , and Dohert, P. C. (2001). Measuring the diaspora for
virus-specific C08+ T cells. Proc Natl Acad Sci USA 98, 6313-6318.
Marth , T., Zeitz, M. , Ludviksson, B. R. , Strober, W. , and Kelsall, B. L. (1999). Exinction
of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells. J
Immunol162, 7233-7240.
Martinez Peralta, L. A. , Laguens, M. , Ponzinibbio, c., and Laguens, R. P. (1990).
Infection of guinea pigs with two strains of lymphocyic choriomeningitis virus. Medicina
(B Aires) 50, 225-229.
Mason, O. (1998). A very high level of crossreactivity is an essential feature of the T-
cell receptor. Immunol Today 19, 395-404.
Masopust, D. , Vezys, V. , Marzo, A. L., and Lefrancois, L. (2001). Preferential localization
of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417.
Mathew, A. , Kurane, 1. , Green, S. , Stephens, H. A. , Vaughn, O. W. , Kalayanarooj, S.
Suntayakorn, S., Chandanayingyong, D., Ennis, F. A., and Rothman, A. L. (1998).
Predominance of HLA-restricted cytotoxic T-Iymphocye responses to serotype-cross-
reactive epitopes on nonstructural proteins following natural secondary dengue virus
infection. J Virol 72, 3999-4004.
Matloubian , M"; Kolhekar, S. R., Somasundaram, T. , and Ahmed, R. (1993). Molecular
determinants of macrophage tropism and viral persistence: importance of single amino
218
acid changes in the polymerase and glycoprotein of lymphocyic choriomeningitis virus. J
Virol 67, 7340-7349.
Mattei, F. , Schiavoni , G. , Belardell , F. , and Tough, O. F. (2001). IL-15 is expressed by
dendritic cells in response to type I IFN , double-stranded RNA, or lipopolysaccharide and
promotes dendritic cell activation. J Immunol167, 1179-1187.
McKane, B. W. , Trulock, E. P. , Patterson, G. A., and Mohanakumar, T. (2001). Lung
transplantation and bronchiolitis obliterans: an evolution in understanding. Immunol Res
24, 177-190.
McNally, J. M. , Zarozinski , C. C. , Lin, M. Y. , Brehm, M. A. , Chen , H. D., and Welsh, R. M.
(2001). Attrition of bystander C08 T cells during virus-induced T-cell and interferon
responses. J Virol 75, 5965-5976.
Moser, B. , and Loetscher, P. (2001). Lymphocye traffc control by chemokines. Nat
Immunol 2, 123-128.
Moskophidis, D. , and Kioussis, D. (1998). Contribution of virus-specific C08+ cytotoxic T
cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell
receptor transgenic mouse model. J Exp Med 188, 223-232.
Muller, U. , Steinhoff, U. , Reis, L. F. , Hemmi, S. , Pavlovic, J. , Zinkernagel, R. M.
, and
Aguet, M. (1994). Functional role of type I and type II interferons in antiviral defense.
Science 264, 1918-1921.
Mi'
llli.
219
Murali-Krishna, K., Altman, J. D. , Suresh, M., Sourdive, O. J. , Zajac, A. J. , Miller, J. D.
Slans , J. , and Ahmed , R. (1998). Counting antigen-specific C08 T cells: a reevaluation
of bystander activation during viral infection. Immunity 8, 177-187.
Murali-Krishna, K. , Lau, L. L. , Sambhara, S. , Lemonnier, F. , Altman, J. , and Ahmed , R.
(1999). Persistence of memory C08 T cells in MHC class I-deficient mice. Science 286,
1377- 1381.
Murayama, T. , Mukaida, N. , Khabar, K. S., and Matsushima , K. (1998). Potential
involvement of IL-8 in the pathogenesis of human cyomegalovirus infection. J Leukoc
Bioi 64, 62-67.
Mutimer, O. J. , Shaw, J. , O' Donnell, K., and Elias, E. (1997). Enhanced
(cytomegalovirus) viral replication after transplantation for fulminant hepatic failure.
Liver Transpl Surg 3, 506-512.
Mylin , L. M., Schell, T. D. , Roberts, D. , Epler, M. , Boesteanu , A. , Collins, E. J. , Frelinger
J. A. , Joyce, S. , and Tevethia, S. S. (2000). Quantitation of C08( +) T-Iymphocyte
responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6
mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus
recombinants expressing full-ength T antigen or epitope minigenes. J Virol 74, 6922-
6934.
Nahill, S. R. , and Welsh, R M. (1993). High frequency of cross-reactive cytotoxic T
lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte
response. J Exp Med 177, 317-327.
, ,"" ,.
Ii'
Imf
!!'
i',
-..'=..; (, ,
, t
220
Nathanson, N. , and Tyler, K.L. (1997). Entry, dissemination, shedding, and transmission
of viruses. In Viral Pathogenesis, N. Nathanson, Ahmed, R. , Gonzalez-Scarano, F.,
Griffn, O.E., Holmes, K. , Murphy, F. , and Robinson, H. , ed. (Philadelphia,
Lippincott-Raven), pp. 13-34.
Nelson, D., Strickland, D. , and Holt, p, G. (1990). Selective attrition of non-recirculating
T cells during normal passage through the lung vascular bed. Immunology 69, 476-481.
Nettesheim, P. , Hanna , M. G. , Jr., Dohert, o. G. , Newell , R. F., and Hellman, A. (1971).
Effect of calCium chromate dust, influenza virus, and 100 R whole-body x radiation on
lung tumor incidence in mice. J Natl Cancer Inst 47, 1129-1144.
Nettesheim, P. , and Szakal , A. K. (1972). Morphogenesis of alveolar bronchiolization.
Lab Invest 26, 210-219.
Neurath, M. F. , Finotto, S. , Fuss, 1., Boirivant, M. , Galle, P. R. , and Strober, W. (2001).
Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is
the mucosal question. Trends Immunol 22, 21-26.
Niedbala, W. , Wei , X., and Liew, F. Y. (2002). IL-15 induces type 1 and type 2 C04+
and C08+ T cells proliferation but is unable to drive cytokine production in the absence
ofTCR activation or IL- 12 / IL-4 stimulation in vitro. Eur J Immunol 32 341-347.
Oehen, S., Hengartner, H., and Zinkernagel, R. M. (1991). Vaccination for disease.
Science 251, 195-198.
.. . --_ ,,,, ...
l,,
:, :,, - .
221
!1'
Olson, J. K. , Croxford, J. L. , Calenoff, M. A., Oal Canto, M. c. , and Miller, S. O. (2001). A
virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest lOB, 311-318.
Neill , E., Krauss, S. L., Riberdy, J. M. , Webster, R. G. , and Woodland, O. L. (2000).
Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus
infection in C57BL/6 mice. J Gen Virol , 2689-2696.
Openshaw, P. , Murphy, E. E., Hosken, N. A., Maino, V. , Davis, K. , Murphy, K. , and
Garra , A. (1995). Heterogeneity of intracellular cyokine synthesis at the single-cell
level in polarized T helper 1 and T helper 2 populations. J Exp Med 1B2, 1357-1367.
Oppmann, B., Lesley, R. , Blom, S. , "fmans, J. C., Xu, Y., Hunte, B. , Vega, F. , Yu, N.
Wang, J. , Singh, K. et at. (2000). Novel p19 protein engages IL-12p40 to form a
cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity
, 715-725.
Orange, J. S. , Wolf, S. F., and Biron, C. A. (1994). Effect of IL-12 on the response and
susceptibility to experimental viral infections. J Immunol 152, 1253-1264.
Ostler, T. , Hussell , T. , Surh , C. D. , Openshaw, P., and Ehl , S. (2001). Long-term
persistence and reactivation of T cell memory in the lung of mice infected with
respiratory syncytial virus. Eur J Immunol 31, 2574-2582.
, ;1 Pabst, R. (1990). Compartmentalization and kinetics of lymphoid cells in the lung. Reg
Immunol 3, 62-71.
(",::- ,,. . .
K::
CO-
222
Pabst, R. (1992). Is BALT a major component of the human lung immune system?
Immunol Today 13, 119-122.
iI.
",c
Pabst, R., and Binns, R. M. (1995). Lymphocytes migrate from the bronchoalveolar
space to regional bronchial lymph nodes. Am J Respir Crit Care Med 151, 495-499.
Pabst, R., and Tschernig, T. (1995). Lymphocyes in the lung: an often neglected cell.
Numbers, characterization and compartmentalization. Anat Embryol (Berl) 192, 293-299.
Pien, G. c., Satoskar, A. R. , Takeda, K. , Akira, S. , and Biron, C. A. (2000). Cutting edge:
selective IL -18 requirements for induction of compartmental IFN-gamma responses
during viral infection. J Immunol 165, 4787-4791.
Pihlgren , M. , Dubois, P. M. , Tomkowiak, M., Sjogren , T., and Marvel, J. (1996). Resting
memory C08+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med 184
2141-2151.
Polic, B., Kunkel , D., Scheffold, A. , and Rajewsky, K. (2001). How alpha beta T cells deal
with induced TCR alpha ablation. Proc Natl Acad Sci USA 98, 8744-8749.
Pottathil, R., Pottathil, 1. R., Cheung, K. S. , and Lang, O. J. (1986). Enhanced replication
of murine cyomegalovirus in murine leukemic lymphocyes. Cancer Res 46, 124-126.
Price, O. A. , Klenerman, P. , Booth , B. L., Philips, R. E., and Sewell, A. K. (1999).
Cytotoxic T lymphocytes, chemokines and antiviral immunity. Immunol Today 
20, 212-
216.
""'- . .. ,-,
!\".
1;.
:
223
Quinnan , G. V. , Manischewitz, J. E. , and Ennis, F. A. (1978). Cytotoxic T lymphocye
response to murine cytomegalovirus infection. Nature 273, 541-543.
Rakasz, E. , Mueller, A., Perlman, S. , and Lynch , R. G. (1999). Gammadelta T cell
response induced by vaginal Herpes simplex 2 infection. Immunol Lett 70, 89-93.
Ramshaw, 1. A. , Ramsay, A. J. , Karupiah, G., Rolph, M. S. , Mahalingam , and Ruby, J.
C. (1997). Cytokines and immunity to viral infections. Immunol Rev 159, 119-135.
Razvi, E. S. , Welsh, R. M., and McFarland, H. 1. (1995). In vivo state of antiviral CTL
precursors. Characterization of a cycling cell population containing CTL precursors in
immune mice. J Immunol 154, 620-632.
Reddehase, M. J. (2000). The immunogenicity of human and murine cyomegaloviruses.
Curr Opin Immunol 12, 738.
Reddehase, M. J. , Mutter, W. , Munch , K., Buhring, H. J., and Koszinowski, U. H. (1987).
C08-positive T lymphocytes specific for murine cytomegalovirus immediate-early
antigens mediate protective immunity. J Virol 61, 3102-3108.
Reddehase, M. J., Rothbard, J. B. , and Koszinowski , U. H. (1989). A pentapeptide as
minimal antigenic determinant for MHC class I-restricted T lymphocyes. Nature 337,
651-653.
Reinhardt, R. L., Khoruts, A. , Merica, R. , Zell , T., and Jenkins, M. K. (2001). Visualizing
the generation of memory C04 T cells in the whole body. Nature 
410, 101-105.
.... ''''-'' .
II'
I!,ii-
&,c
224
Reis eSousa , c., Sher, A. , and Kaye, P. (1999). The role of dendritic cells in the
induction and regulation of immunity to microbial infection. Curr Opin 1mmunol 11, 392-
399.
Rhodes, J. , Ivanyi , J., and Cozens, P. (1986). Antigen presentation by human
monocyes: effect of modifying major histocompatibility complex class II antigen
expression and interleukin 1 production by using recombinant interferons and
corticosteroids. Eur J Immunoll6, 370-375.
Rickinson, A. B., and Kieff, E. (1996). Epstein-Barr virus. In Virology, B. N. Fields, O. M.
Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman , and S. S.
Straus, eds. (Philadephia, Lippincott-Raven Publishers), pp. 2397-2446.
Rodolfo, M. , Salvi, c., Bassi, c., Sensi, M. , and Parmiani, G. (1990). Adoptive
immunotherapeutic treatments with interleukin 2 and lymphocytes in a mouse colonic
adenocarcinoma model. Ann 1st Super Sanita 26, 423-432.
Rodriguez, F., Zhang, J. , and Whitton, J. L. (1997). DNA immunization: ubiquitination of
a viral protein enhances cytotoxic T-Iymphocyte induction and antiviral protection but
abrogates antibody induction. J Virol 71, 8497-8503.
Ruby, J. , and Ramshaw, 1. (1991). The antiviral activity of immune C08+ T cells is
dependent on interferon-gamma. Lymphokine Cytokine Res 10, 353-358.
!I.
"!-
225
Sallusto, F. , Lenig, D. , Forster, R. , Lipp, M. , and Lanzavecchia, A. (1999). Two subsets of
memory T lymphocyes with distinct homing potentials and effector functions. Nature
401, 708-712.
Sallusto, F. , Mackay, C. R. , and Lanzavecchia, A. (2000). The role of chemokine
lli
receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18,
593-620.
Salvato, M. , Borrow, P. , Shimomaye, E., and Oldstone, M. B. (1991). Molecular basis of
viral persistence: a single amino acid change in the glycoprotein of lymphocytic
choriomeningitis virus is associated with suppression of the antiviral cyotoxic T-
lymphocyte response and establishment of persistence. J Virol 65, 1863-1869.
Salvato, M. S. , Schweighofer, K. J. , Burns, J. , and Shimomaye, E. M. (1992). Biochemical
and immunological evidence that the 11 kOa zinc-binding protein of lymphocyic
choriomeningitis virus is a structural component of the virus. Virus Res 22, 185- 198.
Salvato, M. S., and Shimomaye, E. M. (1989). The completed sequence of lymphocytic
choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger
protein. Virology 173, 1-10.
Sambucetti , L. c., Cherrington , J. M. , Wilkinson , G. W. , and Mocarski, E. S. (1989). NF-
kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator
and by T cell stimulation. Embo J 8 4251-4258.
226
r--
Scherle, P. A., Palladino, G. , and Gerhard , W. (1992). Mice can recover from pulmonary
inftuenza virus infection in the absence of class I-restricted cyotoxic T cells. J Immunol
148, 212-217.
Schlesinger, c., Meyer, C. A., Veeraraghavan , S., and Koss, M. N. (1998). Constrictive
(obliterative) bronchiolitis: diagnosis, etiology, and a critical review of the literature. Ann
Oiagn Pathol 2, 321-334.
Schluns, K. S., Kieper, W. c., Jameson, S. c., and Lefrancois, L. (2000). Interleukin-
mediates the homeostasis of naive and memory C08 T cells in vivo. Nat Immunol 
426-432.
Schwart, R. H. (1985). T-Iymphocye recognition of antigen in association with gene
products of the major histocompatibilty complex. Annu Rev Immunol 3, 237-261.
Selin, L. K. , Un , M. Y. , Kraemer, K. A. , Pardoll , O. M. , Schneck, J. P. , Varga, S. M.
Santolucito, P. A., Pinto, A. K. , and Welsh , R. M. (1999). Attrition of T cell memory:
selective loss of LCMV epitope-specific memory C08 T cells following infections with
heterologous viruses. Immunity 11, 733-742.
Selin, L. K. , Lin, M. Y. , Varga, S. M. , and Welsh, R. M. (2000). C08 memory to viruses
and the T cell network. In Cytotoxic Cells: Basic mechanisms and medical applications,
M. V. Sitkovs y, and P. A. Henkart, eds. (Philadelphia , Lippincott Wiliams & Wilkins), pp.
327-361.
227
Selin, L. K., Nahill , S. R. , and Welsh, R. M. (1994). Cross-reactivities in memory cytotoxic
T lymphocyte recognition of heterologous viruses. J EXp Med 179, 1933- 1943.
.'I -
Selin , L. K., Santolucito, P. A. , Pinto, A. K. , Szomolanyi-Tsuda, E. , and Welsh , R. M.
(2001). Innate Immunity to Viruses: Control of Vaccinia Virus Infection by gamma/delta
T Cells. J Immunol166, 6784-6794.
Selin , L. K., Varga , S. M. , Wong, I. C., and Welsh , R. M. (1998). Protective heterologous
antiviral immunity and enhanced immunopathogenesis mediated by memory T cell
populations. J Exp Med 188, 1705- 1715.
Selin, L. K. , Vergils, K. , Welsh , R. M. , and Nahil, S. R. (1996). Reduction of otherwise
remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral
infections. J Exp Med 183, 2489-2499.
Selin, L. K. , and Welsh, R. M. (1997). Cyolytically active memory CTL present in
lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J
Immunol 158, 5366-5373.
Shanley, J. D. , and Pesanti , E. L. (1983). Murine peritoneal macrophages support murine
cytomegalovirus replication. Infect Immun 41, 1352- 1359.
Sharpe, A. H. , and Freeman, G. J. (2002). The B7-CD28 superfamily. Nat Rev Immunol
, 116-126.
18'
IlL
228
Sheil, J. M. , Bevan, M. J. , and Lefrancois, L. (1987). Characterization of dual-reactive H-
2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells. J
ImmunoI138 3654-3660.
Shimojo, N. , Maloy, W. L., Anderson, R. W., Biddison, W. E., and Coligan , J. E. (1989).
Specificity of peptide binding by the HLA-A2. 1 molecule. J Immunol143, 2939-2947.
Shortman, K. , Wu, L. , Suss, G. , Kronin, V. , Winkel, K. , Saunders, D. , and Vremec, O.
(1997). Dendritic cells and T lymphocytes: developmental and functional interactions.
Ciba Found Symp 204 130-138; discussion 138-141.
Skinner, P. J. , Daniels, M. A. , Schmidt, C. S. , Jameson, S. c., and Haase, A. T. (2000).
Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol
165, 613-617.
Slezak, K., Guzik, K. , and Rokita , H. (2000). Regulation of interleukin 12 and interleukin
10 expression in vaccinia virus- infected human monocyes and U-937 cell line. Cyokine
, 900-908.
Slifka, M. K. , Matloubian , M. , and Ahmed , R. (1995). Bone marrow is a major site of
long-term antibody production after acute viral infection. J Virol 69, 1895-1902.
Slifka, M. K. , Rodriguez, F. , and Whitton, J. L. (1999). Rapid on/off cycling of cytokine
production by virus-specific C08+ T cells. Nature 
401, 76-79.
229
Small , B. A. , Dressel , S. A. , Lawrence, C. W., Drake, O. R. , 3rd, Stoler, M. H. , Enelow, R.
, and Braciale, T. J. (2001). C08( +) T cell-mediated injury in vivo progresses in the
absence of effector T cells. J Exp Med 194, 1835-1846.
Smee, O. F. , Bailey, K. W. , Wong, M. H. , and Sidwell, R. W. (2001). Effects of cidofovir
on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral Res
, 55-62.
Speir, J. A. , Garcia , K. c., Brunmark, A. , Oegano, M. , Peterson, P. A. , Teyton, L. , and
Wilson , I. A. (1998). Structural basis of 2C TCR allorecognition of H-2Ld peptide
complexes. Immunity 8, 553-562.
Sprent, J. , Zhang, X. , Sun, S. , and Tough, O. (1999). T-cell turnover in vivo and the role
of cytokines. Immunol Lett 65, 21-25.
Spriggs, M. K. , Koller, B. H., Sato, T. , Morrissey, P. J. , Fanslow, W. c. , Smithies, 0.
Voice, R. F. , Widmer, M. B. , and Maliszewski, C. R. (1992). Beta 2-microglobulin-, C08+
T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit
altered IgG responses. Proc Natl Acad Sci USA 89, 6070-6074.
Staczek, J. (1999). Murine cyomegaloviruses. In Encyclopedia of Virology, Granoff, A.
and Webster, R.G. eds. (London, Academic Press), pp. 363-369.
Steffens, H. P., Kurz, S. , Holtappels, R. , and Reddehase, M. J. (1998). Preemptive C08
T-cell immunotherapy of cute cyomegalovirus infection prevents lethal disease, limits
rc:
Ii"
230
the burden of latent viral genomes, and reduces the risk of virus recurrence. J Virol 72,
1797- 1804.
Sun, S., Zhang, X. , Tough , D., and Sprent, J. (2000). Multiple effects of
immunostimulatory DNA on T cells and the role of type I interferons. Springer Semin
Immunopathol 22, 77-84.
Tabi, Z. , Lynch, F. , Ceredig, R. , Allan, J. E., and Dohert, P. C. (1988). Virus-specific
memory T cells are Pgp- 1 + and can be selectively activated with phorbol ester and
calcium ionophore. Cell Immunol113, 268-277.
Tan , J. T. , Ernst, B. , Kieper, W. c., LeRoy, E. , Sprent, J. , and Surh , C. O. (2002).
Interleukin (IL)-15 and IL -7 jointly regulate homeostatic proliferation of memory
phenotype C08+ cells but are not required for memory phenotype C04+ cells. J Exp
Med 195, 1523-1532.
Taswell , C. (1981). Limiting dilution assays for the determination of immunocompetent
cell frequencies. I. Data analysis. J Immunol126, 1614-1619.
Tay, C. H. , Yu, L. Y. , Kumar, V., Mason, L., Ortaldo, J. R. , and Welsh, R. M. (1999). The
role of L Y49 NK cell subsets in the regulation of murine cytomegalovirus infections. J
Immunol 162, 718-726.
Testi, R., D'Ambrosio, D. , De Maria , R., and Santoni , A. (1994). The C069 receptor: a
multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15, 479-483.
231
Thomsen, A. R. , and Marker, O. (1988). The complementary roles of cellular and
humoral immunity in resistance to re-infection with LCM virus. Immunology 65, 9-
15.
Topham, O. J. , Castrucci, M. R. , Wingo, F. S., Belz, G. T. , and Dohert, P. C. (2001). The
role of antigen in the localization of naive, acutely activated, and memory C08( +) T cells
to the lung during influenza pneumonia; J Immunol167, 6983-6990.
Tough, O. F., Borrow, P., and Sprent, J. (1996). Induction of bystander T cell
proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950.
Tough, O. F., Sun, S. , and Sprent, J. (1997). T cell stimulation in vivo by
lipopolysaccharide (LPS). J Exp Med 185, 2089-2094.
Tough, O. F. , Sun , S., Zhang, X., and Sprent, J. (1999). Stimulation of naive and
memory T cells by cyokines. Immunol Rev 
170, 39-47.
Tough, O. F. , Zhang, X., and Sprent, J. (2001). An IFN-gamma-dependent pathway
controls stimulation of memory phenotype C08+ T cell turnover in vivo by IL- , IL-18,
and IFN-gamma. J Immunol 166, 6007-6011.
Townsend, A. R. , Gotch, F. M. , and Davey, J. (1985). Cytotoxic T cells recognize
fragments of the influenza nucleoprotein. Cell 42, 457-467.
Trinchieri, G. (1995). Interleukin-12: a proinflammatory cytokine with immunoregulatory
functions that bridge innate resistance and antigen-specific adaptive 
immunity. Annu
Rev Immunol13, 251-276.
232
Tripp, R. A., Hou, S., McMickle, A. , Houston, J., and Dohert, P. C. (1995a). Recruitment
and proliferatio of CD8+ T cells in respiratory virus infections. J Immunol 154
, 6013-
6021.
Tripp, R. A. , Sarawar, S. R., and Dohert, P. C. (1995b). Characteristics of the influenza
virus-specific C08+ T cell response in mice homozygous for disruption of the H-
2IAb
gene. J Immunol 155, 2955-2959.
Tschernig, T., and Pabst, R. (2000). Bronchus-associated lymphoid tissue (BAL T) is not
present in the normal adult lung but in different diseases. Pathobiology 68, 1-
Tufariello, J., Cho, S., and Horwitz, M. S. (1994). The adenovirus E3 14. kilodalton
protein which inhibits cytolysis by tumor necrosis factor increases the virulence of
vaccinia virus in a murine pneumonia model. J Virol 68 453-
462.
Tuma , R. A., and Pamer, E. G. (2002). Homeostasis of naive, effector and memory C08
T cells. Curr Opin Immunol 14, 348-353.
Turner, S. J., Cross, R. , Xie, W., and Dohert, P. C.(2001). Concurrent naive and
memory C08( +) T cell responses to an influenza A virus. J Immunol 167, 2753-
2758.
Valitutti , S., Muller, S., Cella, M., Padovan, E. , and Lanzavecchia, A. (1995). Serial
triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375, 148-
151.
van der Most, R. G., Murali-Krishna, K. , Whitton, J. L., Oseroff, c., Alexander
, J.
Southwood, S. , Sidney, J., Chesnut, R. W. , Sette, A. , and Ahmed, R. (1998).
233
Identification of Ob- and Kb-restricted subdominant cytotoxic T-cell responses in
lymphocytic choriomeningitis virus-
infected mice. Virology 240, 158-167.
van Stipdonk, M. J. , Lemmens
, E. E. , and Schoenberger, S. P. (2001). Naive CTLs
require a single brief period of antigenic stimulation for clonal 
expansion and
differentiation. Nat Immunol 2, 423-429.
Varga, S. M., Selin, L. K. , and Welsh, R. M. (2001). Independent regulation of
lymphocytic choriomeningitis virus-specific T cell memory pools: relative 
stabilty of C04
memory under conditions of C08 memory T cell loss. J Immunol166, 1554-1561.
Veiga-Fernandes, H. , Walter, U. Bourgeois, , McLean, A. , and Rocha, B. (2000).
Response of naive and memory C08+ T cells to antigen stimulation in vivo. Nat
Immunol 1, 47-53. ,
Viola, A. , and Lanzavecchia, A. (1996). T cell activation determined by T cell receptor
number and tunable thresholds. Science 273, 104-106.
Vitiello, A. , Yuan, L., Chesnut, R. W. , Sidney, J. , Southwood, S. , Farness, P. , Jackson, M.
, Peterson, P. A. , and Sette, A. (1996). Immunodominance analysis of CTL responses
to influenza PR8 virus reveals two new dominant and subdominant Kb-
restricted
epitopes. J Immunol 157, 5555-5562.
Walker, O. H. , and rvurphy, F. A. (1987). Pathology and pathogenesis of arenavirus
infections. Curr Top Microbiol Immunol 133, 89-113.
234
Walzer, T. , Arpin, c., Beloeil, L., and Marvel , J. (2002). Differential in vivo persistence of
two subsets of memory phenotype C08 T cells defined by C044 and C0122 expression
levels. J Immunol168, 2704-2711.
Walzl, G. , Tafuro, S., Moss, P. , Openshaw, P. J. , and Hussell , T. (2000). Influenza virus
lung infection protect from respiratory syncyial virus-induced immunopathology. J Exp
Med 192, 1317-1326.
Wang, Z. X. , M.A. Brehm, H.O. Chen, L.K. Selin , and R.M. Welsh (2002). Virus-specific
C08 T cells in peripheral tissue are more resistant to apoptosis than those in lymphoid
organs. Revising for Immunity.
Webster, R. G. (1999). Influenza viruses. In Encyclopedia of Virology, Granoff, A. and
Webster, R.G. eds. (London, Academic Press), pp. 825-829.
Wedemeyer, H. , Mizukoshi, E. , Davis, A. R. , Bennink, J. R. , and Rehermann , B. (2001).
Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific
cytotoxic T cells. J Virol 75, 11392-11400.
Wehrle, P. F., Posch, J. , Richter, K. H. , and Henderson, O. A. (1970). An airborne
outbreak of smallpox in a German hospital and its significance with respect to other
recent outbreaks in Europe. Bull World Health Organ 43, 669-679.
Weinstein , L., and Meade, R. H. (1956). Respiratory manifestations of chickenpox. Arch
Intern Med 98, 91-99.
235
. \
Wells, M. A., Daniel, S., Ojeu, J. Y., Kiley, S. C. , and Ennis, F. A. (1983). Recovery from
a viral respiratory tract infection. IV. Specificity of protection by cyotoxic T lymphocytes.
J Immunol130, 2908-2914.
Wells, M. A., Ennis, F. A. , and Daniel , S. (1979). Cyotoxic T-cell and antibody responses
to influenza infection of mice. J Gen Virol 43, 685-690.
Welsh , R. M. (2000). Lymphocyic Choriomeningitis Virus as a Model for the Study 
Cellular Immunology. In Effect of Microbes on the Immune System, M. W.
Cunningham, and R. S. Fujinami , eds. (Philadephia, Lippincott William &Wilkins), pp.
289-312.
Welsh, R. M. , Un, M. Y., Lohman , B. L., Varga, S. M., Zarozinski
, C. c., and Selin, L. K.
(1997). Alpha beta and gamma delta T-cell networks and their roles in natural resistance
to viral infections. Immunol Rev 159, 79-93.
Welsh, R. M. , O' Donnell , C. L., Reed, O. J. , and Rother R. P. (1998). Evaluation of the
Galalphal-3Gal epitope as a host modification factor eliciting natural humoral 
immunity
to enveloped viruses. J Virol 72, 4650-4656.
Welsh, R. M. , and Selin, L. K. (2002). No one is naive: the significance of heterologous
T-cell immunity. Nat Rev Immunol 2, 417-426.
Welsh, R. M., and Sen, G. G. (1997). Nonspecific host responses to viral infections. 
Viral Pathogenesis, N. Nathanson Ahmed, R. , Gonzalez-Scarano, F., Griffn, O.
236
Holmes, K. , Murphy, F. , and Robinson, H.L, ed. (Philadephia, Lippincott-Raven), pp.
109-141.
Weninger, W. , Crowley, M. A. , Manjunath, N. , and von Andrian, U. H. (2001). Migratory
properties of naive, effector, and memory C08( +) T cells. J Exp Med 194, 953-966.
Whitton, J. L. , Southern, P. J. , and Oldstone, M. B. (1988). Analyses of the cyotoxic T
lymphocye responses to glycoprotein and nucleoprotein components of lymphocytic
choriomeningitis virus. Virology 162, 321-327.
Wittek, R. (1999). Vaccinia Virus (Poxviridae). In Encyclopedia of Virology, Granoff, A.
and Webster, R. G. eds. (New York, Academic Press), pp. 1865-1872.
Wright, P. F. (1997). Respiratory diseases. In Viral Pathogenesis, N. Nathanson, Ahmed,
, Gonzalez-Scarano, F., Griffn, O. , Holmes, K. , Murphy, F. , and Robinson, H.L
ed. (Philadelphia, Lippincott-Raven), pp. 703-711.
Xing, Z. , Zganiacz, A. , Wang, J. , Oivangahi, M. , and Nawaz, F. (2000). IL-12-
independent Thl-type immune responses to respiratory viral infection: requirement 
IL- 18 for IFN-gamma release in the lung but not for the differentiation of viral-reactive
Th1-type lymphocyes. J Immunol164, 2575-2584.
Yamaguchi, R. , Iwai, H. , and Ueda , K. (1988). Variation of virulence and other
properties amongSendai virus strains. Microbiol Immunol 32, 235-240.
Yang, H. , and Welsh , R. M. (1986). Induction of alloreactive cytotoxic T cells by acute
virus infection of mice. J Immunol136, 1186-1193.
237
Yang, H. Y., Dundon , P. L., Nahill, S. R., and Welsh, R. M. (1989). Virus-
induced
polyclonal cytotoxic T lymphocyte stimulation. J Immunol 142, 1710-
1718.
Yang, H. Y. , Joris, 1., Majno, G. , and Welsh, R. M. (1985). Necrosis of adipose tissue
induced by sequential infections with unrelated viruses. Am J Pathol120, 173-
177.
Yang, J. , Zhu, H. , Murphy, T. L., Ouyang, W. , and Murphy, K. M. (2001). IL-
18-
stimulated GA0045 beta required in cyokine- induced, but not TCR-
induced, IFN-gamma
production. Nat Immunol 2, 157- 164.
Yang, Y., Chang, J. F. , Parnes, J. R., and Fathman, C. G. (1998). T cell receptor (TCR)
engagement leads to activation- induced splicing of tumor necrosis factor (TNF) nuclear
pre-mRNA. J Exp Med 188, 247-254.
Yap, K. L., Braciale, T. J. , and Ada, G. L. (1979). Role of T-cell function in recovery from
murine influenza infection. Cell Immunol 43, 341-
351.
Yerkovich, S. T., Olver, S. D., Lenzo, J. c., Peacock, 
C. D., and Price, P. (1997). The
roles of tumour necrosis factor-alpha , interleukin-1 and interleukin-
12 in murine
cytomegalovirus infection. Immunology 91, 45-52.
Yewdell, J. W., and Bennink, J. R. (1999). Immunodominance in major histocompatibility
complex class I-restricted T lymphocyte responses. Annu 
Rev Immunol 17, 51-88.
Zarozinski , C. c., Fynan, E. F. , Selin, L. K. , Robinson
, H. L., and Welsh, R. M. (1995).
Protective CfL-dependent immunity and enhanced immunopathology in mice immunized
238
by particle bombardment with DNA encoding an internal virion protein. J 
Immunol 154,
4010-4017.
Zarozinski, C. c., and Welsh, R. M. (1997). Minimal bystander activation of C08 T cells
during the virus- induced polyclonal T cell response. J Exp Med 185, 1629-
1639.
Zhang, X., Sun, S. , Hwang, !., Tough, O. F., and Sprent
, J. (1998). Potent and selective
stimulation of memory-phenotype C08+ T cells in vivo by IL-
15. Immunity 8, 591-599.
Zhao, Z. S. , Granucci, F. , Yeh, L., Schaffer, P. A.
, and Cantor, H. (1998). Molecular
mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.
Science 279, 1344-1347.
Zinkernagel, R. M. (1996). Immunology taught by viruses. Science 271
, 173-178.
Zinkernagel , R. M. , Bachmann, M. F., Kundig, T. M.
, Oehen, S. , Pirchet, H., and
Hengartner, H. (1996). On immunological memory. Annu Rev Immunol14
, 333-367.
Zinkernagel , R. M. , and Dohert, P. C. (1974). Restriction of in vitro T cell-mediated
cytotoxicity in lymphocytic choriomeningitis within a syngeneic or 
semiallogeneic system.
Nature 248, 701.,702.
Zinkernagel, R. M. , and Dohert, P. C. (1975). H-2 compatability requirement for T-cell-
mediated lysis of target cells infected with lymphocyic choriomeningitis virus. 
Different
cytotoxic T-cell specificities are associated with structures coded for in H-
2K or H-20. J
Exp Med 141, 1427-1436.
